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In February 1987, responding to the need for a neutral 
forum for the many interest groups concerned about 
agricultural biotechnology, Robert B. Nicholas, Esq., 
McDermott, Will & Emery and Ralph W. F. Hardy, 
President of the Boyce Thompson Institute for Plant 
Research, developed the concept of a university/insti- 
tute consortium concerned with agricultural biotech­
nology for the benefit of all sectors of society. In Janu­
ary 1988, with initial funding from The Joyce Founda­
tion and the United States Department of Agriculture, 
the National Agricultural Biotechnology Council was 
formed representing leading national, not-for-profit 
agricultural research, extension and educational institu­
tions: The Boyce Thompson Institute, Cornell Univer­
sity, Iowa State University and the University of Cali­
fornia at Davis. The Texas A & M University System 
joined in 1989, giving NABC national regional represen­
tation.
At the June 1990 Council meeting it was unanimous­
ly agreed to open NABC membership to other not-for- 
profit agricultural institutions. Purdue University im­
mediately expressed interest and joined. Several other 
institutions across the U S. are currently in the process 
of joining NABC.
The principal objectives of NABC are to:
—identify issues and public policy questions related 
to biotechnology in the food and agricultural indus­
tries.
—provide a vehicle by which institutions can work 
together to think about and handle the complex 
issues surrounding biotechnology and its implica-
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tions for agriculture and agricultural institutions. NABC also strives to 
create a sense of responsibility, individually and collectively.
—gather and disseminate information, analyses and recommendations to 
assist practitioners, researchers, administrators, policy makers and 
other concerned citizens in understanding the many facets to current 
issues and to ensure the effective and safe development of agricultural 
biotechnology for the benefit of society.
—provide a neutral forum for those with differing interests and concerns 
to come together to speak, to listen, to learn, and to participate in 
meaningful dialog.
NABC annual meetings, open to all, address timely national issues in 
areas in which the impact of biotechnology is expected to be high. The first 
two meetings have demonstrated that those responsible for research, de­
velopment and policy decisions in universities, state and federal govern­
ments and the agribusiness community benefit from a broadened under­
standing of the issues and policy questions biotechnology poses. One ma­
jor realization of the Second Annual Meeting was the extent to which all 
parties in the food area have failed to communicate with each other. The 
meeting’s lecture-workshop format allowed a diverse mix of disciplines 
and viewpoints, effectively providing a broad range of learning experiences 
for most participants.
This volume is not a “proceedings” of the Second Annual NABC Meet­
ing, but rather a report communicating the results of the lively workshop 
discussions and the conclusions and recommendations of the meeting to 
those outside the immediate areas of agricultural biotechnology and food 
safety and nutritional quality. Hopefully Parts One and Two will convey 
the flavor of the meeting and provide a synopsis of the issues identified and 
the recommendations generated in each workshop.
For more in-depth and specific information, the reader is referred to the 
plenary addresses (Part Three) and the topical lectures (Part Four). Most 
are papers prepared by the authors for the meeting, although a few papers 
were edited from transcriptions of the actual presentations.
It is hoped that this report will contribute to an increased understand­
ing of the diverse viewpoints involved and provide a foundation for ad­
dressing many of the concerns about agricultural biotechnology, food 
safety, nutritional quality and communication among different groups.

Part One Overview
12 Summary
21 Workshop Recommendations 
27 Robert Barker
Concluding Remarks
11
Summary
NABC/jOYCE FELLOWS 
Candace W. Collmer
Boyce Thompson Institute 
with
Harrison L. Flint
Iowa State University 
Russell C. Parker
U California, Davis
NABC/JOYCE GRADUATE 
FELLOWS 
Cassandra Klotz
U California, Davis 
Johan Swinnen
Cornell University
The second annual meeting of the National Agricultural 
Biotechnology Council (NABC), Agricultural Biotechnol­
ogy, Food Safety and Nutritional Quality for the Consumer, 
was held in June, 1990, co-sponsored by the NABC and 
the Agricultural Research Institute. The selected topic 
was without doubt a timely one. Increasing media atten­
tion given to food safety and food quality has mirrored 
skyrocketing consumer concerns in this area. In the year 
of the first United States approval of a genetically-engi­
neered product for use in food production (a microbially 
produced enzyme for making cheese), the coming of bio­
technology to the food arena has not gone unnoticed. 
One example is the intense public debate that accompa­
nied the introduction of a growth hormone for use in 
milk production. Genetic engineering techniques provi­
ded a plentiful supply of bovine somatotropin (BST), a 
growth hormone that improves efficiency of milk pro­
duction in dairy herds. However, the expressed public 
concern about its use resulted in at least a temporary 
ban in some parts of Europe, and if approved by the Fed­
eral Drug Administration (FDA) it will be initially 
banned in some parts of the United States.
In its 1990 meeting, the NABC continued to provide 
a neutral forum for the expression of diverse viewpoints. 
Here representatives of different interest groups together ex­
plored issues related to applications of biotechnology to food 
quality and food safety, with particular emphasis on consu­
mer perceptions and receptivity. That diverse viewpoints 
were expressed is documented later in this report in the 
invited talks and summary reports from the workshops. 
This opening chapter presents an overview as well as a
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“sense of the body” as a whole that had developed by the closing of the two 
and a half day meeting.
Through the course of the meeting, participants were presented with 
specific examples of numerous potential benefits that applications of the 
“new” biotechnology can bring to food safety and food quality. Biotechno­
logical applications promise a wide range of advances, including leaner 
meat, enhanced flavor, quality, and processing qualities of foods, more ef­
fective monitoring for possible microbial contamination in the current food 
supply, and reduced pesticide usage on food crops. It is noteworthy that 
several promises of the past are now products ready for use in food produc­
tion. The first genetically-engineered, food-grade microbe, a baker's yeast 
with enhanced leavening properties, has just obtained regulatory approval 
in Europe. In addition, the FDA has just approved Chymosin as the first 
product produced by a genetically engineered organism for use in food pro­
duction. According to Susan Harlander, food microbiologist from the Uni­
versity of Minnesota, Chymosin is “nature identical” to the enzyme rennet 
which is isolated from calf stomach, but it is purer, in more consistent sup­
ply, and microbiologically safer (see Harlander, page 145). There is little dis­
agreement that this represents an advance in both the means and the ends 
of the production of enzymes useful in food production. The DNA probe 
technology described by George Parsons, Director of Diagnostics at 
GeneTrak Systems (see Parsons, page 118), with its increased sensitivity, 
detects more quickly and earlier in the production process microbial con­
taminations thereby significantly improving the safety of our food supply.
However, as pointed out repeatedly from the beginning to the end of the 
meeting, some of the first seeds of the new biotechnology are falling on un­
expectedly barren ground. Stated quite simply, society has thus far failed to 
embrace the scientist’s perception of the value of the new biotechnology in 
the food arena. Given the truly powerful potential of biotechnology to ad­
dress important consumer concerns about the food we eat, keynote speaker 
Carol Tucker Foreman, a partner in the consulting firm Foreman and Heide- 
priem, addressed the question on the minds of many meeting participants: 
Why aren't the crowds cheering in the streets? Her answers were thought-pro­
voking, and their themes (lack of trust, value conflicts, unequal distribution 
of benefits and risks, failure to communicate) were reiterated throughout 
the meeting (See Foreman, page 74).
First, public mistrust of scientific advances is rampant, most probably 
having been fueled by past experience, when the Better Living Through Chem­
istry motto of the 1950s saw some products brought to market without ad­
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equate prior evaluation. Accordingly, while the promises of DDT, aerosol 
sprays and nuclear power were acclaimed at the time of their introduction, 
it was only later, and sometimes much later, that negative impacts were 
experienced and belatedly acknowledged. As a result, there exists a public 
concern that biotechnologically-derived food advances also may bring with them 
unannounced environmental or health risks. “Natural” foods sound more ap­
pealing. There is little interest in “new/manufactured” foods unless they 
can be guaranteed to be safe and healthful.
Secondly, there is a public perception that the risks and benefits of the 
new biotechnology may be unequally distributed. In such a view, the pub­
lic bears the (perceived) risks while someone else—the farmers, food pro­
cessors, scientists or biotechnology companies—gain the benefits (prof­
its). Surprising to many participants, “scientists” are now defined as out­
side the group of “concerned citizens”. On some issues related to biotech­
nology there exists a true conflict of values among different interest 
groups. Something that is scientifically sound, and environmentally and 
nutritionally safe, may have social or economic consequences that are un­
acceptable to certain segments of the population. Such is certainly the 
case with the growth hormone BST, once questioned only in terms of milk 
production efficiency, and animal and consumer safety. The BST debate 
now is about social and economic conflict and not about science, although 
the demand for greater and greater proof of safety remains. Yet many par­
ticipants were surprised at the range of values they shared with other participants 
identified as being in a different group.
Third, the public appears to have lost confidence in the governmental 
institutions it once counted on to resolve questions of safety and conflicts 
between scientific, social, and economic viewpoints. The deregulation of 
the Reagan era coupled with the scandals in the Environmental Protection 
Agency (EPA) and other governmental agencies resulted in a loss of faith in 
the government's ability or desire to protect the public’s environment, air, 
or water, and now, its food supply. The 1990s has a concerned citizenry 
that has lost faith in the authority figures it once turned to for information 
and protection. While public confidence is low, Peter Barton Hutt, Esq., a 
partner at Covington and Burling, when reviewing government regula­
tions related to food safety stressed the adequacy of existing laws to cover bio­
technologically-derived foods and food ingredients. (See Hutt, page 154).
Other speakers pointed out that social and demographic issues as well 
as health and fitness concerns are bringing an additional charge to the food 
arena. The aging baby-boomers are becoming more concerned with
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healthy foods and ever increasing numbers of working mothers demand 
both fast but also nutritious foods to accommodate changing family life­
styles. These trends are evident in new food marketing strategies where 
foods for the first time are being differentiated, and successfully marketed, 
on the basis of safety and quality.
However, the current lack of stringent food labeling guidelines, a scien­
tifically undereducated public, and a loss of faith in traditional “experts" 
has resulted in a marketplace that is emotional and highly volatile in terms 
of food issues. Several speakers agreed that the current marketplace is one 
in which “perception has overtaken fact" in regard to food issues. This is 
perhaps best documented by studies which show that the public's ranking of 
various food-related "risks" based on perception of relative danger, is in fact al­
most perfectly inverted in comparison to a ranking based on actual occurrence of 
illness or death and scientifically determined "risk factors" (See Pariza, page 
167). The obvious, imminent danger of such a climate is that decisions 
about product acceptability, and regulations for products derived from bio­
technology could be made based on such misperceptions rather than on sci­
entifically-derived data about product quality and safety. Lester Crawford, 
Director of the Food Safety and Inspection Service, United States Depart­
ment of Agriculture, made clear that safety determinations must be based on 
science, but science open to public scrutiny (See Crawford and Clarke, page 
161).
Over the course of the meeting, it became clear to what a great extent all 
concerned parties in the food arena have failed to talk with each other, much less 
communicate. And perhaps because every person in society deals with food 
on a daily basis, the list of stakeholders or “concerned or involved parties” 
(the scientific community, the government, and the food industry) have 
not only failed to listen to the public but have done a poor job in bringing 
their messages to the citizenry. Not only did scientists and technologists 
come before the public with misperceptions of the general attitude in pre­
sent society towards technology, its products, and the institutions that 
produce and control it, but also their messages were often couched in a 
“hype” that only tended to rouse suspicions. America’s citizenry is not par­
ticularly well-educated scientifically and many have found it difficult to 
understand the science behind the new technologies or simply “tune-out” 
to science. It is not surprising that what is not understood is feared and/ 
or rejected.
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The "hype" needs to he dropped and the whole spectrum of issues related to bio­
technology and food needs to he quietly discussed and carefully evaluated. In or­
der to reach meaningful resolution, all voices must be heard. However, all 
parties must first be “educated” so that a true dialog between all concerned 
parties, including the consumer, is possible. As stated succinctly in closing 
remarks by NABC Council member Robert Barker, Cornell University’s Se­
nior Provost, “All need to speak, all need to listen, all need to learn” (See 
Barker, page 27).
Before dialog can begin, all stakeholders need to understand both terms 
(definitions) and concepts which are currently unfamiliar. For example, 
the consumer and farmer must learn about scientific technologies to join 
the discussion with an equal voice. It also must be recognized that con­
sumer opinions, however, varied, must be treated with respect. At the 
same time, scientists and food producers need to be educated about the re­
lationships between scientific advances and the public interest. They need 
to assess the impact of “unanticipated effects” of biotechnology and be­
come sensitive to the fact that all scientific advances inevitably change so­
ciety. While it appears that the implementation of agricultural biotech­
nology will merely continue the already present trend toward an increas­
ingly technological agricultural system, it does not follow that every new 
technology should be adopted. It is no longer acceptable to assess the ef­
fects of a technology after the fact. Risk assessment, impact assessment and 
public involvement need to he started early in the research process and continued 
through to commercialization.
Covernment regulators also need to be part of these discussions, particularly as 
the parties struggle to resolve the issue of the degree to which regulations, now 
based primarily on science, should be informed by social issues. Farmers, too, 
must come into the dialog. Ann Sorensen, Assistant Director of the Natu­
ral and Environmental Resources Division of the American Federation of 
Farm Bureau, reported on studies that indicated that farmers both need 
and want to interact with consumers to learn what it is they really want 
(See Sorensen, page 103). Thus we return full circle to the need for con­
sumer “education” from which the public can better understand about ag­
ricultural practices and realistic options (for example, limited pesticide us­
age versus blemished fruit) so that valid choices can be made.
The economists and marketing people made it clear that it is no longer 
in question if the consumer will participate in making the choices regard­
ing biotechnology and foods. The consumer has spoken, and will continue
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speak, in the marketplace. It became obvious to those in attendance, that the 
consumer, the farmer, etc. needs to be involved in planning and prioritiz­
ing research related to agricultural biotechnology from the earliest stages.
It is vital to identify the real concerns of each group, the real parties of ac­
tion and find real ways to address concerns. Both the benefits and the risks 
should be discussed and fully assessed. In addition, the consumer needs to 
understand the technical process of risk assessment currently utilized in 
the food industry. And scientists, regulators and others need to understand 
the process of individual and personal risk assessment. Further, all need to 
distinguish from “zero risk” from “acceptable risk”.
One conclusion arising from the NABC meeting is that there exists a 
pressing need for a "mediating organization" both nationally and at local levels 
where issues can be examined from many diverse viewpoints in a neutral 
forum. While “education” of all concerned parties is a prerequisite for such 
a discussion, it should not be expected to eliminate differences in values 
among the different groups. The challenges of structuring such a forum are 
great as some very basic questions at the moment have no answers. For ex­
ample, who can speak for “the consumer”? Who will establish “the facts”? 
Do all professionals have vested interests? Given that the values of govern­
ment regulators, scientists, industry officials, farmers and consumers can 
be very different, is it possible to find shared values common to all?
While the challenge of consensus building among all concerned parties 
is great, the consequences of failing to interact and dialog together may 
even be greater. What could be at stake is the budding agricultural biotech­
nology area in the United States and its potential to benefit all segments of 
society. What is possible is an implementation failure due to a lack of pub­
lic acceptance, not a lack of scientific expertise. The demand for feeding an 
ever increasing world population coupled with ever increasing stresses on 
the environment insures that newly developing agricultural biotechnology 
will be utilized in the world. For example, BST technology was developed 
in the United States but was first used with government approval in Rus­
sia, Czechoslovakia, and our neighbor—Mexico.
Mediating forums are needed where all concerned parties can meet with 
mutual respect and lowered voices to work together. The forums must 
consider issues in addition to safety including economic and social ones. 
Acceptable protocol for evaluation of individual products and processes of agricul­
tural biotechnology need to be developed and periodically revisited. One model 
for such a protocol may be the updated decision tree presented recently by
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the International Food Biotechnology Council (IFBC) and discussed by 
keynote speaker Ian Munro, Director of the Canadian Centre for Toxicol­
ogy, for use in safety evaluation of foods derived using genetic modifica­
tion (see Munro and Hall, page 64). Whole foods, whether biotechnologi- 
cally-derived of not, and complete diets need to be evaluated for safety.
Keynote speaker Foreman made three proposals for increasing public 
trust in the area of food-related biotechnology (see page 74). First she sug­
gested that President Bush state clearly that the first priority of govern­
ment is the health and safety of the American people and that food bio­
technology will continue only if it is deemed safe. Second, regulatory pro­
cedures related to food biotechnology should be changed to support an ac­
tive level of public participation including environmental and consumer 
activists, state and local public officials, and the citizenry at large. Finally, 
she envisioned a mediating institution where the public could watch indi­
vidual scientists and individual proponents of food and environmental 
safety working side by side to find common ground. Such an approach 
powerfully defuses controversy and tacitly invites the public to join the 
search for a workable solution to what then becomes a shared problem.
By the close of the two and a half day meeting, the need for a vehicle(s) 
to foster increased communication about agricultural biotechnology in re­
lation to food safety and nutritional quality was clear. There also surfaced 
a clear need for all concerned parties to better understand the biological, in­
stitutional and social constraints and incentives now facing agricultural 
biotechnology. Exactly how those concerns will be addressed for the ben­
efit of society is possibly the single most important challenge of the 1990s.
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June Fessenden 
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Following the two and a half day meeting, members of 
the NABC Council and Operating Committee, NABC 
Joyce Fellows and Graduate Fellows, AR1 representa­
tives, and workshop chairs and rapporteurs met in two 
post-meeting sessions to consider the many recom­
mendations brought forth from the workshops and to 
develop a follow-up strategy for NABC and its member 
institutions.
Following lively debate, the group collectively de­
veloped the following:
i Individual institutions are in a critical position 
to facilitate the implementation of recommendations 
at the local/institutional level. While the appropriate 
focus for NABC is a national one member institutions 
have state and/or regional orientation.
Z At the national level, the scientific ranking of 
the food risk list—1) Microbial Contamination, 2) Nu­
tritional Imbalance, 3) Environmental Contaminants, 
4) Naturally-occurring Toxicants, 5) Pesticide Resi­
dues, and 6) Food Additives—needs to be evaluated by 
a nationally established group (e.g., National Academy 
of Science) using clearly defined risk criteria to aid in 
establishing research needs and setting priorities in the 
food area with special focus on biotechnology, while 
recognizing these needs and priorities are continuously 
evolving.
3 There is general recognition of the need and 
value of impact assessments when doing science. At 
the institutional level, social and economic impact 
should be integrated into the land-grant research and 
applied development process. Impact assessment is a 
very substantial undertaking. Land-grant institutions 
may need to add specific expertise for socioeconomic
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assessments. NABC can play a role in facilitating this with networking 
among member institutions.
4 There is a need to educate scientists to the value dimension of their 
work, about impact assessment, public responses to biotechnology and 
communication with different groups. Individual institutions are in the 
best position to lead in the education of scientists (public and private), es­
pecially during the graduate and post-doctoral training period. At the na­
tional level, timely discussion and interactions among different groups 
should be encouraged at national professional meetings and special confer­
ences.
5 Public sector research is encouraged in areas of special need where it 
is unlikely others (e.g., industry) will undertake the basic research due to 
the lack of commercial viability. In particular, research is encouraged into 
the use of biotechnology 1) to reduce natural toxins and allergens in foods 
and 2) to create specialty or designed food products for special subpopula­
tions such as those with allergies, or diabetes, or nutritionally-related dis­
orders . Another area identified in need of more research (and funding) is 
nutrient requirements (e.g., ideal fat intake—how much below 30 percent 
should it be?) of different groups in the population (e.g., infants, the eld­
erly).
6 A national study on biotechnology relating to safety and nutritional 
impact of “designer foods” should be commissioned (e.g., a National Re­
search Council study involving the Board on Agriculture and the Food and 
Nutrition Board).
7 AR1 will develop a Points To Consider document for organizing the 
scientific information regarding the safety, nutrition and wholesomeness 
of biotechnologically produced foods and to conceptualize how that infor­
mation can best be shared with the public as well as interested non-govern­
ment agencies.
8 There was consensus that the goal of all should be to promote rea­
soned discourse about agricultural biotechnology in our society among sci­
entists and varied publics recognizing that in a pluralistic democratic soci­
ety consensus is not always achieved.
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Workshop Recommendations
Improving Food Safety Through Biotechnology
Improving Nutritional Quality Through 
Biotechnology
Safety of Biotechnologically-Derived Foods and 
Food Ingredients
Improving Communication on Biotechnology
Following two days of intense discussion and some­
times vigorous disagreement, participants in each 
workshop identified several major issues and key topics 
needing additional research and presented specific re­
commendations to the entire group on the last morning 
of the meeting. There was more consensus generated in 
each workshop than might have been expected given 
the diversity of each group. Many similarities in the 
findings and recommendations can be found in the four 
workshop reports. Summarized here, these reports are 
presented in full in the next section of this publication, 
and represent the major contributions of the NABC 
meeting.
Readers are encouraged to address the issues raised 
and implement those recommendations relevant to 
them.
Improving Food Safety Through Biotechnology
Procedures to detect and identify pathogens at the earliest possible stages 
should continue to be developed.
New and rapid methods are needed for detection and identification of na­
turally-occurring toxicants since the importance and 
significance of these toxicants will increase as the spec­
trum of these toxicologic properties is determined.
Need to support research and development efforts to identify genes that 
regulate and produce naturally-occurring toxicants, 
allergens and antimetabolites. Molecular genetic 
technologies should be applied to reduce or minimize 
risks from these toxicants. There is a need to facilitate 
detection and identification of contaminants by devel­
opment of specific, rapid, sensitive and reproducible 
analytical methods including more efficient, labor-sav­
ing and cost-effective testing procedures.
Carefully monitor and evaluate food plants modified by molecular proce­
dures, as is done in traditional plant breeding, so that 
other properties such as appearance, flavor, texture, 
aroma, keeping quality, nutrient content and toxicity 
are not adversely affected.
The food risk—biotechnology matrix (see workshop report page 36 ) should 
be elaborated further and used to evaluate the efficacy 
biotechnology for reducing each food-related risk.
Development of practical and workable standards is a very important as­
pect of assuring the safety of products derived from bio­
technology.
Consumers should be empowered to participate in the process of biotech­
nology product development through advisory councils 
and committees, national mediation institutes or other 
formal structures.
Well-targeted allocation of resources to research—both in the public and 
private sectors—will provide cost-effective improve­
ments in the safety of the food supply through biotech­
nology.
Commercial adoption and diffusion of biotechnology products will depend 
on the risk assessment process, the promulgation of 
state, federal and scientific standards and how effec­
tively information is shared with the public.
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Improving Nutritional Quality Through Biotechnology
The application of biotechnology for improving nutritional qualify
must be tailored to the specific needs of the target 
population.
Food choices by individuals and households are major factors affecting 
the nutritional quality of diets in the United States
which has an abundant, varied, and a highly nutri­
tious food supply. Inappropriate food choices and li­
mited access caused by lack of economic resources re­
sult in poor quality diets for many people.
There are significant limitations in our understanding of the details of 
the ideal nutritional profile for individuals of differ­
ent ages, gender, health status, economic status, and 
genetic makeup. Biotechnology’s ability to produce 
changes currently exceeds our capacity to predict the 
utility and significance of those changes within our 
diet.
Biotechnology has the ability to affect the nutritional profile of major 
foodstuffs, and thus to improve diets without requir­
ing changes in food choices.
Entrance into the market of biotechnologically-derived food products 
could have a secondary impact on nutritional qual­
ity by affecting dietary choices. The resulting nutri­
tional impact could be positive or negative, depending 
on the overall dietary effect.
Labeling of biotechnologically-derived food products will be an issue of 
considerable public interest. There should be a mecha­
nism (ideally, a national forum) to debate all sides of 
this issue and to recommend a national policy.
Existing regulations appear to be adequate to deal with most issues in­
volving biotechnologically-derived food products and 
related technical changes in food production and 
manufacturing in terms of their impacts on nutri­
tional quality.
High priority should be given to building public knowledge and under­
standing of biotechnology. The public can then make 
informed choices which will ease pressure on regula­
tory and policy agencies.
WORKSHOP RECOMMENDATIONS
Biotechnology offers certain advantages over conventional means of en­
hancing the nutritional qualify of foods. However, 
cost considerations and consumer acceptance of bio- 
technologically-derived foods must be carefully as­
sessed.
Five highest-priority nutritional quality objectives are:
1) Decrease total fat in the diet and improve the fatty 
acid profile of foods.
2) Develop effective nutritional education and con­
sumer information delivery strategies.
3) Identify and characterize unintended/unknown 
nutritional changes that may result from the intro­
duction of biotechnologically-derived foods.
4) Develop specific foods with increased or decreased 
levels of selected nutrients to meet needs of subpopu­
lations with specific nutrient requirements.
5) Decrease anti-nutrient content and increase phy- 
togenic substances of health significance (“protective 
substances”) in foods.
Safety of Biotechnologically-Derived Foods and Food Ingredients
Each food product, whether or not it involves biotechnology, generates 
particular safety questions which must be addressed. 
The scientific and regulatory communities have the capabilities to
evaluate the safety of new food products using ex­
isting procedures.
Data requirements for safety decisions—the concept of a decision tree 
can be used to determine the amount and nature of 
data that should be required to make assessments 
about the human safety of biotechnologically-derived 
foods and food ingredients is endorsed (see workshop 
report, page 53).
Opportunities for involving the public in dialog on food safety issues 
should be encouraged.
Post-approval labeling which would allow consumers to make informed 
decisions needs thorough discussion.
Increased coordination and consistency between federal regulatory agen­
cies is needed and urged.
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Harmonization and coordination of state and federal regulatory pro­
cesses, understanding that harmonization does not 
necessarily imply standardization, should be under­
taken. The federal government should play a leading 
role in those discussions. There should also be move­
ment towards international harmonization of data re­
quirements, safety standards and regulations.
Improving Communication on Biotechnology
Acknowledge the legitimacy of a broad set of values. Concerns about the 
use of biotechnology in food production are not likely 
to be resolved if all but the most “scientific” perspec­
tives are discounted.
Promote conversation with more than one voice. A distinction must be 
made between discussion and monologue.
Discussion about biotechnology is clearly desirable, and should take
place in settings where a broad set of perspectives can 
be aired, considered, and used to guide reasoned hu­
man action.
Work towards a national strategy for biotechnology. A forum at the fed­
eral level should be established and constituted so as 
to be broadly representative of the stakeholders in ag­
ricultural biotechnology.
Promote discussion about agricultural biotechnology at many levels.
Forums for information exchange and discussions 
should be established at the state and local levels. 
Credible regional clearinghouses for information 
about agricultural biotechnology need to be devel­
oped.
Encourage communication between the media and researchers. Take 
steps to train scientists to responsibly handle media 
inquiries, and reciprocally, to provide opportunities 
for journalists to increase their knowledge about agri­
cultural biotechnology. Extension units of land-grant 
universities should be encouraged to further address 
issues related to biotechnology.
Strengthen all citizens' knowledge about the diverse issues related to 
biotechnological innovation. Strengthen the teach­
ing of basic bioscience at all levels, the integration of 
biotechnology into science curricula, and continuing
WORKSHOP RECOMMENDATIONS
education for teachers in the areas related to biotech­
nology.
Acknowledge the importance of effective public relations efforts, but
avoid substituting public relations for other commu­
nications activities. Stakeholders who use public rela­
tions as a tool for shaping public opinion should con­
tinually scrutinize the ethics of their efforts.
Promote care and consistency in terminology. A brief but readable glos­
sary of terms would be a useful companion for future 
meetings, and might also be useful for school teach­
ers, the media and others.
Encourage multidisciplinary research on communications about agricul­
ture-related biotechnology.
Part Two contains the full text of the four workshop reports.
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Concluding Remarks
Robert Barker
Biochemistry, Mole­
cular and Cell Biology 
Member NABC 
Senior Provost 
Cornell University 
443 Day Hall 
Ithaca, NY 14853
Let's briefly consider the title of the conference, Agri­
cultural Biotechnology, Food Safety and Nutritional Quality 
for the Consumer. It is important to realize we are focus­
ing on food safety, nutritional quality and the consumer. 
We can easily lose that focus, even though we are all 
consumers.
One of the reasons for NABC coming into existence 
was a realization that the world in which we do sci­
ence, particularly, but not uniquely, agricultural sci­
ence, is changing. Agricultural science and technology 
is different than it was 10 or 15 years ago. Biotechnol­
ogy in particular seems to be resonating in the public 
mind as very different than other kinds of technolo­
gies. NABC tries to bring together the many constitu­
encies concerned with biotechnology impacts so that 
the issues identified by each can be addressed as we 
have been doing for the last couple of days.
If we look back at the beginning of public aware­
ness of biotechnology, it was born in hype, which is 
not the usual way in which science gets started. The 
majority of the scientists were not responsible for the 
high public relations profile, but there were quite a few 
of our colleagues who really pushed the prospects of 
biotechnology. Wall Street picked it up, and the hype 
increased. There was talk of the 100 billion dollars of 
productivity enhancement that was going to occur. 
Dollar signs were visible in almost everybody’s eyes, 
including those of the biotechnologists. This back­
ground is important to keep in mind as we consider the 
future.
It is also important to note that the public raised a 
lot of questions about biotechnology that had not been
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raised in the same fashion about basic biological sciences before. For those 
of us who have been dealing with the commercialization of biological sys­
tems (I am not speaking just of biotechnology), or with commercial agri­
culture, or food production, etc., many of the questions raised seemed il­
logical. There was even a bit of a wonderment—why are such questions 
being asked now? What is so different about biotechnology?
The people who do science in agriculture quite rightly perceive them­
selves as doing science in the public good. Yet they now find themselves de­
fined out of a part of the discussion; no longer part of that group of con­
cerned citizens in which they previously may have placed themselves. By 
definition, or by difference, agricultural biotechnology scientists are per­
ceived to be in the group that is exploitative and self-interested rather than 
as workers in the public good. That is part of the new framework in which 
we, the people concerned with scientific progress and its application to the 
enhancement of agricultural productivity, must operate.
There are more than scientists and producers involved when dealing 
with the issues that biotechnology raises. This was a major point raised 
at this meeting and one each of us must keep in mind. The consumer, the 
public (consumer and public being interchangeable words here), the regula­
tor, and the legislator are all partners in addressing the issues.
It is quite clear that the sense of this meeting is that dialog is essential, 
and that all parties in the dialog need "education"—need to be informed. 
Dialog is not a matter of “us” educating “them”. No matter who you are, an 
“us" or a “them”, it must be such that ALL people speak, ALL people lis­
ten, and ALL people learn for the dialog to have any value—1) to the par­
ticipants in it, or 2) to those whose lives may be affected by the decisions 
and recommendations that come out of the dialog.
There is a need for a mediating organization, (whether NABC can be 
such an organization is worth talking about, but this should not be a rec­
ommendation of this meeting). However, there is definitely a need for an 
organization which allows the various interested parties (stakeholders) to 
come as co-equals to the dialog—not as invitees coming to be educated by 
the organizers. If we can get into a situation where a true dialog can occur, 
there are some important points to consider:
Who can establish the facts? That may seem like a funny question to 
ask, but it came up at a conference in March at Cornell that had to do with 
multicultural education. There may seem to be no connection between 
that and biotechnology, but one discussion section was about science in re­
lation to multicultural education and different values. An interesting point
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was the disagreement as to what the facts of science might be. Does 2 + 2 
always make four? Establishing the facts of science in these dialogs will be 
quite important. A current example of this need is seen in the bovine soma­
totropin (BST) area, it is important to establish as a fact that most of the 
human race digests BST when consumed in milk or meat—when consum­
ed it is just a readily digestible protein. That may not be the major determi­
nant of acceptance, but it is important to have this digestibility recognized 
as an established fact in order to move on to other considerations of the use 
of BST (i.e., a social impact assessment).
Who can speak for the consumer? In the United States there is a pro­
fession, the members of which represent the interests of the public and the 
consumer; and it is separate from the duly elected representatives and 
their appointees in governmental agencies. This is a very important point 
to recognize as groups who “represent the consumer” are engaged in dialog 
and as they identify issues. What is the role of consumer polls?. The me­
dia? And again, who can be trusted to provide the “right facts” (a redun­
dancy or an oxymoron?) to inform the debate?
Does everyone want to resolve the issues? This point was raised in one 
of the workshops. As you attempt to have a dialog you need to try to be 
sure that those who come to the table are genuinely interested in a resolu­
tion of issues and finding the best of solutions.
Do all professionals have vested interests?, including professionals in 
the areas of consumer or environmental advocacy as well as professionals 
in biotechnology, or in communications, or in marketing or in farming. Do 
they all have vested interests that we need to understand as we get into a 
dialog? If these vested interests never get on the table, the dialog can take a 
very different orientation and have a very different outcome than if all 
vested interests are recognized and understood by all.
Are there shared values among the participants in any dialog? is an­
other important issue raised at this meeting and one which must be con­
sidered as we move ahead in agricultural biotechnology. This question is 
somewhat different than “Are there vested interests?” Are there shared val­
ues? For example, there is the perception that agricultural research in this 
country has been driven by the concept that increased productivity is 
good. That is a value. But others who come to the dialog perceive agricul­
tural research to be driven by a desire to improve the quality of food and 
feed—a different value. It is important to know where those differences 
are and where the agreements are.
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Who can communicate and how to communicate are both important 
issues. It is important in a dialog that individuals are seen as coming to it 
openly and that the outcomes are going to be arrived at fairly. So we need 
to understand better how communication occurs and how people can 
work toward shared outcomes. We need to learn how to dialog.
Who can evaluate the possible outcomes of biotechnology ? The con­
sequences of what a technology is and how it is used? All who are en­
gaged in applying or assessing biotechnology in agriculture need to consi­
der the potentials for unanticipated outcomes from biotechnology. It 
would be wise, perhaps, to think about everything we do in our life that 
way, but it is worth stating again here. A real concern that has been raised 
by both consumers and scientists is whether biotechnology’s outcomes 
will be unanticipated and dreadful. Scientists in particular must recognize 
that scientific advances do change society and learn to consider outcomes 
of their science as part of doing sciences; particularly those that generally 
might be unanticipated.
Even relatively small scientific advances that most people would con­
sider not just benign but actually great improvements, do change society. 
The concern for what those changes are and whether they are for the best 
has increased. As an example (which I always present with a little hesita­
tion), the human race did not hesitate to use porcine insulin to affect the 
consequences of diabetes. Yet the consequences of the development of in­
sulin and its widespread application to control diabetes, in the long term 
may have a fairly significant impact on the gene pool in the human race. I 
am not suggesting that we should have made a different decision, but we 
should understand that there were effects, perhaps unanticipated, that ex­
tend well beyond those on the individual treated with insulin.
Even the development of a diagnostic technique could have a social con­
sequence. A diagnostic technique that determines whether or not a plant 
contains a pathogen eventually may change the economic viability of one 
farm versus another. That does not mean you do not do the science, but we 
(speaking of the agricultural colleges and the agricultural experiment sta­
tions) have to understand those potential changes and evaluate them as we 
do the research.
Biotechnology will continue to change agriculture. We must continue 
to study the changes that have occurred and that are continuously occur­
ring and try to anticipate events that may accelerate change. In particular, 
we have to anticipate the ways in which biotechnology may accelerate 
changes across the entire agricultural spectrum from field to supermarket.
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The potential benefits of agricultural biotechnology to the consumer 
are enormous. An important point to keep in mind as we talk about the 
downsides, the possible hazards and the risks, is that the benefits are enor­
mous. In the areas of food safety alone there will be major positive conse­
quences for the consumer—fewer food contaminants, improved foods for 
special populations, improved workplace safety, and the elimination of 
many plant and animal diseases—to name but a few.
There is a difference in perception among stakeholders as to whether 
enhanced productivity is a good consequence of biotechnology. Agricultu­
ral scientists are enhancing productivity in this country; often in commod­
ity areas such as milk where there is already a surplus. The public wrestles 
with the issue of why should we be doing that? And the intersection be­
tween science and the politics of subsidy is real, but it is far from clear that 
it is understood or used in making policy.
Risks and benefits are not equally distributed. Risks and benefits, 
both real and perceived, are not only terms which have different meanings 
to different people, but all too often the risks and the benefits flow to dif­
ferent parties. It is important that assessments of risks and benefits pre­
cede technological development and commercialization and be made 
known to those potentially affected. That has been stated often at this 
meeting and to the extent it can be done, it should be done.
Agricultural Experiment Stations, Colleges of Agriculture and the 
USDA have a particular role to play here. Some biotechnological innova­
tions have been assessed, not always successfully, but there have been at­
tempts and there should be more, to make assessments of what may hap­
pen if a new technology is put into practice. To go back to a point made at 
the beginning of the report—the way, the place, and by whom that assess­
ment is done, with all stakeholders involved, might be a role of the mediat­
ing organization 1 recommended earlier.
To return to the point of risks and benefits, a point that is important for 
those of us who come to these issues from a scientific background is that 
we understand and deal with risks in a technical, probabilistic sense, while 
the public generally does not. They deal with risk in a personal sense.
When asking about risk, what the public really wants are assurances of 
safety. This is not just a semantic problem, it is a real problem. Can scien­
tists and technologists find a way to convey to the public what they 
would call “risk” and what the public would understand as a measure of 
safety?
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United States’ society has a zero-risk, absolute-safety expectation. For 
example, in the food area there is a regulation, the Delaney Clause, which 
requires that food additives or ingredients, if they can cause cancer at any 
level tested in an animal, not be added to food. The fact that almost all 
foodstuffs are replete with natural carcinogens has no political signifi­
cance. It is in this context that any new biotechnological, or any other kind 
of technological development is considered.
Regulations are the vehicle by which society says what can or cannot 
be done, and when it can be done. There is a need to resolve the issue of 
the degree to which regulations are, or should be, informed by scientific 
and social considerations. Especially in areas of food quality and food safe­
ty regulation.
There is also a need to understand why concerns about food hazards 
are inverted when considering the view of scientists/experts or the pub­
lic view. If we could understand the differences in concern about real ver­
sus perceived food hazards, we would learn a lot about how to communi­
cate effectively in the future about potential risks and hazards.
The public trust in science, in the “Better Living Through Chemistry” 
approach to the world, as it has in all authorities, has eroded. There is a 
consumer interest in “natural” things in which greater trust is placed. One 
of the problems facing biotechnology in the food industry is that when 
“bio” and “technology" and “food" are linked, it sounds like someone is 
messing with Mother Nature, and messing with what should be, in the 
public’s view, the most natural thing in the world—Their Food.
To return to a point made before—that is, that the values of the in­
formed groups—the scientists, the producers, the regulators—differ from 
those of the public. Scientists have to accept that and understand that 
moving ahead in agricultural technology with the help of biotechnology, is go­
ing to increasingly require scientists to be responsive to the public view, 
and to understand what values they bring to the dialog. Although the 
point was made earlier, it is worth repeating. The public is diverse. That is 
a very important point. It is extraordinarily diverse, but so are the other 
players—scientists, producers, regulators, etc. Although perhaps they are 
not as diverse in their views and values as the public. Nevertheless, they 
do differ and it is important to understand that those differences exist.
The public's failure to embrace the scientist's view of the benefits of 
biotechnology came as a surprise to most scientists. Perhaps a few of the 
reasons why this might have occurred is that biotechnology, as I said ear­
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lier, was born amid a certain level of hype. Scientists engaged in biological 
research saw biotechnology as a very natural and gradual outcome of ear­
lier work in biochemistry, microbiology and genetics. They did not antici­
pate either the degree to which it would become a public issue or the nega­
tive response of some of the public to it. But again, in understanding how 
to communicate effectively, scientists need to better understand why pub­
lic concern has been so strongly expressed.
The public also is skeptical of regulatory agencies and of their commit­
ment to the public good. That also was a surprise to many regulators who 
have traditionally thought of themselves (in my view quite correctly) as 
servants of the public good and who find that the public is not necessarily 
seeing them that way anymore. Regulators and others need to understand 
why that happened.
Another point—when a technology (or a biotechnology) fails to get im­
plemented, mostly it is not due to the technology being faulty in a techni­
cal sense, but rather due to a lack of public acceptance and failure to mar­
ket (i.e., properly prepare for public acceptance).
The public needs to be involved in planning and prioritizing research 
as welt as in ensuring that appropriate information is made available. 
Maybe the latter is more important than the former. I would point out 
that the public is involved through its legislators and other elected officials 
in deciding what research will get priority (i.e., public funding). But again, 
that segment of the “public” which does not see itself fully reflected in 
what legislators and other public agencies do, has to be considered as well 
as that part of the “public” which does. All stakeholders must be part of 
the dialog.
Who can represent the public in any dialog?, is really a very important 
question to be addressed. Also it seems necessary to understand more fully 
why many, if not most, public agencies especially at the federal level, are 
not perceived as providing adequate protection of the public interest.
Existing standards and regulations are adequate to provide protec­
tion with respect to safety and nutritional value of foods. There will be a 
need to modify or create new regulations as the world changes. Still, the 
established modes of changing or creating new regulations are adequate to 
produce good and effective regulations and guidelines; they just need to 
be better coordinated and, perhaps, more generally understood.
There is a need to develop protocols for decision-making as has been 
suggested in the workshops, that are arrived at with consideration of
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the different values of different constituencies. Decision trees or proto­
cols that are subject to full scrutiny and revisited regularly, can assure the 
public that the best possible decisions about risks and benefits are being 
made.
One final point—the impact of biotechnology, and 1 would broaden it 
to include all future technological developments in agriculture (but bio­
technology may lead the way), on the traditional structures of research 
and development in agriculture—the Agricultural Experiment Sta­
tions, the Colleges of Agriculture, the USDA, the regional laboratories 
etc., is likely to be very significant. The relationships between producers 
of biotechnological products, researchers, the public, the state and public 
agencies are changing. I urge those of you who direct Agricultural Experi­
ment Stations, (and I wish there were more of you here), to consider that 
impact. It is an issue deserving consideration. And to keep thinking about 
it and keep working on it because it would not be in the public good, if 
the Agricultural Experiment Stations' role in public service is lost be­
cause they lost the public trust.
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Improving Food Safety Through Biotechnology
The workshop met to discuss the complex issues re­
lated to the influence of biotechnology on food 
safety. The twenty-four workshop participants, who 
represented a broad spectrum of interests, disciplines 
and organizations began their deliberations by identi­
fying a long list of important issues.
After considerable discussion of the issues and the 
direction the workshop would pursue, a matrix that 
incorporated the major food-related risks and ways 
that they can be reduced through biotechnology was 
suggested.
chairs:
Robert B. Gravani
Food Science 
Cornell University 
L.J. "Bees" Butler
Agricultural Economics 
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A matrix for relating food risks to biotechnology
select one item from each box
risk
assessment ^
detection
identification
reduction
minimization
source of
risk ^
pathogenic 
microorganisms 
nutritional concerns 
naturally occurring 
toxicants 
pesticide residues 
food additives
product 
of interest ^
plant
animal
microbial
biomolecular
levels of the 
food system
production
processing
distribution
For example:
Would it be productive to do biotechnology research on the 
detection of naturally occurring
toxicants in plants at the processing
stagei
rapporteur:
John G. Babish
Vet Pharmacology 
Cornell University
NABC/JOYCE FELLOW: 
Russell C. Parker
U California, Davis
This food risk—biotechnology matrix provides a 
description of where each food-related risk can be 
quantified in plant, animal and microbial food pro­
ducts in each segment of the food chain. The purpose 
of the matrix is to identify all the key components 
that need to be addressed and establish the most pro-
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ductive direction of biotechnological research for en-suring the safety of 
the food supply.
Source of Risk
After discussing the matrix, workshop participants then addressed each 
source of risk and expanded on ways that biotechnology could be used to 
reduce these risks and improve food safety.
Pathogenic Microorganisms Since pathogenic microorganisms are 
considered by many scientists to be the source of greatest risk in food prod­
ucts, a major thrust of research should be the development of techniques to 
detect, identify, reduce, and minimize the presence of these organisms.
For detection and identification of pathogens in all food products at all 
levels of the food chain, DNA probe assays and immunoassays continue 
to be enormously beneficial to manufacturers, processors and consumers. 
These methods are not only faster, more sensitive and accurate than tradi­
tional testing procedures, but are more cost-effective. In the future, auto­
mated systems will be available for detecting and identifying pathogenic 
organisms. For example, biotechnological procedures for the amplification 
of DNA (PCR, LCR and Q Beta assays) are currently under development. 
The workshop group stressed that procedures to detect and identify 
pathogens at the earliest possible stages of food production and pro­
cessing should continue to be developed.
To reduce and minimize food pathogens in food production, the group 
suggested that immunization in the form of subunit vaccines for animals, 
preproduction environmental/source testing and the possible modification 
of the intestinal flora of animals be considered to reduce and minimize the 
types and numbers of pathogens present.
In food processing plants, in-line safety assessments and assurances 
can be obtained with genetically engineered biosensors, “dip stick” diag­
nostics, and antimicrobials developed through biotechnology. These meth­
ods are especially useful as monitoring tools in processing plants that uti­
lize the Hazard Analysis Critical Control Point concept as part of their pro­
duct safety system.
In the food distribution system, the use of “dip stick” diagnostics to de­
tect the presence of pathogens, time/temperature abuse indicator systems, 
and microbial biosensors would provide another level of product safety as­
surance.
Nutritional Concerns Since another workshop was given the task of 
developing information on improving nutritional quality of foods through 
biotechnology, our group did not address this issue.
WORKSHOP REPORTS
Naturally Occurring Toxicants The naturally occurring sub-chronic 
and chronic toxins, allergens and antimetabolites that are contaminants in 
many common foods are another food-related risk. The importance and 
significance of these toxicants will increase as the spectrum of these 
toxicologic properties is determined, so new, rapid methods are needed 
for their detection and identification.
Foods derived from plant, animal and microbial sources all have the po­
tential to contain naturally occurring toxicants. Although the biotechnol­
ogy research base is small, the workshop group felt that the development 
of diagnostic assays for the detection and identification of naturally occur­
ring toxic chemicals especially during food production is needed.
Molecular genetic technologies should be applied to reduce or mini­
mize risks from naturally occurring toxicants. These approaches may in­
clude deletion of genes, inactivation of gene expression or antisense meth­
ods.
Each of these approaches could yield plants that are free of the natural 
toxin, allergen or antimetabolite. This area may be a major opportunity for 
biotechnology to improve food safety.
As an example, mycotoxins pose multiple risks because of their carcino­
genic and immunosuppressive properties. In addition to developing detec­
tion systems for mycotoxins, researchers are currently trying to produce 
highly field-competitive Aspergillus strains that lack the ability to produce 
aflatoxin. The objective is to develop a biological control agent that re­
duces the likelihood of aflatoxin contamination.
While there are major research opportunities in this area, there are some 
limitations with these genetic manipulations and culture techniques. The 
plant’s susceptibility to insects, disease, drought, and other environmental 
conditions could be affected. Genetically-altered “toxin free" animals and 
microbes might also be adversely affected. A major limitation is the possi­
bility of public resistance to the release of genetically altered microorgan­
isms into the environment.
There is a real need to support research and development efforts to 
identify genes that regulate and produce naturally-occurring toxicants.
Contaminants Contaminants in the environment represent another 
food related risk. These contaminants range from nitrate contamination of 
water supplies to the accumulation of heavy metals in plants and are usu­
ally the result of human error. They need to be rapidly detected and identi­
fied to minimize the risks to humans. All food products, at all levels of the 
food chain, are susceptible to chemical contamination.
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To facilitate detection and identification of contaminants, attention 
needs to be focused on the development of specific, rapid, sensitive, and 
reproducible analytical methods including more efficient, labor-saving 
and cost-effective testing procedures.
Techniques of biotechnology have limited applications in the reduction 
or minimization of contaminants, however plant biosensors could possibly 
be used to detect physiological changes resulting from contamination.
Pesticide Residues Although the risks due to synthetic pesticide resi­
dues in foods are not rated highly by scientists, they are as perceived by the 
public as very important. Biotechnology can be used to reduce the usage of 
pesticides in production agriculture, food processing and food distribution. 
Current methods to detect and quantify residues on raw agricultural prod­
ucts and processed foods are sensitive and accurate, but require sophisti­
cated laboratory instrumentation and expertise. Genetically modified bio­
controls have the potential to reduce and minimize the types and amounts 
of pesticides used in plant and animal agriculture. Genes for the microbial 
insect toxin from Bacillus thuringiensis have been incorporated into plants 
to protect them from insect pests. Genes for coat proteins of plant viruses 
have also been incorporated into plants and protect these transgenic plants 
from viral infection. This plant genetic modification research by molecu­
lar processes must be carefully monitored and evaluated, as is done in 
traditional plant breeding, so that other properties of the foods, such as 
appearance, flavor, texture, aroma, keeping quality, nutrient content 
and toxicity are not adversely affected.
Food Additives Although the detection and identification of food ad­
ditives are not significant problems, many consumers prefer foods that are 
as natural and “additive-free” as possible. Processed foods of plant, animal 
and microbial origins often use direct additives such as preservatives, col­
ors, flavors, flavor enhancers, emulsifiers, stabilizers, thickness, textur- 
izers, leavening agents, humectants, and anti-caking agents.
Biotechnology is currently being used in the production of acidulants, 
antimicrobial preservatives, vitamins, thickeners, flavors and many other 
food ingredients. In addition, genetic manipulation of food-grade microor­
ganisms has improved the fermentation of dairy, meat and alcohol prod­
ucts.
In the future, biotechnology research may provide genetically-altered 
food-grade organisms capable of surviving in the gastrointestinal tract 
that can protect animals, or even humans, from invasion by pathogenic or­
ganisms.
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All of these techniques are aimed at improving or maintaining the nutri­
tional value, quality, and safety of foods, while enhancing consumer accep­
tance and facilitating food preparation. If, through biotechnology, food in­
gredients and additives can be produced more efficiently and function 
more effectively, then a reduction in the use of additives is possible.
Indirect food additives, such as residues of veterinary drugs in food, oc­
cur in animal products and originate during food production. Techniques 
of biotechnology, particularly immunoassays, can be used to detect and 
identify residues through quick and inexpensive on-farm screening tests.
In addition, minimization and reduction of risks from drug residues can be 
achieved through the development of new-generation veterinary drugs 
from biotechnology that are effective yet leave no harmful residues.
The workshop recommends that the matrix presented above be fur­
ther elaborated and used to evaluate the efficacy of reducing each food- 
related risk through biotechnology.
Limitations to Research and Development
Workshop participants also recognized and discussed the limitations that 
can impede the research and development of biotechnology. These limita­
tions include the broad policy issues of standards, consumer communica­
tions, as well as the development, adoptation and diffusion of technology. 
Each area is summarized below.
Standards There is a lack of scientific standards for the products of 
biotechnology, including reference standards for product/process efficacy, 
federal regulatory standards (including an organized framework for prod­
uct approval and utilization) and advertising standards for products being 
sold to others. This lack of standards tends to erode consumer confidence 
in the safety of biotechnologically derived products as well as continues to 
reinforce the many negative impressions associated with this emerging 
field of technology. Development of practical and workable standards is 
a very important aspect of assuring the safety of products derived from 
biotechnology.
Consumer Communications Scientists have not adequately articu­
lated the risks and benefits associated with the products of biotechnology 
to the public. Involving the public in the decision-making process and 
communicating this information to consumers in an understandable and 
unbiased manner are also integral concerns of this workshop. The group 
felt that consumers should be empowered to participate in the process 
of biotechnology product development through advisory councils and
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committees, national mediation institutes or other formal structures.
Early dialogue is very important in assuring that safety concerns are effec­
tively being addressed.
Adoption and Diffusion of Technology The commercial adoption of 
products derived from biotechnology and the development and diffusion 
of biotechnologies will depend upon the risk assessment process, the pro­
mulgation of state, federal and scientific standards and how effectively in­
formation is shared with and communicated to the public. If products 
and technologies are developed that have not carefully and adequately 
addressed these three areas of concern, then commercial adoption and 
diffusion of these technologies will be limited.
Priorities and incentives for future research, development and commer­
cialization will certainly be driven by economics. New products and pro­
cesses will emerge in the areas with both perceived need and large markets.
The workshop concluded that the well-targeted allocation of re­
sources to research—both in the public and private sectors—will pro­
vide cost-effective improvements in the safety of the food supply 
through biotechnology.
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There is general agreement among nutritionists that in­
dividuals with access to an abundant and varied food 
supply can select a nutritionally adequate diet from 
available foods, provided they make appropriate food 
choices. To promote health and prevent disease, the 
U.S. Departments of Agriculture and Health and Hu­
man Services have issued Dietary Guidelines for Ameri­
cans (USDA, HHS, 1985) to assist consumers with food 
choices. These seven dietary guidelines recommend eat­
ing a variety of foods; maintaining desirable weight; 
avoiding too much fat, saturated fat, and cholesterol; 
eating foods with adequate starch and fiber; avoiding 
too much sugar; avoiding too much sodium; and mod­
erate drinking for those who choose to drink.
While these guidelines address some of the major 
nutritional concerns in the U.S., for much of the rest 
of the world inadequate intakes of calories, protein, 
and certain vitamins and minerals are major problems. 
Therefore, the application of biotechnology for im­
proving nutritional quality must be tailored to the 
specific needs of the target population.
Procedure
The workshop group discussion began by settling on a 
definition of nutritional quality. The definition used by 
the group was as follows:
Nutritional quality of foods and diets is defined by the 
content of essential nutrients and other components 
needed for health. Diets of high nutritional quality 
provide nutrients and other factors in optimal amounts 
and proportions for achieving and maintaining good
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health. The nutritional needs of all individuals or subpopulations are not 
necessarily the same. The nutritional quality of individual foods is best 
considered in the context of the overall diet and with respect to traditional 
foods.
Based on this definition, key objectives for improving nutritional qual­
ity of foods and diet were identified. These objectives, in descending order 
of importance according to an anonymous vote of the workshop partici­
pants, were: 1) Decrease total fat in the diet and improve the fatty acid 
profile of foods, 2) Develop effective nutrition education and consumer in­
formation delivery strategies, 3) Identify and characterize unintended/un- 
known nutritional changes that may result from the introduction of bio- 
technologically-derived foods, 4) Develop specific foods with increased or 
decreased levels of selected nutrients to meet needs of subpopulations 
with special nutrient requirements and 5) Decrease antinutrient content 
and increase phytogenic substances of health significance (“protective 
substances”) in foods.
The workshop group then proceeded to a discussion of these five high- 
est-priority nutritional quality objectives. These discussions led to two 
types of results or conclusions which are summarized in the two main 
parts of this report. First, several of the findings of the group’s discussions 
are quite general in nature. These general findings constitute the first seg­
ment of this report. Second, the report includes a summary of the results 
relating to the five highest-priority objectives discussed by the workshop 
group. Each of the five high-priority objectives, except for that pertaining 
to nutrition education and consumer information is discussed with a com­
mon format, in which the following matters are treated: (a) technical feasi­
bility of biotechnology having a significant impact (b) importance of 
the objective as a public health/consumer issue, (c) advantages and disad­
vantages for pursuing this priority with the use of biotechnology (d) rec­
ommendations for policy, and (e) recommendations on research priorities.
General Findings
1. The United States has an abundant, varied and a highly nutritious food 
supply. However, inappropriate food choices and limited access caused 
by lack of economic resources results in poor quality diets for many 
people.
2. Food choices by individuals and households are the major factor affect­
ing the nutritional quality of diets in the United States.
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3. Nutritional goals can be achieved simply by consumers exercising sound 
food choices among currently-available products, i.e., without the in­
tervention of biotechnology, chemical engineering, food engineering, or 
any other advanced technology. The importance of food choice high­
lights the important role that nutrition education and consumer infor­
mation must play.
4. There are significant limitations in our understanding of the details of
the ideal nutritional profile for individuals of different ages, genders, 
health status, economic status, and genetic make-up. The ability of 
biotechnology to produce changes currently exceeds our capacity to pre­
dict the utility and significance of those changes within our diet.
5. Biotechnology has the ability to affect the nutritional profile of major 
foodstuffs, and through this to improve diets without requiring 
changes in food choices.
6. Entrance into the market of biotechnologically-derived food products 
could have a secondary impact on nutritional quality by affecting di­
etary choices. These biotechnologically-derived products may be more 
or less attractive and therefore may replace other “traditional" food 
items. The resulting nutritional impact could be positive or negative, 
depending on the overall dietary effect.
7. Labeling of biotechnologically-derived food products will be an issue of 
considerable public interest. There should be a mechanism (ideally, a 
national forum) to debate all sides of this issue and to recommend a na­
tional policy.
8. Existing regulations appear to be adequate to deal with most issues in­
volving biotechnologically-derived food products and related technical 
changes in food production and manufacturing in terms of their im­
pacts on nutritional quality. However, new regulations in the areas of 
nutrition labeling and food composition analysis may be required.
9. Current public mistrust of nutritional information (especially from the 
scientific community and private firms) and public concerns about 
biotechnology will combine to produce difficult environment for set­
tling policy and regulatory issues. High priority should be given to 
building public knowledge and understanding of biotechnology. The 
public can then make informed choices which will ease pressure on 
regulatory and policy agencies.
10. In general, biotechnology offers certain advantages over conventional 
means of enhancing the nutritional quality of foods. However, cost con­
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siderations and consumer acceptance of biotechnologically-derived foods 
must be carefully assessed.
Objectives for Improving Nutritional Quality Through Biotechnology
I. Decrease total fat in the diet and improve the fatty acid profile of 
foods.
Background
Americans on average ingest 37 percent of their total calories from fat. It is 
widely accepted that this percentage should be reduced to 30 percent of calo­
ries or less. High fat diets are associated with a variety of chronic diseases.
For this reason the fat content of foods and of the “national diet” are pri­
mary considerations relating to nutritional quality.
Feasibility
1. It was judged to be highly feasible that:
a. Through the use of growth regulators such as BST/PST, growth hor­
mone releasing factors, and beta-agonists in the swine and beef indus­
tries, a 2 to 3 percent aggregate reduction in the fat content of the diet 
could be achieved.
b. Through plant breeding or changes in processing techniques soybean 
and corn oils could be modified in their fatty acid composition so as to 
achieve a more nutritionally favorable fatty acid profile.
2. The use of biotechnology to lower the cholesterol content of foods, while
feasible, is unlikely to have a significant impact of serum cholesterol lev­
els or heart disease risk.
Importance
The overall importance of decreasing total fat in the diet is very high. Lower­
ing fat content of the diet is likely to lower chronic disease risk. Altering the 
fatty acid profile of dietary fats may also yield a health benefit.
Advantages and Disadvantages
1. Advantages
a. Increasing the availability of low fat animal products could result in re­
duced fat intakes with little or not change in food habits.
b. There are cost-efficiency, resource-use efficiency (water and energy), 
and international competitiveness gains as well as nutritional quality 
advantages of using growth hormones in livestock production. The esti­
mated 30 percent reduction in costs to farmers would likely be largely 
passed on to the consumer.
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c. A decrease in fat (and, hence, in calorie) content of foods may reduce 
the high prevalence of obesity.
d. Reduction of fat intake and changes in fatty acid profiles may de­
crease risk of heart disease and cancer.
2. Disadvantages
a. If decreases in the fat composition of meat leads to an increase in pro­
tein intake, health consequences associated with excessive protein in­
takes might increase in susceptible individuals.
b. The scientific community is yet uncertain about what the optimal 
fatty acid composition of the diet should be.
c. As with the example of aspartame (a sugar substitute) which despite 
widespread use has not led to the decreased consumption of sugars or 
lower prevalences of obesity, the availability of lower-fat foods may 
not result in reduction in fat intake or improved health status.
Policy Recommendations
1. There should be changes in the marketing system (particularly in grad­
ing systems and in nutritional labeling) to support nutritional change. 
Quality grades for beef are currently based on fat content, such that fat­
ter animals command higher prices for the farmer. The grading system 
should be based on protein or some other component(s). In general, 
there should be a “value-based marketing system,” in which prices re­
ceived by farmers from “first handlers” would be proportional to nutri­
tional quality.
2. There is a need for a mechanism to review and recommend policy having
to do with the labeling of food as “biotechnology-derived" foods.
3. Agencies and regulations for controlling altered foods are already in
place.
Research Recommendations:
1. Develop better methods for determining the composition of food prod­
ucts—particularly rapid methods for determining fat composition of 
live animals as well as the fat and fatty acid composition of carcasses 
and retail cuts.
2. Develop and implement a value-based market system.
3. More accurately determine fat intakes by individuals and subpopula­
tions and improve understanding of relationships between dietary fat 
and disease risk.
4. Elucidate mechanisms of regulation of plant and animal growth.
5. Identify unintended or unknown changes (biological, physical, sensory 
changes) in products resulting from the application of biotechnology.
BIOTECHNOLOCY, FOOD SAFETY AND NUTRITIONAL QUALITY FOR THE CONSUMER
II. Develop Effective Nutrition Education and Consumer Information 
Delivery Strategies.
Background
Given the overriding importance of dietary choices in determining the nu­
tritional quality of diets, nutrition education and consumer information 
remain vital. The growing importance of biotechnologically-derived foods 
will add new dimensions to nutrition education and consumer informa­
tion.
Recommendations
1. Nutrition education and consumer information must deal with both 
perceptions and realities. Several questions must be addressed in order 
to develop effective strategies:
a. What does the consumer need and/or want to know?
b. What information should be on food labels? How can consumer com­
prehension of the information on labels be improved?
c. Who should be responsible for nutrition education and information? 
(Industry may not be a good choice due to possible conflicts of interest.)
2. Education should begin early and continue throughout life in order to af­
fect behavior.
a. The science curriculum in elementary and secondary schools should 
be strengthened so that graduates will be prepared to understand and 
evaluate complex technological issues.
b. Teaching materials dealing with nutrition and food science should be 
developed and made available to elementary and secondary school 
teachers.
3. Scientists should make efforts to communicate their findings to the con­
sumer. Scientists need to be more aware of consumer needs and percep­
tions and be prepared to dispel misperceptions and misinformation in 
an unbiased manner.
4. Food advertising should be carefully designed to avoid misleading and 
exaggerated claims about diet and health. “Marketing with Integrity” 
should be the motto of all ad agencies with food accounts.
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III. Identify and characterize unintended/unknown nutritional changes 
that may result from the introduction of biotechnologically-derived 
foods.
Background
As with any intervention in the food system, the introduction of biotech­
nologically-derived foods have may unintended and/or unknown impacts 
on nutritional quality. There is a need to better understand the nutritional 
effects of altering food composition whether by conventional means or 
means of biotechnology. For example, genetic alterations of plants may af­
fect nutrient interactions, nutritional bioavailability, vitamin potency, 
levels of antinutrients, etc.
Feasibility
Biotechnology could be a powerful and feasible tool for evaluating compo­
sition of food, and hence can help in monitoring.
Importance
1. Public health importance is potentially great. For example, there will be 
a growing emphasis on “engineering” of plants to produce higher levels 
of naturally-occurring toxicants to control pests, and it will be impor­
tant to determine whether these toxicants make their way into the food 
supply and/or whether they will have adverse impacts on nutritional 
quality and health.
2. Monitoring of new foods (by comparison with the reference standard of 
old or “traditional" foods) can help to maintain the nutritional quality 
of the food supply.
3. Since the significance of any single food to overall nutrition is low in the 
industrialized countries, unintended changes in one food are not likely 
to have major effects on overall nutritional quality. In low-income 
countries, however, a single food may have a major impact on the nutri­
tional quality of the diet.
Advantages and Disadvantages
1. Advantages
a. Monitoring of nutritional changes will ensure that there are “no sur­
prises”.
b. If these data are routinely collected, it could speed up regulatory ap­
proval processes.
2. Disadvantages
a. Excessive monitoring and assessment requirements for biotechnologi­
cally-derived foods may lead to prohibitive product development costs.
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Policy Recommendations
1. Regulatory guidelines are in place and are reasonable. The current “10 
percent” FDA guidelines (that there should be scrutiny of new foods in 
which there is a 10 percent or greater departure from the “parent,” “ref­
erence,” or “traditional” food in any nutritional parameter) is reason­
able.
2. While changes in concentration of nutrients are relatively easy to moni­
tor, changes in the bioavailability of nutrients are much more difficult 
to measure. Additional regulatory guidelines governing bioavailability 
may be necessary.
3. Nutrition labeling regulations should be revised and should specifically 
address the issue of “new foods.”
Research Recommendations:
1. Develop improved methods for measuring the nutrient composition of
foods.
2. Develop improved methods for assessing nutrient interactions and nu­
tritional bioavailability.
IV. Develop Specific Foods with Increased or Decreased Levels of Se­
lected Nutrients to Meet Needs of Subpopulations with Specific Nu­
trient Requirements
Background
While for the majority of Americans the food supply is abundant and safe, 
there are some specific subpopulations, particularly infants, the elderly, 
and other persons at high risk of disease, for whom foods with particular 
nutrient characteristics may make a major contribution to their well-be­
ing. Altering the levels of selected nutrients (e.g., beta-carotene) in foods 
may have especially widespread benefits in low-income countries where a 
small number of foods account for a large share of food intake.
Feasibility
Biotechnology could significantly affect several specific foods. For ex­
ample:
1. Biotechnology could contribute to the development of high-protein 
grains and improve amino acid balance in staple foods of the Third 
World.
2. Improved infant formula products (simulated breast milk) could provide 
major benefits to infants who cannot be breast fed or who require spe­
cial diets as a result of allergies or metabolic abnormalities.
WORKSHOP REPORTS
3. Availability of new or altered plants may lead to increased variety in di­
ets.
4. Specialty foods for individuals with allergies, lactose intolerance, diabe­
tes, etc., are now feasible through biotechnology.
Public health importance
1. Internationally, public health importance is high.
2. In the U.S., the public health importance is low, since, in general, the 
population is already relatively well-nourished.
3. For particular subgroups in the U.S. (e.g., infants, persons with lactose 
intolerance), however, the importance may be very high.
Advantages and Disadvantages
1. Advantages
a. Increasing the nutrient content of selected foods may decrease risk of 
nutritional deficiencies.
b. Appropriately designed foods may improve treatment of patients 
with nutritionally-related disorders.
c. These foods may allow improvement of nutritional quality of diets 
with little or no change in food habits since the foods should be similar 
to traditional foods in organoleptic qualities.
d. These foods may reduce the need for nutrient fortification and 
supplementation since nutrient levels could be increased through ge­
netic manipulation of the plant or animal.
2. Disadvantages
a. It is difficult to predict the overall impact of many of these changes; 
in fact, in some cases the impact might be negligible or negative.
b. Interventions to increase or decrease selected nutrients may lead to 
adverse changes in sensory characteristics of food. Other solutions to 
poor nutritional quality (such as improved nutrition education) may be 
more efficacious.
c. There should be caution not to view these methods as a panacea. 
Policy Recommendations
1. Many of these products will be similar to “orphan drugs” and thus not 
cost effective for companies to develop. There will a need for alternative 
means (e.g. government funding) for developing several of these tech­
nologies.
2. Delivery systems must be targeted to the appropriate subpopulations or 
subgroups.
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Research Recommendations:
1. Evaluate consumer reaction to modified products (both global and do­
mestic).
2. Determine if the application of these methods is practical. In some cases, 
conventional applications may be less costly and more effective at ac­
complishing the task at hand.
3. Increase understanding of plant metabolism to determine the nature of 
the biochemical pathways that affect the nutrient composition and nu­
trient bioavailability of foods. Currently, these pathways are not well 
understood.
V. Decrease antinutrient content and increase phytogenic substances of 
health significance ("protective substances") in foods.
Background
Many constituents of foods are known or suspected to be “anti«utrients” 
or “protective substances”. Examples of anti«utrients are goitrogens, tryp­
sin inhibitor, oxalic acid, and gossypol. Examples of “protective sub­
stances” are anti-carcinogenic substances (phytoestrogens, flavonoids, 
and other antioxdants).
Feasibility
In general, it seems relatively feasible to use biotechnology processes to de­
crease antinutrients and increase protective substances.
Public Health Importance
1. Internationally, the importance is potentially high.
2. In the U.S., the importance is low for antiwutrients, and potentially 
high for protective substances.
Advantages and Disadvantages
1. Advantages
a. Increased levels of certain protective substances may reduce cancer 
risk.
b. Reduction in certain antinutrients may improve the bioavailability of 
nutrients.
c. Reduction of antinutrients may make previously inedible foods avail­
able for food utilization.
d. Removal of antinutrients by biotechnology means may reduce pro­
cessing costs since the objective of some current processes is to inacti­
vate antinutrients.
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2. Disadvantages
a. Modifications could decrease the acceptability of some foods.
b. Modified foods may require redesign of processing procedures.
c. There is the potential for “overages” in some substances that might be 
harmful, and thus there is a need to monitor these alterations closely. It 
is possible to have too much of a good thing.
Policy Recommendations
There is a need for a regulatory definition of new foods (“designer foods”) 
so that it can be known precisely when a food is to be treated in the regula­
tory processes as a food or as a drug.
Research Recommendations:
Identify active phtogenic components and their mechanisms of action in 
foods, and to find the safe and adequate range of various substances.
Reference
United States Department of Agriculture, U.S. Department of Health and 
Human Services, Nutrition and Your Health: Dietary Guidelines for Ameri­
cans, Second Edition, Home and Garden Bulletin Number 232, Washing­
ton, DC: USDA, 1985.
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The workshop’s first challenge was to identify differ­
ent issues related to the safety of biotechnologically- 
derived foods and ingredients. Initial discussion identi­
fied approximately 50 issues considered important and 
relevant—issues as diverse as the participant's back­
grounds, ranging from questions about particular as­
pects of the genetic engineering process to concerns 
about implications for the current food safety and 
regulatory system, including a consideration of the so­
cial and economic impact of these safety issues for rel­
evant industries, their workers, and consumers. These 
issues were prioritized into the following clusters of 
concern: Safety Considerations; Regulations and Deci­
sion-Making; Data and Research; Consumer Consider­
ation; Environmental Consideration; and Produce Is­
sues in the Appendix, page 56.
The discussions on these issues raised two major 
questions which continued to surface throughout the 
workshop: One, the relationship between issues of 
food safety to biotechnology. Two, whether issues 
should relate exclusively to products or processes.
The question of whether biotechnologically-derived 
foods present any unique safety considerations was de­
bated extensively. If so, would they require changes in 
the current regulatory system? And furthermore, does 
the entire existing regulatory and assessment process 
need to be revised, or even overhauled? Intertwined 
was the question of whether safety assessments should 
include the process or focus exclusively on the product. 
A notable line of thought emerging from the discussion 
was that a “scientific” or “technical” assessment does 
not account for potential conceptual differences of
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unique safety considerations which may exist for biotechnologically-de- 
rived products. It was agreed that there is nothing unique about biotechno- 
Iogically-developed foods or food ingredients and that existing regulatory, 
assessment, and legislative systems are sufficient to safely reg ulate new 
technologies.
However, when the discussion broadened to include areas such as con­
sumer concerns, the group recognized that biotechnologically-derived 
products are perceived to have unique features.
The workshop developed the following statements and recommenda­
tions:
1. Each food product, whether or not it involves biotechnology, gen­
erates particular safety questions which must be addressed.
2. Molecular biotechnology is a process which can produce new food 
products, however, the scientific and regulatory communities have the 
capabilities to evaluate the safety of these products using existing pro­
cedures.
3. It was felt that safety assessment should focus on the product, not 
the process. Further, no unique safety considerations were deemed to be 
needed for biotechnology products, although there is a need to be alert to 
possible undesirable changes (e.g., increases in a natural toxin).
A critical need to establish what kind and how much data should be re­
quired for a safety assessment was recognized by the group and actively de­
bated. Questions such as “Which kind of information and how much of it 
is required for safety assessment? What is the time frame for data collec­
tion? Who does it? Who funds it?” drove the discussion. A proposal to en­
dorse the decision trees in the recent International Food Biotechnology 
Council (IFBC) report was not supported because few participants were 
sufficiently familiar with the report to judge its quality. However, the con­
cept of a decision tree was approved and with it a number of topics that 
should be addressed in food safety evaluations.
Participants endorsed the concept of a decision tree as a guide to de­
termine the amount and nature of data that should be required to make 
assessment about the human safety of biotechnologically-derived food 
and food ingredients. The following types of information should be con­
sidered in food safety evaluations:
i) composition of final products and the biological safety of the com­
ponents of the food;
ii) the genetic system: donor system; vector; and host expression sys­
tem;
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iii) target animal safety;
iv) marker gene;
v) dissemination of trait to other organisms;
vi) effects of the abiotic environment—land, wafer, air;
vii) effects on the biotic environment—wild and domestic animals,
insects, fish, birds etc.
4. Extensive discussion focused on the questions:
—when in the process and how to include considerations of potential 
social and economic implications of biotechnological products; and
—whether the public should be considered a recipient needing informa­
tion or be an active partner in the decision-making process.
A number of participants argued for more active public involvement in 
government and in the agribusiness decision-making process with respect 
to food safety questions. According to these participants, the public, as 
well as the scientific community, offers valuable insights to government 
and agribusiness, and the exchange of information between the public and 
these groups should increase and improve. Additionally, it was argued that 
risk perception is related to information exchange. An advance public dia­
log can change perceptions about potential products and provide industry 
with important information about consumer attitudes.
Debate followed, but the workshop as a whole stopped short of endors­
ing these points. Participants regarded their principal mandate to be the 
consideration of the technical basis of food safety and associated regula­
tory policy. However, the group fully recognized the existence of other di­
mensions such as social and economic factors in the public perception of 
safety and refers the reader to the report of the Improving Communication 
About Biotechnology to cover this area in more depth.
All participants agreed to a more general recommendation that op­
portunities for involving the public in dialogue on food safety issues 
should be encouraged.
The adequacy of the Federal Register as a vehicle of public notification 
was questioned. Several participants suggested there needed to be public 
forums where concerns and divergent views could be aired before a safety 
decision is made, while recognizing that not every food or food ingredient 
could have its own “hearing”.
5. There was concensus that post-approval labeling which would al­
low consumers to make informed decisions needed more thorough dis­
cussion than these workshop sessions allowed.
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While the current standards and regulations are sufficient to insure a 
safe food supply, these regulations are scattered among several federal 
agencies and there is enormous overlap. The next two recommendations 
followed from further discussions on the issue of regulatory and assess­
ment methodology harmonization between different agencies, both na­
tionally and internationally. There was surprising agreement.
6. Increase coordination and consistency between federal regulatory 
agencies.
7. Harmonize and coordinate state and federal regulatory processes 
(understanding that harmonization does not necessarily imply stan­
dardization).
The federal government should play a lead role in those discussions. In 
addition, there should be movement toward international harmonization 
of safety standards and regulations.
Further, it is critical that the regulatory review of biotechnologically- 
derived foods and food ingredients be completed in a timely manner. It was 
noted that, currently, there are inadequate resources (e.g., budget, staff, in­
strumentation, etc.) in the regulatory system to address food safety con­
cerns in the time necessary for delivery of products into the market.
Appendix
Safety Considerations
Are there unique safety considerations for biotechnologically-derived 
products (e.g., transgenic plants, animals and microorganisms)? (If yes, 
may need new safety paradigm/protocols; if no, do not need a new 
process, just use the existing one).
Containment for fermentation microorganisms—traditional or different? 
Effect of biotechnology on the traditional food safety and delivery system. 
Should there be a pre-market review of human food and/or feed prod­
ucts—traditional and bio-engineered?
Avoiding or initiating a total evaluation system for food safety. 
Requirements for testing protein toxins (e.g., BT)
Secondary effects of genetic engineering; of the process itself.
Elimination of natural warning systems—how to make safety judgements. 
Assessing and identifying safety differences for special populations (espe­
cially infants).
Regulation and Decision-Making
Use of biotechnology as a leverage to revise the regulatory system. 
Overview of regulatory issues—identify and involve all players.
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Regulatory decision tree.
International harmonization and acceptance & compliance methodologies. 
State and local regulations re: federal regulation—harmonization.
Balance the cost of regulation vs. the value of the product (cost includes 
private and social costs).
Is the gene product the only regulated article or should it be something 
else?
Laws keeping pace with science.
What agencies are regulating; and EPA’s role in regulating pesticides pro­
duced in plants.
Data and Research
What and how much data are required to support safety decisions and 
what are the time frames?
Who is doing the research and how is it funded?
Characterization of novel proteins.
Identification and purity of genetically modified materials.
Horizontal transfer of genes.
Need food chemistry and food safety methodologies for traditional and 
new foods.
Improve database for naturally-occurring toxicants.
Animal feeding studies with whole foods.
Methodology for moving from whole foods to whole diets.
Consumer Consideration
Risk perception.
Identification of the societal and economic factors that impact consumer 
decision-making regarding the safety of biotechnology.
What sorts and sources of information have credibility with consumer? 
Development of food safety information (with appropriate educational 
strategies) for consumers.
Consumer decision tree.
Environmental Consideration
Defining areas of uncertainty for long term usage (ecosystem wide). 
Including environmental and worker safety in food safety decisions.
Use of transgenic pest-resistant crops.
Use of products of biotechnology to reduce the total risk in the ecosystem.
Product Issues
Product identification and segregation issues.
Labeling of genetically-modified foods.
How to open the marketplace for products of biotechnology.
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This workshop met to consider issues related to improv­
ing communication and transfer of technical informa­
tion. The 27 workshop participants began by generating 
a long list of issues, later clustered into three themes:
1. General and philosophical issues.
2. Communicative and educational strategies.
3. Significant parties.
Three subgroups of workshop participants met to fo­
cus on these themes. “Research and evaluation,” initially 
identified as another theme, was addressed by all three 
subgroups.
Following deliberation by the subgroups, the entire 
group reconvened to prepare summary remarks to the 
Meeting. Nine specific recommendations are listed on 
the following pages. As important as these recommenda­
tions, however, is some commentary on how the group 
redefined its charge in order to promote productive dis­
cussion.
Rethinking Our Task
The original title of this workshop was, “Improving 
Communication and Transfer of Technical Informa­
tion.” Early in our deliberations, we noted two tensions 
that were aggravated by this title. First, “communica­
tion" and “transfer of technical information" mean dif­
ferent things to different people. Furthermore, placing 
the terms together suggests that the key to improving 
communication about biotechnology is simply to facili­
tate the transfer of technical information among inter­
ested parties.
A second problem with the title of our workshop was 
that the word “transfer" struck some participants as
biotechnolocy, food safety and nutritional quality for the consumer
disconcertingly unidirectional. Although we noted that “technology transfer” 
carries other specific meanings in some linguistic communities—specifically in 
discussing exchanges of data between universities and industries—our conver­
sations dealt with a broad conception of communication. Hence, we chose to 
discard the expression, “transfer of technical information,” and retitle our 
workshop, “Improving Communication”.
This semantic streamlining reflects two important conclusions about com­
munication and agricultural biotechnology. First, in talking about technology 
and food, we must acknowledge the legitimacy of a broad set of values. 
Concerns about the use of biotechnology in food production are unlikely to be 
resolved if we discount all but the most “scientific” perspectives. Although sci­
entific research will have a critical role in guiding public policy about biotech­
nology, other perspectives should be and will be considered. The democratic 
process is poorly served if we view public policy discussion as a conflict be­
tween polemical extremes, such as “scientific fact” versus “emotion”. To com­
municate productively about biotechnology, we must sensitize ourselves to the 
many legitimate ways through which humans make sense of their world.
Also critical to promoting communication is that we must distinguish be­
tween discussion and monologue. We recommend that efforts should be di­
rected at promoting conversation with more than one voice. Clearly, one part 
of our communicative challenge is to provide people with accurate information 
about new technologies and their scientific merits and drawbacks. However, it 
is unlikely that fruitful discussion will occur among the stakeholders in bio­
technology if we fail to recognize that constraining policy discussion to scien­
tific evidence effectively disenfranchises most Americans.
Although the participants in our workshop held many different opinions 
about the wisdom of promoting agricultural biotechnology, we left with 
strong consensus on the next steps to take. Discussion about biotechnology is 
clearly desirable, and should take place in settings where a broad set of per­
spectives can be aired, considered, and used to guide reasoned human ac­
tion.
Recommendations
1. Work toward a national strategy for biotechnology. Although we ac­
knowledge the legitimate involvement of smaller communities in the policy­
making process, both the stakes and the costs are very high in the area of agri­
cultural biotechnology. At this time, many states lack the resources to ade­
quately consider the issues raised in this meeting.
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To most workshop participants, it appears that the regulatory mechanisms 
currently governing food safety, which are concentrated at the federal level, 
serve the public interest and help to ensure safety and quality of food. This is 
true in part because human and technical expertise is concentrated in a small 
number of agencies, and in part because manufacturers can familiarize them­
selves with a comprehensible body of regulations.
Missing at the federal level is a forum for policy consideration and develop­
ment in the area of agricultural biotechnology. Such a forum would be a useful 
resource to lawmakers, regulatory agencies, and other groups. We recommend 
that such a forum he established, and constituted so as to be broadly repre­
sentative of the stakeholders in agricultural biotechnology, some of whom 
we identify at the end of our report.
Participants in such a forum may eventually conclude that the best national 
strategy is to leave many decisions about biotechnology in the hands of state 
government. Alternatively, participants may argue that agenda setting and leg­
islation should be concentrated at the federal level. We offer no prejudgments, 
except to note that alternative scenarios may have diverse economic and social 
outcomes. Food safety and nutritional quality are not the only factors that 
should be considered in the development of a national strategy.
2. Promote discussion about agricultural biotechnology at many levels. 
Concurrent with the development of a national strategy, we recommend that 
forums for information exchange and discussion be established at the state 
and local levels. A national forum, although important, will not be directly ac­
cessible to most Americans.
3. Encourage the development of credible clearinghouses for information 
about agricultural biotechnology. Several workshop participants noted that it 
is unclear where the media or the general public can go for information about 
agricultural biotechnology, particularly when there are concerns about public 
health.
We recommend that regional clearinghouses for such information be es­
tablished, but our group lacked the time and expertise to develop a specific 
proposal concerning the organization of such clearinghouses. Among the op­
tions discussed were university-based hotlines, links with Cooperative Exten­
sion, or ties to other existing organizations like the Scientists’ Institute for Pub­
lic Information. Minimally, a regional clearinghouse should be able to refer call­
ers to people who can provide expertise on a range of issues related to agricul­
tural biotechnology. The recent Alar incident, although not biotechnology re­
lated, points out how volatile public health sentiment can be about food issues 
and underscores the importance of taking proactive measures to responsibly 
handle inquiries.
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4■ Encourage communication between the media and researchers doing 
scientific research in the area of agricultural biotechnology. We note that 
many scientists lack skills or interest in dealing with media representatives. 
Coupled with the fact that few reporters have expertise in agriculture-related 
biotechnology, the potential for miscommunication is high.
We recommend that steps be taken to train scientists to responsibly 
handle media inquiries, and, reciprocally, to provide opportunities for jour­
nalists to increase their knowledge about agricultural biotechnology. These 
two activities might sensibly take place together. Productive communication is 
facilitated when participants in discourse know each other.
The extension units of Land-Grant universities, which already play an im­
portant role in communication related to technical research, should be encour­
aged to further address issues related to biotechnology.
5. Strengthen all citizens' knowledge about the diverse issues related to 
biotechnological innovation. Productive discussion about agricultural biotech­
nology may require significant educational efforts targeted at a number of dif­
ferent groups. Several recent reports have documented the scientific illiteracy 
of Americans; without question, this impedes public participation in policy dis­
cussion about biotechnology. Our group recommends strengthening the 
teaching of basic bioscience at all levels, the integration of biotechnology 
into science curricula, and continuing education for teachers in areas re­
lated to biotechnology.
Less obvious than the illiteracy of the general public, but potentially as det­
rimental to effective communication, are other forms of ignorance. Applied bi­
ology, for example, cannot be discussed without reference to social, economic, 
and legal issues. Even among scientists, a toxicologist and an ecologist may use 
the same words in very different ways; rely upon different standards of evi­
dence, and consequently have difficulty communicating with each other. Pro­
ductive discussion is not simply a matter of giving people a chance to talk; it 
requires providing all speakers with a corpus of shared understanding about the 
topics being discussed.
6. Acknowledge the importance of effective public relations efforts, but 
avoid substituting public relations for other communications activities. Pub­
lic relations can be a powerful tool for the diverse stakeholders in the arena of 
agricultural biotechnology. When a group wishes to promote an attitude, a 
product, or a position, public relations may be indispensable.
We recommend that stakeholders who use PR as a tool for shaping pub­
lic opinion continually scrutinize the ethics of their efforts. If stakeholders 
work hard to know their audiences, acknowledge both the strengths and weak­
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nesses of their positions, and avoid misleading or inaccurate statements, the 
possibility of other forms of productive discourse in other settings is enhanced. 
Public relations should be used as a credibility enhancing tool.
Public relations efforts alone are unlikely to resolve conflicting positions be­
tween different groups of people, because the goal of PR is often to promote a 
position, not to negotiate resolutions to complex problems.
7. Promote care and consistency in terminology. During this meeting, we 
noted that biotechnology-related terminology was used inconsistently and 
could be very confusing, particularly to non-scientists. Given the different 
groups attending, this inconsistency was not surprising, but it did make com­
munication unnecessarily difficult. A brief but readable glossary of terms 
would be a useful companion for future meetings, and might also be useful 
for school teachers, the media, and others.
8. Encourage research on communication about agriculture-related 
biotechnology. We recommend that multidisciplinary communications re­
search be conducted to help frame and answer questions like the following: 
What information is needed by participants in discourse about biotechnology? 
Where do people get information about biotechnology, and how do they use 
that information to form opinions? How do public perceptions about technol­
ogy and food influence personal decision making (e.g., food preferences)?
9. Identify other communications needs. We suspect that we have failed to 
identify a number of other critical needs in the area of communication about 
agricultural biotechnology, and recommend that assistance be sought from 
communications professionals to further develop an agenda in this impor­
tant area.
In conclusion, we offer a list, by no means exhaustive, of some of the 
groups that have important interests in the development of agricultural bio­
technology. Representatives from these groups should be included in a broad 
scope of communicative activities.
Stakeholders
Advocacy groups 
Consultants 
Consumers 
Cooperative Extension 
Distributors
Environmental organizations 
Exporters
Veterinary Health Professionals 
Teachers
Scientists (academic, government and industry)
Farmers
Government officials (elected & appointed)
Media
Processors
Public Health Professionals
Regulators
Retailers
Suppliers
Trade Associations
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Reay Tannahill (1973), in her fascinating booh Food in 
History, points out that the safety and quality of foods 
has been a concern of humankind since primitive 
times. Concerns over food safety and quality magni­
fied substantially along with the development of the 
food trade, due to the widespread practice of food adul­
teration employed by earlier food purveyors. It is inter­
esting to note historically that the legislation these 
practices prompted form the basis for the development 
of modern food control legislation. But concerns over 
food safety today extend beyond the question of adul­
teration which, as we all know, is infrequently prac­
ticed by today’s food merchants. In terms of their sci­
entific importance, microbiological safety of foods is 
the predominant concern, followed by nutritional fac­
tors, natural toxicants, industrial pollutants, and fi­
nally, pesticides and food additives. The emerging sci­
ence of biotechnology and the impact it will have on 
food safety and quality is added to these traditional ar­
eas of food safety concern.
To grasp the potential food safety and regulatory is­
sues that might occur pursuant to the introduction of 
biotechnology into the food and agriculture industry, it 
is necessary to understand the nature of the issues be­
ing dealt with. An industry survey conducted in 1988 
by the Food and Drug Administration (FDA, 1988) in­
dicated that about 40 percent of the research and de­
velopment in food biotechnology was focused on im­
proved agricultural products, 43 percent was targeted 
at the food processing industry and the balance, ap­
proximately 20 percent, was targeted in the area of 
food safety diagnostics and related applications. The
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research and development programs in agriculture 
were evenly divided between livestock biotechnology, 
the bioengineering of pest resistance into food crops 
and the development of improved cultivars. In the 
food processing industry, two-thirds of the activity 
was focused on new or improved food ingredients
and food processing 
industry.
The important point 
here Is not the quan­
titative distribution of 
resources, but the 
fact that biotechnol­
ogy holds great pro­
mise for application 
in essentially all sec­
tors of the agricultural while the balance was targeted on food processing
techniques such as enzyme technology and improved 
final products. The important point here is not the 
quantitative distribution of resources, but the fact that biotechnology 
holds great promise for application in essentially all sectors of the agricul­
tural and food processing industry.
Given this breadth of application, what will the major scientific issues 
associated with the application of biotechnology to the food system be? 
Certainly the principal concern is one of food safety. A second concern re­
lates to the possible impact biotechnology will have on the nutrient com­
position of the food supply. From a government perspective, the regulatory 
issues that will undoubtedly be associated with biotechnology cannot be 
overlooked. These range from if and how biotechnology food products 
should be regulated, i.e., “Will specific product approvals be required?”, to 
the whole question of regulatory compliance procedures, including anal­
ytical requirements, labeling etc. The impact biotechnology will have on 
food safety has been evaluated by the International Food Biotechnology 
Council (IFBC, 1990) and some of these remarks are
A key premise of the 
law, however, is that 
safety standards and 
regulatory proce­
dures should be tai­
lored to the nature of 
the food substance in 
question and the po­
tential safety ques­
tions it may pose.
based on the recently completed IFBC report.
It is important to consider the legal framework in 
which we have to operate in any consideration of the 
effect of biotechnology on food safety. The overriding 
objective of current food safety laws is, of course, to 
assure that consumers are not harmed by the foods 
they eat. To achieve this objective, the law provides 
an array of safety standards and enforcement tools 
which the FDA can use to control foods that are po­
tentially harmful to health. A key premise of the law is that safety stan­
dards and regulatory procedures should be tailored to the nature of the 
food substance in question and the potential safety questions it may pose.
Whole foods are not required to undergo any pre-market review or ap­
proval by FDA. Under the law, however, any person who introduces food 
into commerce is responsible for assuring that it complies with all require-
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ments of the Food, Drug and Cosmetic Act, including the requirement that 
it meet the applicable safety standards. The FDA has enforcement powers 
under the statute that permit it to seize adulterated food, seek a court or­
der preventing its further distribution, and criminally prosecute firms and 
individuals responsible for its distribution.
The law also recognizes that the food supply contains many naturally- 
occurring substances that, when consumed alone in large amounts, are 
toxic, but that are not harmful when consumed as inherent constituents of 
food. The FDA is empowered to act against such substances if it finds that 
they render the food “ordinarily injurious” to health.
Substances added intentionally to accomplish a function in food are 
subject to yet another safety standard, and may be required to undergo 
pre-market review and approval by FDA. Even here, however, the intent is 
to foster innovation in food technology, as well as assure safety. These 
goals are achieved by adopting a protective but realistic safety standard 
and by not requiring pre-market approval when safety assurance is not re­
quired, for example, when the food substance is “generally recognized as 
safe” (GRAS). As FDA has interpreted and applied the law over the years, 
formal pre-market approval has generally been reserved for new chemicals 
and new uses of chemicals that are not GRAS. The FDA has also developed 
special procedures and practices for the regulation of GRAS substances.
Clearly, the extent of regulatory concern, as well as safety and nutri­
tional components, will vary depending upon the food product or ingredi­
ent of biotechnology being considered. To deal with the easy problems 
first, a regulatory structure already exists to ensure the safety of ingredi­
ents such as food additives and GRAS substances. It is fairly clear that new 
ingredients and even old ingredients produced through biotechnology will 
be required to meet present regulatory requirements. This covers the bulk 
of enzymes, microorganisms, food additives such as thickening agents and 
preservatives as well as GRAS food ingredients such as specific sources of 
dietary fiber, modified carbohydrates, etc. Collectively, this represents a 
vast array of substances used by the food processing industry. Except for 
specific examples, there is really nothing new about these groups of sub­
stances. Humans have used microorganisms to “process” foods for centu­
ries, albeit it is only recently that controlled fermentations have been com­
monplace. Likewise, food additives and other ingredients have enjoyed 
widespread legitimate use and are now well integrated into the technology 
of the food processor. The existing regulatory practices will apply to all 
such products. That does not mean that each new product will require for­
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To comment on the 
safety Issues asso­
ciated with biotech­
nology in the food 
processing industry,
It can be safely stated 
that existing proce­
dures for safety eval­
uation and regulatory 
control will effectively 
eliminate any poten­
tial risks that may be 
perceived to exist.
mal review by FDA. In many cases, new products 
will be considered GRAS substances. In a great many 
other cases, biotechnology is simply a convenient, 
cost-efficient way to produce existing, already ap­
proved food ingredients. To comment on the safety is­
sues associated with biotechnology in the food pro­
cessing industry, it can be safely stated that existing 
procedures for safety evaluation and regulatory con­
trol will effectively eliminate any potential risks that 
may be perceived to exist.
The primary issue in food biotechnology relates to its 
application in agriculture. The real or perceived issues associated with bo­
vine somatotropin are now familiar, along with other emerging problems 
associated with the genetic manipulation of food-producing animals. Less 
well recognized, and probably less well understood, are the issues that re­
late to the application of biotechnology in the plant kingdom. Again, the 
regulatory and food safety issues differ depending on the application and 
the end product in question. Two general categories of application can be 
envisioned. One of these relates to the use of biotechnology to produce 
herbicide, insect, drought and other forms of plant resistance by engineer­
ing foreign genetic material into the plant, while a second category relates 
more to altering the traditional characteristics of existing cultivars by the 
insertion of genetic material derived from traditional food sources. These 
latter changes might include alterations in composition; for example, im­
proved nutritional quality or improved processing characteristics, and in­
creased yield and marketability. In future years the development of new 
varieties of cultivars, at least new to our palate, might be anticipated.
A record of regulatory experience existing in plants does not yet exist in 
the safety evaluation of plants or genetic variants of existing plants. Yet a 
great deal of human experience is available—in fact, many generations of 
experience in the area of traditional plant breeding techniques. The key to 
dealing with the problem of biotechnology as applied to plants lies in large 
part, in the historical experience and the safety record of human use on 
past practices which exists but is not well documented. The experience of 
that record provides an important foundation for the safety evaluation of 
genetically-modified plants.
Primitive humans soon learned which plants were poisonous and 
should not be eaten and which were not. Yet even today, several poisonous 
plants are consumed of necessity and are stored, processed or prepared in
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such a way as to alter or eliminate their toxicity. A typical example is the 
root plant cassava which, once properly processed, provides a wholly suit­
able and nutritious basic food staple for large segments of the world’s pop­
ulation. Many other such examples exist, including soybeans, lima beans 
and even potatoes. Prudent and judicious selection of foods derived from a 
broad selection of plant fauna available to early humans provided the ge­
netic stock for the plant foods eaten today.
The introduction of plant breeding brought with it not only changes in 
genetic elements, but vast improvements in the food supply. The genetic 
lineage of modern cultivars is lost in antiquity, but a perspective on the ge­
netic variations people have historically been exposed to provides an ex­
ample of the genetic diversity inherent in the present food supply. One of 
the world’s staple foods—maize—probably originated from the wild grass 
teosinte commonly found in remote areas of Mexico and Central America. 
Selection and cultivation changed teosinte into Indian corn and finally 
into modern maize. Unquestionably, humans have been exposed to a wide 
array of genetic variants of today’s maize without apparent adverse health 
effects over time. The extent of change with time of the genetic diversity 
in the food supply becomes evident when the differences between culti­
vated plants and their wild relatives is considered. Cultivated plants usu­
ally have one or more of the following traits that are uncommon in their 
wild relatives: lessened ability to disseminate seed, 
reduced concentrations of bitter or toxic principles, 
loss of delayed germination attribute, reduced life 
span, higher harvest index or altered color and fruit 
size. This illustrates the point that we and our ancestors 
have been exposed to wide diversity of genetic material. 
This becomes important in assessing the impact of 
biotechnology on food safety.
The extent of compositional variation inherent in the foods tradition­
ally eaten is another factor to consider in assessing the safety of geneti­
cally-modified foods. Some of this variation is due to genetic differences, 
while some is due to environmental influences. Among the macronutrients 
present in commercial vegetables, intraspecies variations in protein, fat 
and carbohydrate content range from 1.5-2.5 fold. Similar variations are 
present in common commercial fruit varieties. Among essential trace ele­
ments within species, variations in composition of up to 10 fold are not un­
common. The intraspecies content of some trace elements such as sele­
The sxtent of compo­
sitional variation in­
herent in the foods 
traditionally eaten is 
another factor to con­
sider in assessing the 
safety of genetically- 
modified foods.
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nium may vary up to 18 fold while vitamin content varies up to approxi­
mately 4 fold. While not immediately apparent, these are very wide varia­
tions in composition. An example illustrates: if a variety of carrots that 
contains the higher of the range of vitamin A traditionally present is con­
sumed, all daily vitamin A needs from that source would essentially be met. 
But if a variety low in vitamin A is consumed, only 25 percent of the daily 
requirement would be met. This highlights the importance of understand­
ing the impact of biotechnology on the nutrient composition of foods.
A third, and probably the most important factor to consider in determin­
ing the consequences of genetic manipulation of plants, is the affect it has 
on the concentration of naturally-occurring toxic factors. This is a principal 
concern of regulatory agencies, even while recognizing that traditional 
plant breeding practices have been used to advantage to reduce levels of tox­
ic constituents. In the early 1970s, FDA cited six incidents which raised 
questions of safety regarding traditional plant breeding and which brought 
these practices under the purview of GRAS regulations. These included:
—a 60 percent increase in solanine content of potatoes grown from seed tu­
bers treated with 1,000 rads of gamma radiation to break dormancy;
—the development of a high solids potato cultivar with high solanine con­
tent;
—the hypothesis that potatoes resistant to late blight developed additional 
chemicals that are teratogenic;
—the production of the toxic chemical ipomeamarone by sweet potatoes 
under certain environmental conditions;
—the development of cultivars of food plants resistant to insect attack;
—unexpected changes in plant composition due to other varietal changes 
(the example given was reduced vitamin C in tomatoes due to mechani­
cal harvesting).
The FDA indicated that an increase in toxicants of 10 percent or more 
when compared to the parent containing the least toxicant, or a decrease in 
a principal nutrient of 20 percent or more, would require that appropriate 
analytical data be supplied to FDA in a GRAS affirmation petition.
Despite plant breeder’s concern over FDA regulation the vast majority 
of new plant varieties have not been formally reviewed under GRAS regula­
tions and have not required pre-market approval from the FDA. Nonethe­
less, we must be vigilant to the possibility that biotechnology may intro­
duce new toxic factors into plants or alter the levels of existing toxicants.
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There are now over 200 naturally-occurring toxic factors in food that 
have some potential for causing toxic effects in humans, although only 21 
have been firmly documented as causing human harm. These include both 
toxic factors in food plants and in animal feeds and forage where the toxi­
cant is passed on to human food such as milk. These are important for the 
plant breeder to consider because:
—Selection and traditional breeding practices have been among the most 
successful methods used to reduce concentrations of natural toxicants 
to levels that present no significant hazard;
—Natural toxicants will clearly be the principal point of concern in evalu­
ating the safety of foods produced by genetic modification of sources in 
which these toxicants can occur;
—It should certainly be the intent of any genetic modification to reduce, 
or at least maintain the level of any constituent that even approaches 
being a significant hazard;
—Natural toxicants are an important, and, within professional circles, a 
well-recognized source of risk in food.
As with nutrients, genetic variations may markedly alter the toxicant 
content of foods. For example, the solanine content of white table potatoes 
may vary from 2 to a high of 20 mg/100 g, a ten-fold variation. The higher 
level could represent 20 percent of the toxic dose of solanine to humans. In 
fact, during the 1970s, the U.S. Department of Agriculture (USDA) devel­
oped a potato variety (Lenape) with unusually high solids content and, 
therefore, desirable processing characteristics. This variety also derived late 
blight resistance from a wild ancestor, Solarium demissum. In the course of 
routine monitoring of incoming potatoes for glycoalkaloid (solanine) con­
tent, a food company found solanine levels several times higher than nor­
mal in the Lenape variety. The company called the problem to the atten­
tion of USDA and FDA and the variety was quickly withdrawn. Similarly, 
low cyanogen varieties of cassava yield 20 - 40 mg/kg of hydrogen cyanide 
while other varieties may yield 20 times that amount—enough to poison 
a person who is not aware of the proper processing procedures.
The examples quoted are clearly well known, but the potential for ge­
netic modification to alter the levels of less well known toxicants must 
never be overlooked. As recently as 1981, Rymal et al (1984) reported that 
as the result of quality control testing, a large commercial pack of tomato 
sauce containing squash was kept out of commerce because the squash was 
found to be extremely bitter. Samples of the fruit of this cultivar were 
found to contain unusually high levels of the extremely toxic substance
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Cucurbitacin E. This episode, as well as others where people were actually 
poisoned from home garden crops in Alabama and Australia, apparently 
resulted from a “wide cross” contamination of the cultivated seed from a 
wild relative.
Criteria for Assessing Safety and Acceptability
This provides the background to attempt to elaborate on the criteria that 
are important in assessing the safety and acceptability of genetically-mod­
ified food crops. If the process of genetic modification is intended to intro­
duce new genetic elements that result in a wholly new expression product, 
for example, a resistance factor such as a pesticide derived through enzy­
matic means, then clearly we should in theory, identify and characterize 
the substance, its range of levels of occurrence and conduct a safety evalua­
tion on it as a discrete entity if possible. If it is not possible to isolate the 
substance, it may be necessary to evaluate the safety of the whole food.
If the genetic change is intended to enhance the nutritional quality of a 
food, then documentation supporting the achieved objective would be re­
quired. If the genetic change was intended to enhance processing charac­
teristics, yield or marketability, this would likewise need to be demonstra­
ted. In all cases, a critical feature of the safety evaluation would consist of 
characterizing the nature of the introduced genetic material, particularly 
if it is not from a traditional food source. The following should be known 
about the inserted genetic material:
—the physical and functional limits of the coding region, and size and 
structure;
—the physical extent of the signal DNA regions;
—the functional properties of signals such as promoters where the se­
quence, relative strength and start of transcription are known from 
published literature or direct determinations.
—after the genetic material is introduced and an individual genetically- 
modified plant has been selected, the following additional information 
may be obtained: quantitative data on the levels and consistency of the 
expression products from the introduced gene.
—copy number of the introduced gene and vector sequences.
—documentation concerning the concentration of significant nutrients in 
the product. Significant nutrients are defined as those that contribute 
in a major way to achieving recommended daily intakes. Other nutri­
ents, though important, would not be critical to gaining acceptance of 
the product.
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Documenting the levels of any known naturally-occurring toxic fac­
tors inherent in the plant species or its close relatives. This would in­
volve analytical determinations of the precise levels of those naturally-oc­
curring toxic factors in the food on which attention should focus.
If deemed necessary, documenting that genetic manipulation has not al­
tered the physical and elemental composition of the food in such a way as 
to impinge on the microbiological safety of the food when processed in ac­
cordance with usual practices.
In practice, it is important to revise these criteria in light of the princi­
ple that the standard of safety for biotechnologically-produced foods 
should be no more or no less stringent than that required for food produced 
through conventional breeding techniques. What can be concluded about 
the impact of biotechnology on food safety? It can be stated safely that 
food ingredients and additives produced through biotechnology will not 
be a new issue to the science of food safety because of the well established 
safety evaluation practices that exist for these classes of substances.
With respect to whole foods such as genetically-modified plants, the 
extent of safety evaluation will need to be geared to the nature of the in­
duced genetic change. Given the specificity of modern techniques in mo­
lecular biology, as applied to biotechnology, changes in genetic composi­
tion hopefully could be characterized with greater ease and more precision 
than in the past. The genetic alterations induced through genetic engineer­
ing probably would not be as extensive as those induced through tradi­
tional breeding practices, especially wide crosses.This 
tends to limit the extent of compositional change 
that might occur. The degree of government regula­
tory oversight required will depend on the degree of 
technical excellence the industry demonstrates. The 
reward for adequately characterizing introduced ge­
netic material, and providing other data referred to 
will be reduced time to approval in cases where pre­
market approval is required. The penalty for failing to 
do so will be increased regulatory scrutiny consisting 
of repeated requests for more data, more complete explanations, and, 
worst of all, requests to test the new product in extensive animal feeding 
trials. This is to be avoided in the name of good science.
The science of food safety has the tools and the know-how to provide a 
rigorous safety evaluation of new products. If good science leads, fair regu­
lation will surely follow.
The science of food 
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Food Safety and Quality For The 
Consumer: Policies and Communication
Good morning. As a student thirty years ago, 8 a.m. 
classes were the bane of my existence. Any professor 
who hoped to keep me awake had to have the oral equi­
valent of the 1812 Overture. It is with that memory and 
concern that 1 would like to begin this morning with a 
few quotes:
Hydrochloric acid is the same acid contained in 
the human stomach. So said a spokesman for the So­
ciety of the Plastics Industry, on why plastic, which 
gives off hydrochloric acid when it is burned, could 
not be an environmental irritant.
Most of the chemicals are not a problem as far as 
adverse effects...The stuff you smell is not neces­
sarily anything to worry about. The reassuring re­
sponse of the Health Commissioner of Niagara 
County, New York, to the residents of the Love Ca­
nal area.
There was nothing there that was catastrophic or 
unplanned for. The calming response of the vice 
president for power generation of Metropolitan 
Edison, owner of Three Mile Island nuclear power 
plant, 1979.
A nuclear power plant is infinitely safer than eat­
ing, because 300 people choke to death on food ev­
ery year. Dixy Lee Ray, Governor of Washington, 
1977.
Opponents of peacetime applications of 2, 4, 5—T 
have repeatedly launched false, malicious attacks 
on the safety of the product. Dow Chemical Com­
pany fact sheet after an investigation concluded the 
manufacture of Agent Orange creates dioxin.
Carol Tucker Foreman
Partner, Foreman & 
Heidepriem 
1112 16th St., NW 
Suite 750
Washington, DC 20036
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DDT, the most effective pesticide, was outlawed on the theoretical 
grounds that it might someday, under some circumstances, harm 
someone. Ronald Reagan, 1978-Quoted in Arbeiter, Jean, No Matter 
How You Slice It, It's Still Baloney (Quill. New York, 1984.)
We must help the public understand that a genetically engineered to­
mato is still a tomato...and that this research is being conducted by 
responsible scientists operating under a strict and credible system of 
safety guidelines. Assistant Secretary of Agriculture Charles Hess,
1990 Remarks Prepared for Delivery to Conference on New Food and 
New Food Chemicals: Safety and Regulatory Considerations, at the Na­
tional Academy of Sciences, May 1,1990.
Consumers must understand they do not live in a risk-free society 
and that some risk is necessary for all the benefits that today's tech­
nology brings. Luther McKinney, Senior Vice President, Quaker Oats 
Company “Fields of Fear,” Choices, American Agricultural Association. 
First Quarter, 1990.
One of the hardest things in the world is to convey meaning accurate­
ly from one mind to another. Lewis Carroll
What we have here is a failure to communicate. Prison Warden to the 
still defiant prisoner, Luke, after he has put Luke in chains, compelled 
him to dig a hole and then knocked him into it...the motion picture Cool 
Hand Luke.
As we approach the twenty-first century, the further development of 
biotechnology holds the potential for enormous benefits to society. Advan­
ces in genetic engineering can improve health and control pollution. Bio­
technology can bring us more efficient agriculture by enhancing productiv­
ity of the land, reducing quantities of water and energy needed to raise a 
particular crop, and expanding the geographical range of many crops. 
Biotechnology can address important consumer concerns about food. It 
can: improve food safety by reducing the need to use insecticides and her­
bicides; improve nutritional value of food by helping to produce leaner 
meat; enhance the flavor and the processing capability of food; identify 
and reduce the microbial contamination that brings
Given these virtually 
indiaputabla banatita, 
ona wonders why tha 
erowda aran't cheer­
ing In the streets.
food-borne illness and death to thousands of Ameri­
cans each year.
Given these virtually indisputable benefits, one won­
ders why the crowds aren’t cheering in the streets.
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Why instead, are people concerned—even frightened—about the potential 
impact of biotechnology on our food supply and our lives? Why does Jere­
my Rifkin have an audience? Why do people buy Jack Doyle’s book? It can­
not be dismissed as just another example of America’s love of gothic tales 
and horror stories. What steps can the biotechnology industry and the gov­
ernment take to ensure that the American people are sufficiently comfort­
able with the purposes, benefits and application of biotechnology that 
they will not unduly restrict its development?
Reasons for Concern
There are a number of reasons that Americans are concerned about the 
impact of biotechnology. First, all understand that biotechnology involves 
certain potential risks. There may be health risks arising from the con­
sumption of plants that contain bacteria designed to kill pests. Genetical­
ly-engineered microorganisms may be capable of attacking other microor­
ganisms, plants and animals in unexpected ways. Species under attack by 
genetically-engineered organisms may develop resistance to the toxins. 
There is a threat of ecological damage, as well. The development of herbi­
cide-resistant plants may encourage the use of more, not less, of toxic ma­
terials which may harm wildlife. Biotechnology will surely bring socioeco­
nomic change that will harm some farmers and suppliers, while benefiting 
others. The debate about bovine somatotropin (BST) in Wisconsin contin­
ues to be driven by these concerns.
Second, the social and political context in which the biotechnology re­
volution is occurring is not conducive to an enthusiastic and unquestion­
ing acceptance of any new scientific or technological breakthrough. In 
the 1950s virtually all Americans believed that there was “Better Living 
Through Chemistry.” Today, we are not so sure about it. Americans have 
lived through forty years of “Don't Worry, Be Happy” philosophy about 
new technologies, many of which were put on the market without any ex­
amination of the potentially negative unintended consequences of their 
use. All were told of the promises and none of the problems with DDT, 
aerosol sprays, and nuclear power. When problems arose with some of the 
products, both government and industry were less than honest in report­
ing them. Today, Americans are more skeptical. Instead of accepting scien­
tific developments as a cornucopia, many see just another opportunity for 
Murphy’s Law to rule.
The public’s view of new science and technology is unquestionably col­
ored by this history, and their view of biotechnology will also be influenced
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There is an assump­
tion that, if the public 
can just be made to 
understand, it will 
open its arms and re­
ceive biotechnology 
as an unmitigated 
blessing.
by government’s and industry’s attempts to “communicate" the virtues of 
these new developments.
“Communication” Problem
The proponents of biotechnology have approached these public concerns 
as a “communication” problem. Considering the enthusiasm for this excit­
ing new field among those involved in it, that is not surprising. Some en­
thusiasts in government and the food industry believe the best approach to 
resolving fears about biotechnology specifically or the safety of the food 
supply generally is to “educate” the public.
In this case, “educate” should be read as “reassure." 
They believe public concerns are based on mispercep­
tions and unjustifiable fears. There is an assumption 
that, if the public can just be made to understand, it 
will open its arms and receive biotechnology as an un­
mitigated blessing.
Occasionally, efforts to “communicate” express less 
than a high regard for the intelligence of critics. In 
fact, they sometimes take on the tone of the old “Sat­
urday Night Live” satire of the Jack Kilpatrick—Shana Alexander face-offs 
on television news. You may remember the “Saturday Night Live” version 
would open with Jane Curtin giving her statement on an issue of the day. 
Dan Akroyd would then begin his rebuttal with, “Jane, you ignorant slut.” 
That tone creeps into food industry and even government responses to 
consumer concerns about food safety in general. People concerned about 
the long-term impact of pesticide residues or herbicide-resistant corn are 
viewed as a flock of Chicken Littles, clucking inanely that the sky is falling. 
Industry and government officials seem to assume that if they can just get 
the silly chickens to understand what a great thing this will be, they will 
snuggle up to it like a warm lightbulb on a cold night in the henhouse. The 
jarring, condescending quotes at the beginning of this paper are not atypi­
cal. Rather, they reflect a common tone in both advocacy and defense of 
new technologies.
There are two problems with the “communication” as “reassurance” ap­
proach. It misunderstands communication. Communication is not Me 
speak,—You listen...Me teach,—You learn. Me say,—You do. It is a two- 
way street. It requires that both parties have the opportunity to speak and 
to listen, to hear and be heard, to act and to respond.
More importantly, there is a problem with assuming that communica­
tion will resolve public concerns about biotechnology. Differences over
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this issue may represent not a failure to communi­
cate, but a conflict in values. The risks and benefits of 
biotechnology do not necessarily accrue to the same 
individuals or groups. Getting the farmer a herbicide- 
resistant crop does not necessarily get the consumer 
anything. Economic theory suggests that increased 
production will generate lower prices, but in the real 
marketplace, there are too many steps between farmer and consumer to 
assume or even hope that the savings will reach the ultimate retail 
purchaser. Some consumers may prefer to forego both the advantages and 
the threats of biotechnology. Consumers may feel there is no benefit to 
them in a technology that promises increased productivity, but does not 
promise that savings will be passed through to the purchaser. Small farm­
ers may fear that new products will put them at a competitive disadvan­
tage.
Assistant Secretary of Agriculture Charles Hess noted recently that the 
debate over BST is about social and economic policy, not about science. He 
is right. If it were simply about science, effective communication might ad­
dress the problem. But if it is about social and economic conflicts, a con­
flict of values and interests, communication alone will not do the job.
Resolving these conflicts requires a mediating institution. In a demo­
cratic society, conflicts of values are ultimately resolved by government— 
by legislators, by regulatory agencies and by courts. In our system, the 
public must be comfortable that the hard questions about biotechnology 
are being addressed effectively by the government. And they must believe 
that government’s first priority in this endeavor will be to protect public 
health.
That is not going to be easy. The biotechnology industry began to de­
velop rapidly about the same time the United States was entering a period 
of “deregulation.” Regulatory activity tends to run in cycles. From the 
early 1960s to the late 1970s regulation, especially regulation designed to 
promote health and safety and prohibit invidious discrimination, ex­
panded significantly. In the late 1970s, the public began to view this regu­
lation as partly responsible for the nation’s economic difficulty. President 
Jimmy Carter tried to rein in regulation. Four years later, President Ronald 
Reagan ran and was elected, in large part, because he promised to get gov­
ernment off the backs of American business and let the economy rebuild 
itself. Reagan appointed officials who were committed to cutting back on 
business regulation and on government services. Regulatory agency bud­
Communication is 
not, Me speak,—you 
listen...Me teach,— 
you learn. Me say,— 
you do. It is a two- 
way street.
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A substantial erosion 
of public confidence 
has grown out of the 
era of deregulation.
gets and staffs were cut and new regulations were reviewed and frequently 
killed by the Office of Management and Budget.
A substantial erosion of public confidence has grown out of the era of 
deregulation. We have a tradition of limited government but we expect
government to ensure that our planes are safe and rea­
sonably on time, that purchasing a telephone will 
take less time than buying a house, that air and water 
and food are reasonably clean and that the money we 
put in a Savings and Loan will be safe. After a dozen 
years, “deregulation” is wearing thin.
Nowhere is this concern with the effects of less government control more 
evident than in the public concern about the environment and the safety 
of food and water. The scandals of the EPA during the reign of Anne 
Gorsuch and Rita Levelle and the attack on environmental laws by Secre­
tary James Watt have undermined public confidence that government 
agencies are working hard to protect public health and safety and the envi­
ronment. The results have included a willingness to believe sensationalist 
attacks and a growing reliance on responsive state regulation, rather than 
unresponsive federal regulation.
President George Bush and the Congress are moving to try to restore 
some confidence in the regulatory agencies, trying to increase budgets, 
hampered by the budget deficit. The Bush regulatory team, like the Presi­
dent, appears to be less ideological and more committed to making govern­
ment work. However, we will live with the legacy of the 1980s and efforts 
to generate support for biotechnology must take into account the context 
of American society today. There is little trust that the federal government 
will play a vigorous role in protecting the people or the environment. At
the same time, American business, including the bio- 
tlicts requires a medi- technol°gy industry, fear the delay and adversarial 
ating institution. nature of the regulatory process and the possibility of 
50 or more different sets of state and local regulations,
Benefiting From Biotechnology, Safely
If we want to enjoy the benefits of biotechnology while saving ourselves 
from unintended negative consequences, we need to take some specific 
steps.
First, the President of the United States should find an occasion to state 
simply, plainly and very strongly that the very first concern of the govern­
ment will be the health and safety of the American people and that the de­
velopment of biotechnology will be allowed to proceed only as long as it
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can be shown to be safe. True conservatism, not libertarianism, is an ap­
propriate approach for the leader of the party of Teddy Roosevelt.
The industry should not fear such a statement. Surely this view is held
by everyone involved in the development of biotechnology. This new field
may hold great hope for our nation's international competitiveness and for
improving products, but no one wants it at the risk of public safety. The
President should say that.
Second, the Administration, with support of the
... activists ars biotechnology industry, should propose changes in regu-
going to have a latory procedures and the law, if necessary, to open regu- 
role in regulatory ,
decision making Iatory processes to a very high level of public participa­
tion and make funds available to support vigorous public 
participation.
Let me talk a few minutes about “public participation.” It is not the same 
thing as public relations. There are several “publics” that must be ad­
dressed. They include: —environmental and consumer activists who fol­
low the progress of new technology and new regulations closely;—state 
and local public officials;—national and local media and the public at large.
The first three groups will have a major impact on what the last group 
thinks and how they react. Despite the worst fears of industry and govern­
ment, activists are going to have a role in regulatory decision making. The 
sooner they are involved and the better equipped they are to address the 
scientific and technical issues involved in a decision, the less impact they 
will have on the timing and perhaps the substance of regulatory decision 
making.
It is not enough to file a notice in the Federal Register to hold a hearing. 
Nor will it do much good to try to go around those most likely to raise dif­
ficult questions. If there are value conflicts to be resolved, knowing what 
they are early should improve the decision making process. If businesses 
and government know, in advance, and before they are committed to a 
course of action, what issues are likely to cause the greatest protest by con­
sumer and environmental activists, alternative courses can be adopted. 
Relatively small changes early in the process may save substantial amounts 
of time and money later.
Third, it would be useful to create a quasi- or non- governmental medi­
ating organization to deal with specific issues. There are some interesting 
examples of groups that have worked over a period of years to ease regula­
tory issues. The Joint Labor Management Committee of the Food Industry
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involves the major retailers and the trade unions that organize them. They 
meet regularly to try to avoid the most divisive industry wide issues. The 
Health Effects Institute is a private, non-profit organization funded by 
government money authorized under the Clean Air Act and the auto in­
dustry to set and carry out a research agenda on major auto-related clean 
air problems. A variation of this group could help set the research agenda 
for major biotechnology questions. It should involve individual scientists 
who are known to have a strong environmental bent.
Reducing conflict will not be easy and many fear both delay and the 
threat to trade secrets that may be involved. Industry leaders also may fear 
that they will participate in such an activity, only to be attacked by some 
activist not involved in the process. Any and all of those things may hap­
pen, but history indicates that a considered approach to the introduction 
of new technology provides the greatest opportunity to avoid unintended 
and unpleasant consequences. Moreover, Congress, regulatory agencies, 
the media, state and local officials and the public at large are likely to be 
impressed by any decision which has the endorsement of leaders of both 
consumer and environmental organizations and biotechnology leaders, 
and that certainly is possible.
These kinds of changes in the decision-making apparatus can improve 
“communication,” reduce value conflicts, and ultimately improve the pub­
lic policies governing biotechnology. Perhaps we can write this chapter of 
American history without creating another set of painful misjudgments.
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Safety, Risks and Hazards
The term “safety”, while commonly used when discus­
sing foods, has little scientific meaning. “Safety" im­
plies an absence of harm, just as “honesty” implies a 
lack of dishonesty. Such terms cannot be quantified in 
a scientific or general sense and so are not scientifically 
useful. Scientists think of food safety in terms of hazards 
and risks. A hazard is the capacity of a thing to cause in­
jury or harm while risk is the statistical probability 
that harm will result (NRC,1983). The difference be­
tween hazard and risk can be understood by using the 
analogy of traveling to Europe by boat. The hazard is 
that the boat will sink and you will drown. The risk 
depends on the type of vessel you are traveling on; if it 
is the Queen Elizabeth, your risk is low, if it is a wooden 
row boat, your risk is high. Scientists think of food 
safety in terms of hazards and risks, usually in a com­
parative sense. Hazard analysis identifies a food sub­
stance which at some level or amount, might cause 
harm. Risk assessment gives the probability the harm 
will occur. The magnitude of risk depends on the potency of 
a toxicant and the dose encountered.
Food-Related Risks
All foods, regardless of source, have both environmen­
tal and human health risks associated with their pro­
duction, manufacture, and consumption. These risks 
are generally qualitatively similar whether foods or ad­
ditives are from traditional sources or derived from 
biotechnology. Biotechnology has presented few, if 
any, new Or unknown challenges in food safety. Food 
related risks resulting from biotechnology differ from 
traditional risks only in the speed with which they can
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be introduced into the diet and their potential to 
quantitatively change American diets. The major 
challenge to regulating food safety from 
biotechnology relates to the numbers of safety deci­
sions which must be made. Regulators of food safety 
and those developing new foods or additives from 
biotechnology must insure (and convince the consu­
mer) that non-traditional foods are of equal or lower 
risk and greater benefit than traditional foods.
The health-related risks associated with foods, regardless of the source 
of the food, can be divided into six categories:
1. Pathogenic microorganisms Microbiological risks, such as the oc­
currence of pathogenic bacteria like Salmonella enteritidis or Listeria mono­
cytogenes, in foods are the most well characterized food-related risks (Ryser 
and Marth, 1989) and are usually given top priority. Pathogenic foodborne 
microorganisms are responsible for hundreds of confirmed deaths of 
United States residents each year (Archer and Kvenberg, 1985). The actual 
number of deaths is probably well into the thousands per year. Biotechnol- 
ogically-derived foods must insure that they do not increase these risks by 
altering foods. For example, genetic alterations of tomatoes which produce 
desirable cultural or disease-resistance characteristics would increase mi­
Food related risks re­
sulting from biotech­
nology differ from tra­
ditional risks only in 
the speed with which 
they can be introduced 
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potential to quantita­
tively change Ameri­
can diets.
crobial risks if the acid content were reduced to the point where the pH 
was greater than 4.6 and microbes could more readily grow.
Nutritional misuse of One f°°d-related objectives of biotechnology
foods may be the most that has not been adequately addressed is the role of 
common food safety biotechnology in reducing food-borne disease. For ex­
problem In the United amp]e> there are naturally occurring compounds
which at relatively low levels can inhibit the produc­
tion of toxin by Clostridia hotulinum. If added to foods, either as the chemi­
cal, or through inoculation, or biotechnologically, the potential for botu­
lism would be greatly decreased.
2. Nutrition-related disorders The risks resulting from the misuse of 
foods are nutrition related. With a few exceptions, United States residents 
do not suffer from a lack of nutrients in the classical nutrition sense, but 
imbalances are common. Nutritional misuse of foods may be the most 
common food safety problem in the United States. The over-consumption 
of fat in the American diet, for example, has been discussed by several 
health authorities as undesirable and as increasing our risks of chronic dis­
ease. Less than optimal intake of some nutrients such as iron by some seg­
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ments of the population is a further example of a food-related health risk. 
Changes in major components (e.g., fat) of the American diet may be pos­
sible through biotechnology. These may have both beneficial and negative 
nutritional impacts.
In addition, nutrition research is advancing our understanding of the re­
lations between diet and chronic disease (U.S. HHS, 1988). Less-than-op- 
timal diets increase the risk of chronic life-threatening disease including 
heart disease and cancer. As a recent study from the National Research 
Council (NRC) points out, application of biotechnology shows promise as 
a way to improve the nutritional attributes of some foods (NRC, 1988).
3. Naturally-Occurring Toxicants. Recent evidence suggests that the 
occurrence of natural toxicants in the diet may be a larger risk than com­
monly perceived (Ames et al., 1987). We have learned to avoid acute toxi­
cants but the role of low levels of substances such as aflatoxin (a myco- 
toxin derived from molds), plants toxins, or the formation of mutagens 
when foods are cooked is unknown (Sugimura, 1986).
This food-related risk may be the greatest unknown and largest prob­
lem for foods derived from biotechnology. There are cases where new vari­
eties of edible plants obtained by traditional plant breeding contain suffi­
ciently increased amounts of a toxin compared to the older variety to cause 
acute toxicity in humans (Concon, 1988). For chronic toxicants, such as 
naturally-occurring chemical carcinogens, the problems become more dif­
ficult. How should one view a new vegetable variety with both desirable 
cultural attributes and an increased level of a com­
pound that will cause tumors in laboratory animals 
when fed at very high levels? This question is not un­
like the debate surrounding the occurrence of low 
levels of human-made carcinogens such as pesticides, 
in foods. The speed with which new plant and animal 
breeds may be derived increases the odds of co-devel- 
oping naturally occurring toxicants.
4. Adventitious contaminants One of the conse­
quences of modern life is the contamination of the en­
vironment by potentially toxic substances. Modern food production and 
processing can result in the adventitious addition of trace amounts of some 
of these substances to our foods. Polychlorinated biphenyls (PCBs) are 
prime examples (Safe, 1987). The occurrence of extremely small amounts 
of PCBs in food cannot be totally prevented, but most toxicologists would
As a recent study 
from the National 
Research Council 
points out, applica­
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agree that current levels do not represent a significant hazard. Adventi­
tious additives can also migrate from food contact surfaces such as plastic 
packaging (Hollifield et al., 1988).
Despite much publicity, we control these risks reasonably well because 
we usually understand much about these contaminants.
5. Pesticide residues Pesticide residues are a risk but at a much lower 
level than is commonly perceived. Premarket testing requirements (espe­
cially for newer pesticides) and strict monitoring of residue levels has 
helped ensure that this risk remains low (Gunderson, 1988). Biotechnology 
can produce plants with greater disease resistance, and hence, a reduced 
need for pesticides but caution must be exercised. Pest resistance is often a 
result of phytochemical defenses. Cancer or other toxic risks could be in­
creased when resistance results from increased biosynthesis of naturally 
occurring toxicants. We may be trading the risk from human-made pesti­
cides of known toxicity for plant-derived pesticides of unknown toxicity.
A major food safety problem in viewing biotechnology as an approach to 
decreased dependence on human-made pesticides will be developing way 
of comparing risks from human-made pesticides to those of naturally oc­
curring pesticides.
6. Food additives Despite the common perception otherwise, a con­
siderable amount is known about the safety of food additives. Strict toxi­
cological and use testing of each substance used as an intentional food ad­
ditive is required. Labeling of foods containing food 
additives is also required. In fact, there is indirect evi­
dence that some additives (e g., BHT) may reduce 
cancer risks (Doll and Peto, 1981).
Biotechnology may produce a variety of new addi­
tives or produce current additives more cheaply.
These additives will have to undergo the same rigor­
ous safety testing procedures as current additives.
Identifying Hazards and Determining Risks
Much effort has been expended in testing for hazards 
that may be associated with foods. For microbial con­
taminants, significant progress has been made in the use of rapid screening 
methods. These methods are generally based on some fundamental biologi­
cal or genetic principle; immunoassay, for example. Chemical contami­
nants can be routinely detected in foods at levels lower than 1 jig per kilo­
gram of food. For many contaminants this equates to a daily intake of less 
then 10 nanomoles per day per person.
A major food safaty 
problem in viewing 
biotechnology as an 
approach to de­
creased dependence 
on human-made pes­
ticides will be devel­
oping way of compar­
ing risks from human- 
made pesticides to 
those of naturally oc­
curring pesticides.
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The problem is not in qualitatively or quantitatively identifying food- 
borne hazards but rather interpreting the risks associated with the haz­
ards, if present. This is the same dilemma that foods derived from biotech­
nology must face. For chemical hazards, the fledgling science of risk assess­
ment (NRC, 1983) seems the best currently available tool to assess risk, al­
though the methods are not without sincere critics. Risk assessment, in 
some form, has partially replaced the zero tolerance approach of older risk 
control laws such as the Delaney Clause. The Delaney Clause sets a zero 
tolerance for food additives which “are shown to cause cancer in man or 
animals” (NRC, 1987).
It has been standard practice to essentially set a zero tolerance for some 
microbiological hazards; if a food contains certain pathogenic bacteria such 
as Listeria monocytogenes, then its associated risk is deemed too high. Unfor­
tunately, this zero tolerance is unworkable and often ignored. Once again 
the problem is assessing the degree of risk associated with low numbers of 
a given pathogenic bacteria in foods. Put another way, how many of a spe­
cific pathogenic bacteria must be consumed in order to represent a signifi­
cant risk? This number has not been determined for most pathogens. How 
new technologies such as packaging might influence microbiological risk is 
also of current concern.
Conclusions
The hazards associated with foods in general have been determined. Bio­
technology presents few hazards not previously considered and in some 
cases could substantially reduce risks. Unfortunately, food products de­
rived from biotechnology will face the same dilemma as traditional foods 
when it comes to determining the magnitude and acceptability of each in­
dividual risk.
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This paper presents a nutritionist’s perspective on a 
number of issues consistently raised when discussing 
food and biotechnology.
The nutritionist has not always been welcome at the 
table when the talk was about technology. In fact, any 
time nutritionists get into a discussion about technical 
changes in the composition of the food supply our ad­
vice has not been particularly helpful, due to the fact 
that technology must focus on a particular crop or food 
rather than the whole nutritional picture.
A direct antecedent of this meeting was the interest 
that was generated in the 1960s, when, at Purdue, 
Nelson and Mertz (a plant breeder and a biochemist) 
discovered a particular gene in maize associated with 
higher lysine content of the corn, called the Opaque two 
gene—opaque two corn, or high lysine corn. As lysine 
is the most limiting amino acid in corn protein for the 
growth of many animals, this was exceptionally excit­
ing. This discovery introduced the possibility of raising 
pigs by feeding them little more than high lysine corn 
with minor vitamin and mineral supplements. In addi­
tion, preliminary testing in adults and children revealed 
that diets consisting primarily of Opaque corn retained 
nitrogen more efficiently. Amidst an exceptional 
amount of promise and hyperbole, this development 
was considered as potentially eliminating hunger and 
malnutrition in the world.
That finding led to the idea that crops could be ma­
nipulated to affect nutritional value. This idea caused 
great excitement and led to plant breeders and nutri­
tionists sitting down together to discuss the available 
technological options with the goal of improving the
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nutritional quality of the food supply. Later work demonstrated that the 
early promise would not come as quickly as was hoped. Work showed that 
the yields of some crop varieties incorporating the Opaque gene were low, 
the milling quality of the grain was changed, and its disease resistance was 
poor, clearly demonstrating that many other factors needed to be consid­
ered alongside nutritional content in order to create a successful crop.
About the same time, United States Agency for International Develop­
ment (USAID) carried out three major field studies around the world in or­
der to look at the effect of supplemental lysine in populations where either 
wheat, corn, or rice was the major staple cereal. These grains are a major 
source of calories in many populations around the world.
For example, a study was done in Morocco supplementing wheat with 
lysine. In Thailand, a study was done adding lysine to rice, and in Guate­
mala, lysine was added to corn. These studies were unable to show nutri­
tional benefit from the improved lysine content in any of these popula­
tions.
Why did the laboratory control studies show such elaborate and impor­
tant effects from supplementing grain proteins with lysine, whereas the 
field studies did not? This was due to several factors: human feeding stud­
ies are difficult to carry out, and results difficult to interpret. Human ly­
sine requirements are probably quite low, particularly when compared to 
rapidly growing rats, pigs, and chickens, and therefore the extrapolation of 
these animal studies to human populations was probably unwarranted. 
More importantly, even though the maize, wheat, or rice was the predomi­
nant staple, people still eat a variety of foods which complement each 
other in nutritional quality.
While the discovery of the Opaque two gene was cer­
tainly very important, the effects of any new develop­
ment must be considered within the context of the 
entire diet, and not as a single food.
New varieties of “quality protein maize”, (as opposed 
to Opaque two corn) now eliminate many of the 
problems seen in earlier varieties. Yields are up, and 
the milling quality and other agronomic characteris­
tics have been improved. Once again these varieties 
are still associated with much hyperbole and promoted as potentially eli­
minating many of the world’s nutritional problems.
People eat a variety 
of foods, even in situ 
ations where there is 
very specific and 
heavy dependence 
upon one source of 
food for calories.
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People eat a variety of foods, even in situations where there is very spe­
cific and heavy dependence upon one source of food for calories. Thus diet 
quality is measured by the sum total of everything eaten, and is not gener­
ally based on a single crop or product. Cereal promotions based on the con­
cept of one cereal providing all nutrients necessary continually set a 
nutritionist’s teeth on edge.
Following this era of discovery in the 1960s, nutritionists began to col­
laborate with plant breeders. Nutritionists were asked, “What should tar­
gets be in changing the composition of food? What should be done?” Plant 
breeders were confident that they could select for specific characteristics 
desired, saying, “Look. You give us some characteristics to select for, and 
we’ll give you those characteristics.” However, it is nearly impossible to 
predict what targets should be set for a particular food in order to improve 
the nutritional quality of the diet and thus improve the health of the 
United States or some other part of the world. Again, the problem is that 
people do not eat nutrients. They eat food, and they do not eat a particular 
food, they eat a variety of foods. That continues to be the dilemma as nu­
tritionists and technologists interested in a particular crop discuss what 
we could do to make foods better nutritionally.
In the United States today, concern about human nutrition does not, 
for the most part, focus on deficiency disease. Within this context, setting 
targets for given levels of nutrients is not helpful. Increasing the lysine 
content of corn, the thiamine in cereal grains, or vitamin C in oranges 
would not improve the health of the American population. However, levels 
of saturated fat and cholesterol, the consumption of some kinds of carbo­
hydrates, and changes that occur in manufacturing of foods through the 
addition of sodium and other things of this nature are of prime concern.
As public health problems are examined, the major causes of death are 
still heart disease, cancer, and conditions associated with them such as 
stroke, diabetic complications, and the interaction of these conditions 
with obesity. Increasing evidence points towards modifying these condi­
tions and their progress through diet. Thus diet, as it relates to these con­
ditions, has important public health considerations.
The dietary guidelines for Americans, currently in its third edition, has 
just been submitted to the Health and Human Services (HSS) Secretary 
and the Director of the United States Department of Agriculture (USDA), 
who will publish new guidelines in October. The third edition has not 
changed significantly from the first and second edition, and it will read 
something like this:
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The first guideline: eat a variety of foods.
A varied diet virtually insures sufficient amounts of the various nutri­
ents required for good health. If you do not get some nutrients from one 
food, you will get them from others. There is all this complementarity of 
foods that we have learned about over the years.
In addition, consuming a variety of foods has im­
portant food safety implications. Within a varied diet 
are specific foods which each contribute nutrients 
and in some cases toxins to the total diet. The variety 
insures that no one item provides a majority of total 
nutrition for better or worse. Therefore, consuming a 
variety of foods makes it less likely that you are going to have food safety 
problems (e.g., consume excess toxins or pesticides). Variety is always the 
first on the list. Eat a variety of foods.
The second guideline: maintain healthy weight. There have been some 
interesting problems in attempting to determine exactly what is a healthy 
weight, but nevertheless, that is the guideline.
Other guidelines include: Choose a diet low in saturated fats and cho­
lesterol. Choose a diet with plenty of vegetables and grain products.
Use sugars in moderation. Use salt and sodium in moderation. If you 
drink alcoholic beverages, do so in moderation.
A few years ago, because of the above kind of nutritional concerns of 
the American public, the Division of Nutritional Sciences at Cornell Uni­
versity was asked by the USDA to help set a research agenda for the Agri­
cultural Research Service (ARS) to meet dietary guidelines.
Together with Hub Allaway, who used to direct the Federal Plant Soil & 
Nutritional Laboratory in Ithaca, three workshops were held. A group of 
plant scientists, a group of animal scientists and a group of food scientists 
were brought together (with some mixing of the three groups in the work­
shops) to identify feasible research objectives for meeting nutritional con­
cerns. The thrust of the discussions was as follows:
The plant breeders said “What do you want? We'll create a plant for 
you—tell us how much thiamine you want, how much riboflavin, what­
ever. We can create that plant—with biotechnology we can create it faster 
than we used to when we had to use very long-term selection techniques.” 
The animal scientists determined they could produce meat with less 
fat, and possibly lower fat milk, if only a marketing system existed that 
would pay the necessary premiums.
Consuming a 
variety of foods 
has important 
food safety impli­
cations.
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Food scientists also said “Tell us what you want. Using agricultural 
commodities as raw material, we can fabricate the needed food. We could 
do it—if the regulations on standards of identity and labeling were 
changed.”
And the nutritionists got into the discussion. “Well, on the one hand, 
maybe; on the other hand...”. I have exaggerated a little bit in terms of all 
the content, but the thrust of these workshops were along those lines. But 
nutritionists were not able to provide the recipe as well as would have been 
liked.
It became clear that a better understanding of basic plant biochemistry 
was needed to determine what was possible and what made sense in terms 
of agronomic and other characteristics. Looking to the future of modified 
plants and even animal compositions by means of genetic manipulation, 
our horizons are very broad, and the time scale is probably short in terms 
of how long it might take us to get there. As we look to biotechnology to 
create production systems for future raw materials incorporated into 
foods, it is not possible to comprehend the scope of what might be pro­
duced, or what consumers will accept. It is difficult to foretell what might 
happen on the basis of nutrition.
A particular food is only a small part of a varied diet, and few people 
consume a single food as a total diet. When new foods are created it is most 
appropriate to think about them as new versions of an “old” food, and to 
examine them within the context of what they would replace. Questions 
such as: What is the role of the new food in the diet? What proportions of 
the daily energy does the new food supply? and within that context, What 
features should this new food have?, are appropriate. For example, most 
nutritionists do not believe that new foods need to be super fortified with 
nutrients.
,. Most likely, guidelines will be necessary to determine 
Most likely, guide- 7’5 7
lines will be neces- what foods new foods might replace. Do new foods
sary to determine have a similar micronutrient profile as foods they gen-
what foods new erally replace; and can the nutrients within these
foods might replace. f00js utiliz.ed—are they available, and can they be
ingested and metabolized by the people who are consuming them?
If dietary patterns remain the same, will the nutrient profile of the 
population change, and will that pose a nutritional risk? These are the kind 
of questions that will be asked by nutritionists as we look ahead to some of 
the biotechnological advances. For example, as materials such as olestra 
and other fat substitutes enter the market in foods where they replace ma-
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jor dietary caloric sources, it will be important to consider how the nutri­
ent profile within the overall dietary pattern is affected.
Changes in plant composition may be more valuable in animal feeding 
than for humans. The fact that tailored crops will be more available, and 
more useful for feeding to certain animals, is an very exciting prospect, and 
will continue to be important.
The production of materials of alternate food compo­
sition through biotechnology is not cause for alarm. 
We, as consumers in this country, have a choice whe­
ther or not to consume a specific food. This freedom 
will be an important issue as we look ahead. We will 
need to look carefully at our regulatory laws to ensure 
they accommodate these technological advances 
while still protecting consumers.
It is critical to recognize that we eat a varied diet, and that changes, 
whether through biotechnology or by traditional means, must be viewed 
in the context of entire food patterns, and not in terms of one food. With that 
in mind, those dealing primarily with the nutritional aspects of food could 
actually be helpful to technologists as they plan food changes. We should 
take advantage of this great new world of foods that is coming.
...changes, whether 
through biotechnol­
ogy or by traditional 
means, must be 
viewed in the context 
of entire food pat­
terns, and not In 
terms of one food.
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The last couple of years have been incredible ones to be 
involved in the food business. At no time in memory 
have the American people had a better opportunity to 
understand the complexity, the interdependence and 
the vulnerability of the system upon which all depend 
for nutrition. The timing of this meeting could hardly 
have been better.
Biotechnology is a controversial topic, difficult to 
discuss without provoking heated and divisive debate. 
My responsibility is to raise some of the issues central to 
that debate, hopeful that the opportunities encountered 
in later sessions of this meeting will provide the time to 
begin to form bonds of common interest that will see at 
least a few of us moving beyond the poles from which 
these discussions began. Judging from past meetings on 
this subject, I confess to being less than optimistic.
This presentation will discuss the issues of food safe­
ty and biotechnology from the perspective of the many 
voices of ordinary citizens. As a consumer, I am a mem­
ber of that faceless mass known as the general public; an 
“A” student of citizen movements. I am concerned, 
among other things, with the issues of food safety and 
biotechnology. I believe it is important for all to know 
what this particular voice believes about the way our 
daily bread is produced, processed, and distributed.
This presentation includes thoughts about the con­
text within which citizens find themselves today and 
how that context impacts on their attitudes about the 
food system, the technology that powers it, the public 
policies and regulatory structures upon which it is con­
structed.
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Also, the prospective introduction of biotechnol­
ogy into personal and communal lives and how it af­
fects the picture will be discussed along with some 
ways of thinking about these matters.
A strong and healthy society requires a food sys­
tem which:
—produces affordable, safe and nutritious products in 
adequate supply;
—provides economic return to producers which is fair 
and adequate to their needs and which encourages 
their stewardship of natural resources;
—encourages the sustainable development of healthy 
rural and urban communities, and 
—contributes to the equitable distribution of goods, services and opportu­
nities associated with the system.
Over the last ten years, it has become clear that the current food system 
is not structured to meet the above goals. Rather, it functions primarily to 
maximize profits with little regard to the social or economic stresses cre­
ated for citizens who exist at the extreme ends of the system, namely: The 
primary producers, encouraged by public policies, by technological devel­
opment, and by market forces to maximize production without regard for 
other people or for the environment; and the consumers who are encour­
aged to remain ignorant, to buy cheapness and convenience with little 
thought for the health effects of those decisions upon themselves; or to the 
impacts of their buying habits on the social and economic well-being of 
the people who produce the food; or on the sustainability of the natural re­
source base required to bring it to their tables.
This system, therefore, does not operate in the long-term interests of 
the citizens of this nation. However, there are powerful forces at work 
which derive short-term benefit from this arrangement, and which will 
undoubtedly resist reform.
The Minnesota Food Association (MFA), along with scores of other citi­
zen groups is pursuing an agenda which will bring about changes in the 
food system both here in the United States and elsewhere around the 
globe. If society is to make the changes necessary to bring about a food sys­
tem which will serve the interests of ordinary citizens, it must: become 
very smart about the food system; identify which parts of it serve well and 
which do not; and develop an understanding of the role technology plays
The Minnesota Food 
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ment of great impor­
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and policy develop­
ment activity, at all 
levels of governance 
in society.
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1in the system—which particular technologies contribute to the achieve­
ment of identified goals, and which do not. Finally, it must recognize that 
the current system over-values high technology development at the ex­
pense of economic justice and ecological well-being, and structures its in­
volvement accordingly in order to bring about change.
It is necessary also to examine the social context in which these issues 
are to be considered. Most Americans operate with a given set of values, 
which guide everyday life and provides responses to things encountered in 
the environment. Most important among these values is the sense of secu­
rity; security in knowing that basic needs of both individuals and families 
can be met, security in the predictability of life on a day-to-day basis. This 
sense of security is reinforced by trusting that the “people in charge”— 
elected officials, public servants, scientists and academicians are people 
who can be counted on as: responsive to societal 
needs of safety and security; fair and competent in 
the execution of their given duties; and long on vision 
and courageous in their concern for the future. Citi­
zens value the sense of control felt when their role as 
citizens is fully empowered and respected. 
Consequently, citizens in a healthy society must be 
prepared to accept and exercise power—prepared by 
experience, adequate and accurate information, and 
by access to the processes through which the rules of 
governance are made and enforced.
This empowerment requires sufficient time and op­
portunity to engage in debate and dialog with others 
in the community. People need to feel that there is 
time to expand their knowledge fully before having to 
commit themselves on issues which are significant to 
the sense of security, trust, and control in their communities.
Food, in particular, has special meaning in the context of these values. 
The food supply is one of the most basic aspects of personal and family se­
curity and community trust. Threats to the reliability of supply, break­
downs in distribution, threats of contamination or toxicity will bring 
about public responses—rational or otherwise, which are intended to re­
establish control and predictability in the system.
Today, most people are completely dependent upon others whom they 
do not know, processes they do not understand, and institutions they do 
not trust or control, for virtually every aspect of nutrition. This reality
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greatly affects attitudes toward the food system in 
general, and sets up a volatile political and social envi­
ronment.
The sheer scale of the system has created a situation 
which only recently began to find its way into our 
thinking. The food system is truly global in scope, the 
cast of characters changes rapidly, and brings in 
groups such as LaBatt's Beer from Canada as a major 
player in the East Coast's dairy business, and Texas oil 
men moving into mammoth-scale pig farming in Colorado. One recent 
merger of two major food corporations involved 100,000 employees and 
will position the new company to command 10 percent of the American 
food market—an estimated 22 billion dollars in annual sales!
The rapid evolution of this system has brought with it a parallel and 
complex arrangement of government regulatory agencies and rules de­
signed to protect the vulnerable consumer from dangerous additives, con­
tamination by foreign materials and disease organisms, and adulteration 
by unscrupulous entrepreneurs. This is supposed to defend against the 
enormous scale and impersonal nature of the food system. Today, there is a 
widespread perception that the defense system is inadequate, is perform­
ing badly and, in fact, seems often to be in conflict with the public's inter­
ests by working too closely with those interests being regulated. This is 
certainly the perception in biotechnology’s case.
Over the past few years, the people of this country have been bom­
barded with reports of:
— inadequate inspections of imported meats and fresh vegetables and 
other questions about the intent and/or competency of government 
food safety regulators;
— growth hormones in our meat;
— drug residues in our milk;
— Salmonella in chickens;
— Alar in apples;
— cyanide in grapes;
— resistant strains of human pathogens due to sub-therapeutic doses of 
drugs in animal production;
— genetically-engineered cross-eyed, arthritic hogs;
— releases of genetically-engineered organisms into the environment;
— patenting of animals
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just to name a few. These reports have created a climate of public fear, con­
fusion and suspicion and have served to bring the reality of our dependence 
and vulnerability home with great clarity.
What does all of this have to do with the issues of biotechnology and 
food safety? Social science research indicates that the faster the pace of 
change, and the more complex the proposed change, the greater the resis­
tance to that change by those who perceive it to be a threat to their secu­
rity. On a scale of one to ten, biotechnology scores near 10 on all counts. 
People are concerned:
— that food which is grown or processed using biotechnology will not be 
safe to eat;
— that the system of regulating biotechnology research and testing is inad­
equate to assure the safety of these new techniques;
—that the application of these new processes will permanently alter and/ 
or damage ecological systems;
— that the motives which drive the rapid commercialization of 
biotechnology research discoveries will compromise Land-Grant uni­
versities, seducing them through the promise of fame and fortune to 
short-cut their responsibilities for providing citizens with accurate, 
unbiased information;
— that the high technology, capital intensive aspects of biotechnology will 
further exacerbate the inequities of the current food system speeding 
the centralization and control of production resources, reducing real 
choices for ordinary citizens—all in the name of progress;
—that the prospect of enormous profits will lure people and resources 
away from other areas of needed and useful research and into short­
term, less community-oriented areas of inquiry. For example, research 
to improve the nutritional quality of food will be sacrificed to that 
which will make food items more colorful, more flavorful, or more uni­
form in size, or have a longer shelf-life.
—Finally, people are most concerned about the rapid and unrestrained in­
troduction of this powerful, radically-different technology into today’s 
society—a society in which the hierarchy of science is energized by an 
almost religious conviction that any problems caused by its short­
sighted curiosity and assumptions of dominance can be corrected 
through more of the same. In other words, society may not be “grown­
up” enough to handle the introduction of biotechnology.
What has the response been of the regulatory and scientific community to 
these concerns? There is little positive to report:
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No voice in the pro- —Concerned citizens are called uninformed, emo-
stance, an official used the term “intellectual pygmies” to describe those 
people who would question any aspect of biotechnology;
— Citizen efforts to create locally adapted and accountable regulatory 
mechanisms are threatened by Federal legislation which would preempt 
their right to set tougher standards than those established at the na­
tional level;
— Land grant researchers whose work is being supported by grants from 
biotechnology companies are appearing in legislative hearings and pub­
lic events touting biotechnology benefits without balancing consider­
ations of possible problems;
— Legitimate questions about possible unintended outcomes are glibly 
put aside with assurances that this technology is no different than what 
has been in use for years in agriculture.
Responses such as these are familiar to citizens who have been involved in 
the early anti-nuclear power issue. However, biotechnology is being intro­
duced into a society radically different from the one in which nuclear 
power was introduced. Citizens have more information and less trust in 
their institutions, and more experience in organizing and in confronting 
power. Citizens interests are smarter and better organized. Environmental­
ists, church groups, animal welfare advocates, hunger organizations and 
even small groups of scientists and economists are forming networks and 
coalitions that transcend single issues and national borders.
The so-called “consumer movement” is much more than that. Citizen 
power is being exercised on many fronts, and there are indications that it is 
having an impact. The recent action of the Minnesota and Wisconsin legis­
latures to establish a BGH/BST moratorium is a good example of this im­
pact.
The message is a simple one. We are a society of many voices:
—some rational and reasonable, willing to sit around the table with you 
and debate the many points of view involved with an issue in a civil 
fashion;
—some who are motivated by fear and uncertainty, activated by newspa­
per headlines, confused an randomly powerful as they try to adapt their 
purchasing behavior to the latest report on diet and cancer;
cess should be de­
meaned, ignored 
or stilled.
tional and unscientific zealots by high government 
officials charged with the responsibility for regulating 
the industry on behalf of the public. In one specific in-
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—and some who see biotechnology providing a public platform from 
which to speak out and organize the fundamental reform of our food 
and agriculture system.
The issues being discussed here are far more complex than just a matter 
of figuring out how to communicate a particular message to consumers.
In a democratic society, the sound of many voices, raised in civil dis­
course, is a sign of a healthy society, where the search for the right path is a 
communal process, not simply the exercise of power of one group over an­
other in a win-lose struggle. We all occupy the same planet, deriving basic 
needs and a sense of community from the same base. No voice in the pro­
cess should be demeaned, ignored or stilled.
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American Farm 
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Introduction
The goal of this conference is to identify and evaluate 
the impact of biotechnology on improving the safety 
and quality of food. At the same time, we have been 
asked to evaluate the relative safety of foods and food 
products derived from biotechnology. I am going to ap­
proach this issue from a slightly different perspective. 
Rather than assess the potential of biotechnology, I 
will focus on how farmers can more effectively deal 
with the concerns of consumers over food safety and 
biotechnology. Without consumer backing, biotechnol­
ogy products face a bleak future.
First is a review of two recent public opinion sur­
veys on food safety and on biotechnology. The first sur­
vey indicates that consumers want farmers to speak 
out about food safety issues. The second survey indi­
cates that both consumers and farmers need more in­
formation about biotechnology. On the basis of these 
survey results, strategies will then be discussed. To 
strengthen the link between farmers and consumers to 
prepare the public for the introduction of biotechnol­
ogy products, two goals will then have to be accom­
plished. First, farmers’ awareness of biotechnology 
must be increased. Secondly, means must be developed 
which allow farmers to speak directly to consumers 
about the farmer’s needs and how biotechnology prod­
ucts fit into their farming operations.
Public Attitudes Towards Farmers and Food Safety
Recently, the American Farm Bureau Federation took 
steps to determine more precisely the public’s attitudes 
towards farmers and food safety. Working with the
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public relations firm of Porter/Novelli, the consumers’ image of farmers, 
their current awareness of food safety issues, and their perceptions about 
the involvement of farmers in these issues were examined.
To accomplish our objectives, a nationwide telephone survey was com­
missioned by National Research, Inc., a market research firm located in 
Washington, D.C. Interviews were conducted by telephone between Janu­
ary 4 through 10, 1990. A total of 1,200 interviews were completed. Among 
our findings:
Farmers and Food Safety
In their attitudes toward farmers, nine out of ten respondents (93 percent) 
believed farmers are “trustworthy” and 56 percent felt that farmers are 
“very trustworthy”. The majority (88 percent) agreed or strongly agreed 
(45 percent) that “farmers are doing a good job of producing healthy food”. 
Men (51 percent) and those over 50 (52 percent) were more likely than 
women (39 percent) or age groups between 18-49 (40 percent) to highly 
praise the efforts of farmers.
However, the public was less convinced that farmers are conscientious 
about protecting food safety and the environment. While four out of five 
(79 percent) agreed that “America’s farmers are very concerned about the 
safety of the food they produce”, only one third (34 percent) agreed strong­
ly. Consumers living in the West were less inclined than their counterparts 
to perceive farmers as being very concerned about food safety.
Family Farms and Corporate Farms
Two out of three respondents (63 percent) believed that most of our food is 
produced on large corporate farms. “Corporate farm” believers tended to 
reside in the West, have incomes over 50,000 dollars, and be somewhat 
more distrustful of farmers. They were more concerned than other respon­
dents about pesticides and hormones in farm products. In contrast, the 
third (32 percent) who believed family farms produce most of the food eat­
en were more likely to live in the Midwest, have incomes under 20,000 dol­
lars, and consider farmers to be “very trustworthy”. The actual structure 
of agriculture differs from these perceptions and is reviewed in the Appen­
dix (see p. 114).
The public also felt that the “family farmer” (upon which their positive 
image is based) is rapidly disappearing in favor of large, impersonal, “corpo­
rate” farms. “Corporate" farmers were characterized as relatively uncaring 
business executives. Their “intelligence” and sophistication may be greater, 
but their trustworthiness related to food safety issues is quite suspect.
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Corporate farms were credited as being chief suppliers of food in large gro­
cery stores and as heavy users of agrichemicals. Conversely, small farmers 
were described as caring, honest and less likely to use agrichemicals, seen 
chiefly as suppliers of food for local and pick-your-own markets.
Most believed corporate farms were more likely than family farms to 
“use sophisticated equipment” (90 percent), “adopt new and improved 
farming methods" (66 percent), and “be more efficient and productive” (59 
percent). However, though the public acknowledged the sophistication of 
corporate farms, it doubted their ability to produce safe and wholesome 
food. Compared to corporate farms, the public was more likely to trust 
family farms to “produce foods of higher quality". (72 percent), “use chem­
icals safely” (70 percent), and “respond to consumer concerns and desires” 
(62 percent). The perceived trustworthiness and caring of the “family” 
farmer appeared to be more important than the intelligence and sophistica­
tion of the corporate farmer when the issue was safe use of farm chemicals.
Food Safety Concerns
Most of the concern over food safety centered around the use of agricultur­
al chemicals. Consumers were more concerned about pesticides (89 per­
cent) than other food issues such as spoilage (85 percent), fat and choles­
terol content (82 percent), additives and preservatives (80 percent) and 
hormones (77 percent). Overall, women were more concerned than men 
about food issues. Older consumers (60 percent) expressed more concern 
about pesticides than their middle (54 percent) or younger (48 percent) 
counterparts. Consumers with a high school education or less (59 percent) 
were more concerned than those who had more education (49 percent). 
However, consumer concern had minimal impact on consumption. Only 
one out of three consumers (36 percent) avoided foods because they
thought those foods might be harmful to their health. 
In general, the survey found that consumers were 
“chemophobic”. That is, they were fearful, confused 
and concerned about the use and possible misuse of 
farm chemicals. Farm chemicals were primarily per­
ceived as harmful tools used for financial gain. This 
perception is particularly disturbing in view of a re­
cent study which documents how damaging this kind 
of chemophobia could be on the quality and quantity of our food supply if 
carried to extremes (Knutson et al., 1990).
Only one out of three 
consumers (36 
percent) avoided 
foods because they 
thought those foods 
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Getting Farmers Involved
The food safety survey showed that the public strongly supports farmers 
having a proactive voice in the food safety issue. Most felt that farmers 
should speak out more forcibly about their views on food safety issues (94 
percent), provide consumers with information about all the chemicals they 
are using (93 percent) and educate consumers about their farming practices 
(89 percent).
Public Attitudes Towards Biotechnology
Because few products have reached the market yet, it is difficult to gauge 
public concerns over biotechnology. It is obvious, however, that biotech­
nology is evolving under intense public scrutiny.
Late in 1988 and early in 1989, the North Carolina Biotechnology Cen­
ter and the North Carolina Agricultural Extension Service undertook an 
educational needs assessment of agricultural biotechnology (Hoban and 
Woodrum, 1990). Telephone interviews were conducted at random with 
rural non-farm consumers, urban consumers, and farmers in North Caro­
lina. In addition, information about biotechnology was also collected from 
agricultural leaders through interviews and mail surveys. The results pro­
vide a snapshot of one state’s attitudes towards biotechnology. For survey 
purposes, biotechnology was narrowly defined as genetic engineering.
Awareness of Biotechnology
Public awareness of genetic engineering in North 
Carolina in 1989 was low. Slightly more than one- 
third of the people reported they had read or heard 
something about it. Almost half said they had heard 
only a little about it. The remainder (13 percent) had 
heard nothing about it. Awareness was highest 
among urban residents and those who were younger, 
better educated and more affluent. Farmers were more aware of genetic en­
gineering than were rural non-farm residents. However, only one-third of 
the farmers had heard of how genetic engineering might change their farm­
ing operations. Most of the information on genetic engineering had been 
gleaned from the mass media.
However, only one- 
third of the farmers 
had heard of how ge 
netic engineering 
might change their 
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Desirability of Biotechnology
Respondents were in favor of most genetic engineering applications. Pro­
ducing more nutritious food was cited as a very desirable use of agricul­
tural genetic engineering (77 percent) with frost-resistant plants (58 per­
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cent), insect-resistant plants (53 percent), and herbicide-resistant plants 
(41 percent) also scoring high. On the other hand, only one third of the re­
spondents said that genetic engineering to produce larger or faster growing 
livestock was very desirable. Those who were most favorable towards ge­
netic engineering included people with higher incomes and more educa­
tion. Younger respondents and men were also more favorable.
Attitudes towards genetic engineering of plants as compared to animals 
differed. Only 12 percent of respondents thought plant genetic engineering 
was morally wrong. Rural non-farmers were most 
likely to feel this way and farmers were least likely. 
However, 38 percent of all respondents felt genetic 
engineering of animals was morally wrong. Again, 
non-farmers were more likely to feel this way and 
farmers least likely. About 16 percent of the respon­
dents did not have an opinion about the morality of 
engineering either plants or animals.
Consumers ex­
pressed greater con­
cern about eating ge­
netically engineered 
meat and dairy prod­
ucts than they did 
about genetically en­
gineered fruits and 
vegetables.
Food Safety Concerns
Consumers expressed greater concern about eating genetically engineered 
meat and dairy products than they did about genetically engineered fruits 
and vegetables. One-third of the non-farm respondents said they would 
be very concerned about eating genetically engineered fruits and veg­
etables and 43 percent said they would be somewhat concerned. Twenty- 
three percent said they would not be concerned. Rural non-farm residents 
were significantly more concerned than were urban residents or farmers. 
When asked about eating genetically engineered meat or dairy products, 
most respondents answered that they would be either very concerned (45 
percent) or somewhat concerned (37 percent). Only 18 percent of the con­
sumers said they would not be concerned. Our current diet contains hy­
brid fruit and vegetables and meat and milk from hybrid animals but 33 
percent of consumers were not aware of this.
Farmers in the survey were asked how concerned they thought consum­
ers would be about eating genetically engineered food. When asked about 
genetically engineered fruits and vegetables, one- 
third (35 percent) thought consumers would be very 
concerned, one-half (48 percent) thought they would 
be somewhat concerned, and 13 percent thought con­
sumers would not be concerned. Their perception of 
consumer concerns about genetically engineered meat
Agricultural leaders 
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and dairy products was similar. Agricultural leaders, however, tended to 
underestimate the level of consumer concern over genetically engineered 
products.
Conclusions From Survey Results
These two surveys tell us the following:
1. Consumer concerns over food safety remain high, especially regard­
ing pesticide residues. This concern, along with the lack of knowledge 
about biotechnology, raises the possibility that consumers could react 
negatively to food produced by biotechnology.
2. The public perceives two distinct types of farmers, “family” and “cor­
porate.” Family farmers are seen as caring and honest. Corporate farmers 
are regarded as smarter, more innovative, better trained but basically un­
caring. The public believes that American agriculture is becoming domi­
nated by large corporate farms which mainly supply big grocery store 
chains. Given this belief, it is not surprising that one of the most controver­
sial issues in biotechnology centers around the potential impact of these 
products on small family farms.
3. The public regards farmers as a credible source of information on food 
safety. Consumers are eager to hear from the farm community. However, 
at this point, most farmers do not yet know enough about biotechnology 
to talk to consumers.
Given these findings, where do we go from here? If we believe that 
biotechnology promises many potential benefits for farmers and consum­
ers, we have to work towards two goals. First, we have to raise the aware­
ness level of farmers about biotechnology. Secondly, we have to provide the 
means for farmers to speak out to consumers about what farming looks 
like and how these technologies might be used on their farms.
Increasing Farmer Awareness
Farmers need to know more about biotechnology to adopt these products 
successfully and to interpret the impacts of these technologies on food pro­
duction for themselves and for consumers. In general, farmers will adopt 
the products of biotechnology in much the same way as they have other 
farm technologies. Knowing this, we can design programs to reach all seg­
ments of the farming community (Hoban, 1989).
Basically, farmers adopt new technologies by going through a five step 
process. First they become aware that a new product exists. This leads to 
an interest in finding out more about it. They then try it out on a small 
scale to see if it will work on their farm. They evaluate the results and, if
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they like what they see, they adopt it for the next growing season. Because 
of economics, early adopters often make the greatest profit. A profile of an 
early adopter would look something like this (Hoban, 1988):
A commercially successful operation, large-scale and more specialized than 
the normal farming operation; is a sophisticated financial manager, relying 
on credit; looks at farming as a business rather than a way of life; tends to 
have more formal education; is often more capable farm and business man­
ager who is highly motivated, willing to take risks, well connected to commu­
nication networks, and tends to be a community opinion leader.
In addition, farmers who respond well to biotechnology are younger 
than the average farmer (who is 52 years old), better educated (college or 
beyond), newer to agriculture, and farm more acres with a higher gross in­
come (Bultena and Lasley, 1987). An average farmer is described in the Ap­
pendix (see pagel 14).
In most cases, early adopters will probably not be the “family farmers" 
that the public wants to protect. We can minimize the adverse impacts on 
these farmers by working towards improving their management skills. In­
deed, to more easily integrate technological advances, most farmers will 
need better management skills in the future (Kalter, 1985). According to 
the North Carolina survey, in early 1989 only one-third of their farmers 
had heard of how genetic engineering might change their farming opera­
tions. Most indicated that they would like to receive much more informa-
biotechnoiogy, farm- The best way to reach farmers is through a variety of
Extension Service
To learn about biotechnology, farmers will continue to rely heavily on in­
formation from the Extension Service. They will be particularly receptive 
to information presented by university researchers at local meetings (Tho­
mas J. Hoban, personal communication). As the primary source for infor­
mation, the Extension Service needs to be sensitive to the uniqueness of 
concerns surrounding biotechnology (Sorensen, 1989). The following sug­
gestions are offered as possible ways to address these concerns:
—Extension could increase efforts to assist limited resource farmers in ex­
panding their management skills.
To learn about
tion about genetically engineered products before 
they are marketed.
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sources. Four sources that come immediately to mind 
are the Extension Service, the farm and commodity 
organizations, professional consultants and farm 
publications.
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—Extension could play an expanded role in conducting on-site tests to de­
termine if new crops or products are well-suited to local conditions. 
Companies may not have the resources or incentives to do this. A po­
tential problem is whether or not Extension agents will have access to in­
novations before they are marketed to farmers (Buttel, 1987).
Dr. Thomas Hoban (1989) presents a strong case for making social 
science research available to Cooperative Extension Service directors, re­
search administrators, and public policy makers who are interested in eval­
uating and mitigating the impacts of technology. In particular, there are 
three areas of inquiry worth exploring:
Technology assessment tries to identify a wide range of social, political, 
economic, and environmental consequences that may result from techno­
logical change before they happen. Like cost-benefit analysis it weighs 
beneficial consequences against adverse impacts (Molnaret al., 1987).
Social Impact Assessment includes another related set of useful tools 
and ideas that could help identify, evaluate, and deal with negative impacts 
of new technologies (Freudenburg, 1986). Public participation and educa­
tion play an important role in this type of assessment.
Interorganizational Relationships attempts to analyze relationships 
among organizations and develop mechanisms to insure efficient and equi­
table collaboration with optimum resource exchange (Rogers and 
Whetten, 1982). We will need coordination and cooperation from the uni­
versities, the Extension Service, and the private sector if the transfer of 
new technologies is to be successful.
Farm and Commodity Organizations
General farm organizations and commodity organizations can also serve as 
conduits for information about biotechnology. For example, the American 
Farm Bureau Federation has made biotechnology one of its priority issues. 
Workshops on biotechnology have been held at Farm Bureau national 
meetings, state meetings, and county meetings for the last four years.
State and county Farm Bureaus are encouraged to:
—Identify biotechnology research within the state and develop a list of 
contacts for information. Establish information sources both within in­
dustry and within the academic community.
—Identify state legislators who have shown an interest in biotechnology 
legislation. Notify them if regulations will affect farming operations.
—Make use of free information from the USDA including their newsletter 
and electronic bulletin board on agricultural biotechnology.
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—Keep track of local zoning and environmental statutes. These are impor­
tant determinants of policy that may affect future tests and applica­
tions.
—Help educate the public about farming practices and the need for and 
impact of new agricultural technologies. Work with Agriculture-in-the 
Classroom coordinators to introduce these issues into schools. Partici­
pate in the Adopt-a-Scientist program. Identify effective spokespeople 
that can answer questions on biotechnology and farm issues. (These 
recommendations are explained in more detail in the next section).
Professional Consultants
Professional consultants represent another loosely defined group that will 
be important in technology transfer. They will probably work more closely 
with early adopters than will Extension agents because of resource limita­
tions within the public sector. The demand for qualified experts will grow 
as more products and increasingly sophisticated technologies become 
available.
Over the last few years, representatives of several scientific societies 
have worked to develop a concept of integrated certification for agricul­
tural and environmental professionals. The Board on Agriculture, part of 
the National Academy of Sciences’ National Research Council is currently 
exploring the possibility of examining the potential benefits of a registry 
and certification process for professionals engaged in the delivery of tech­
nical services and advice to farmers. Their efforts are supported by the Na­
tional Association of Independent Crop Consultants.
Farm Publications
Farm publications also have an important role in getting information out 
to the agricultural community. We have seen a sharp increase in the num­
ber of articles about biotechnology in the last few 
years. Most articles are speculative in nature but serve 
to prepare farmers for the wide variety of products 
and potential concerns. As products become more 
widely available, specialized trade journals and Exten­
sion publications can give pointers to farmers on how 
to make use of them.
Once farmers have 
learned more about 
biotechnology, we 
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Linking Farmers to Consumers
Once farmers have learned more about biotechnology, we will have to pro­
vide the means whereby they can speak out on these issues. Since I am
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most familiar with what the Farm Bureau is doing, I will review our pro­
grams as examples of ways in which we can improve the communication 
links:
1. Involving farmers in the early stages of biotechnology research will 
give both the researchers and farmers a better idea of what is needed and 
what to expect. The American Farm Bureau Federation started the Adopt- 
a-Scientist program in 1988. It was developed to improve communications 
and the flow of information between scientists and farmers. The exchange 
program places leading scientists on farms across the United States and 
provides the host families an opportunity to visit the scientist’s lab. More 
importantly, the program opens a dialog between scientist and farmer. The 
scientist visits his or her host family before planting, during the growing 
season, and at harvest. Each visit lasts two to three days. Scientists chose 
which crops or livestock and which area of the country they want to visit 
and are then matched with a farm family. In the inaugural year, nine scien­
tists from three companies teamed up with farm families in eight states. In 
1989, the program involved 18 scientists from nine companies. This year, 
there are 27 scientists gearing up to visit 14 states. At present, the program 
is limited to scientists from private industry. However, several universities 
have expressed an interest in participating as well.
2. Increasing the public's awareness of current farming practices has to 
be a priority. One of the most successful efforts is Ag-in-the-Classroom, a 
program developed by the USDA to teach children in our schools about ag­
riculture. One component of the Ag-in-the-Classroom curriculum is a sec­
tion on new technologies in agriculture. These programs offer an effective 
way to familiarize young consumers with agricultural biotechnology.
Farm Bureau has developed a parallel program called Agriculture-in- 
the-Classroom that compliments the USDA effort and adds a state per­
spective to the material. Along with videos, brochures, and coloring books 
designed by state Farm Bureaus, states have developed programs to educate 
school administrators, state policy decision makers, and others who pro­
vide input to the public about agriculture.
3. Developing effective spokespeople for the agricultural community is 
another priority. Farm Bureau is currently offering spokesperson training. 
These workshops include a session on presentation excellence aimed at im­
proving presentation skills. It focuses on how to improve delivery tech­
niques, gain audience attention, and use visual aids effectively. Participants 
also attend a media workshop. Skills learned include an understanding of 
the print and electronic mass media, how to develop and deliver a message 
and how to anticipate questions.
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4. Identifying appropriate forums for farmers to reach consumers is a 
bit more difficult. County and state fairs offer an opportunity for farmers 
to inform consumers in friendly surroundings. Local civic organizations 
which hold regular meetings are also a good way to exchange information. 
Some of our state Farm Bureaus are now helping to underwrite local public 
television station programs on agriculture and the environment. Through 
Agriculture-in-the-Classroom, some states offer farmers an opportunity 
to adopt-a-classroom. Writing letters to the editor of the local newspaper 
is another way of getting a message heard. Developing contacts with the 
local media, both television and radio reporters, and maintaining those 
contacts by providing reliable and credible information is also effective.
Conclusions
Farmers have always been concerned about providing safe and nutritious 
food to the consumer. However, following the revelations about possible 
pesticide residues and hormones in our food supply, 
this message has fallen on hard times. The lack of 
public understanding about modern farming practices 
is approaching a critical test. In the next few years, 
farmers will have to make choices about products re­
sulting from biotechnology. These technologies are 
poorly understood by the public but they may have a 
profound effect on farming. Farmers have to do a better job of telling their 
story. We can begin by giving farmers as much information as possible 
about biotechnology. Once they decide how these products will affect 
them, they can then convey their needs and concerns to consumers.
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Appendix
The Current Farming Sector
The United States Department of Agriculture defines a farm as any place 
that sells, under normal circumstances, at least $1,000.00 of agricultural 
products in a year (U. S. Department of Commerce, 1989). Almost all of 
our farms are family-owned. About 3 percent of all farms are organized as 
corporations and almost all of these are family-held. Only 0.3 percent of 
farms are owned and operated by a unit other than a family. Eighty-seven 
percent of our farms are owned and operated by a single family. The re­
mainder are operated as multifamily partnerships.
The 6,000 non-family corporate farms account for about 6 percent of 
farm output (Mazie and Carlin, 1990). Despite fears that this form of farm-
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ing is gaining ground, non-family corporate farming did not change as a 
percentage of all farms during 1982-1987. The long-term trends of declin­
ing farm numbers and land in farms, coupled with increasing farm size, did 
continue through the 1980s. At 2.1 million, the 1987 farm count was down 
6.8 percent from 1982. Forty-nine percent of these farms had gross sales of 
less than 510,000, 36.5 percent grossed between $10,000 to $99,999, 12.6 
percent grossed between $100,000 to $499,999, and 1.5 percent grossed 
over $500,000 (U.S. Department of Commerce, 1989). While fewer in num­
ber, hobby farms increased as a proportion of all farms during the 1980s. 
The number of farms with $10,000 to $100,000 gross sales decreased in 
both absolute and relative terms. The proportion of large farms, which pro­
duce the bulk of U.S. food and fiber, continued to increase.
Looking at commodity sales, in 1982, small farms (grossing less than 
$10,000) contributed only 2.7 percent of sales, small family farms (be­
tween $10,000 to $39,999) 8.2 percent, family farms (between $40,000 to 
$249,999) 41.5 percent, large family farms (between $250,000 to $499,999) 
15.1 percent, and very large farms (gross sales over $500,000) contributed 
32.5 percent to commodity sales (Reimundet a!., 1986). By 1988, the 4.9 
percent of our farms with sales in excess of $250,000 produced 54.6 percent 
of all cash receipts (Congressional Budget Office, 1990).
Higher yields from larger farms are attributed to several factors 
(Reimund et al., 1986). First, large farm operators may employ better man­
agement and cultural practices than operators of small farms. Secondly, 
larger farms have better quality resources than smaller farms. And thirdly, 
larger farms are located in areas better suited to the production of a specific 
commodity. If you ask farmers about the size of farms to come, they often 
conclude that as technology improves, they will have to farm more acres to 
stay competitive (Waterloo, 1990).
Slightly less than one-quarter of all farms fall between the small farm 
and large farm categories (Congressional Budget Office, 1990). The grow­
ing predominance of small farms, in terms of numbers, and large farms, in 
terms of production, raises concerns about whether these family-sized 
farms can survive. Many of the 537,000 farms in this middle group are suf­
ficiently large to require a full-time manager-operator. This probably rules 
out off-farm employment as a source of additional income. It is not clear 
whether these farms are large enough to realize economies of scale in pro­
duction, marketing, and finance as mentioned above (Congressional Bud­
get Office, 1990).
A. ANN SORENSEN
The average farm in the United States is now 462 acres. This is a five- 
percent increase from 1982. About 22 percent of our farms grow cash grain, 
11.7 percent grow field crops, 7.1 percent grow vegetables, fruits, and land­
scape plants, 6.6 percent are dairies, 1.9 percent are poultry farms, 42.8 per­
cent raise other livestock, and 8 percent are classified as “other.” (U.S. De­
partment of Commerce, 1989). Last year, 15 to 20 percent of U.S. farm out­
put was sold abroad (Mazie and Carlin, 1990).
For 55 percent of people living on our farms, the principal occupation is 
farming. Thirty-five percent work 200 or more days off the farm to supple­
ment their income. The average age of the farm operator is 52 years old. 
Fifty-percent of our farms are in the Midwest, 14.6 percent in the West, 
29.6 percent in the South, and 5.2 percent in the Northeast (Dunn and 
Walmer, 1989).
In 1988, the mean U.S. household money income was $34,017. The level 
of farm assets required to generate a $30,000.00 cash income for a farmer 
varies with the type of farm. For example, a corn-soybean farmer would 
have to invest $429,000 fora $30,000 return; a wheat farmer, $600,000; a 
cotton farmer, $300,000; a tobacco farmer, $214,000; a hog farmer, 
$375,000; a dairy farmer, $600,000; and a cattle rancher, $1,000,000 
(Dubman and Hanson, 1987).
Most of our farms do not produce government-supported program 
commodities and, among those that do, not all participate for one reason 
or another (Mazie and Carlin, 1990). Nationwide, about one in three farms 
received some of $14.5 billion in direct government payments made in 
1988. Participation varies by size and type of farm, and by location. For ex­
ample, 90 percent of cotton farms reported receiving payments in 1988, 
while 49 percent of dairy farms reported payments. Participation in gov­
ernment programs is highest among producers in the Northern Plains,
Corn Belt, and Lake States. Recipient farms reported average payments of 
$14,300. Government payments helped participating farm families stabi­
lize their financial situation during the financial stress and debt restructur­
ing of the 1980s.
Farming now dominates the economy in less than one-fifth of all U.S. 
counties (Mazie and Carlin, 1990). Those who argue that keeping the farm 
sector strong will preserve rural America must realize that this now applies 
to only a few rural places. In the majority of rural communities, farming is 
no longer the cornerstone of the local economy. Except for meat packing 
and processing, much of the farm input and processing employment has 
also moved away from local communities as well and is now based in met­
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ropolitan areas. This means farm policy is no longer synonymous with ru­
ral policy.
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Food microbiology plays a critical role in providing con­
sumers with a safe food supply. Foodborne illnesses are 
estimated to affect as many as 81 million people per year 
in the United States and to cost the American economy 
40 billion dollars per year (Miller, 1990). The challenges 
of detecting pathogens in food matrices are substantial. 
A single organism in a 25 gram sample of food has the 
potential of growing to levels that can cause human ill­
ness. Recovery of these organisms in the laboratory is 
complicated by the fact that they may have suffered 
sublethal injury from heat, cold, drying or preservatives 
used in food processing. Since food is rarely a sterile me­
dium, competition from other microorganisms can com­
plicate isolation of pathogens as well. Because of the re­
quirements on food quality control laboratories to pro­
vide accurate results for safe product release, assays for 
food pathogens must be rapid and should involve mini­
mal training. Classical microbiology relies on the growth 
of pathogens in broths and on agars for presumptive 
identification. Other techniques are then applied to iso­
lated colonies to determine the exact identity of suspect 
organisms. Although such techniques are the “Gold 
Standard” of food microbiology, they suffer from a num­
ber of limitations. Because food often contains non- 
pathogenic microorganisms that are closely related to 
important pathogens, appearance and biochemical reac­
tions of these nonpathogens can mimic those of their 
more dangerous relatives. Highly trained personnel are 
thus needed to make these critical distinctions. Classical 
procedures are also very time consuming. It can take five 
days to several weeks to determine if food is free of cer­
tain pathogens. (Doyle etal., 1988)
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Analytical procedures derived from biotechnology re­
search have had a substantial impact on human 
health care in the past ten years. Assays based on 
monoclonal antibodies are commercially available for 
a wide range of drugs and hormones. Application of 
such assays to food microbiology has been slower to 
evolve for a number of reasons.
As outlined above, the problems of analysis of patho­
gens in food is quite complicated. An additional complication is the level of 
sensitivity required. Direct detection of a single organism in 25 grams of 
food is beyond the capabilities of even the best present assays and is likely 
to remain so for a number of reasons. All current biotechnology assays, 
therefore, require the cultural enrichment of pathogens to certain levels be­
fore they are detected. Detectable concentrations for both antibody based 
assays and DNA probe assays is about a million organisms per milliliter of 
enrichment broth. Most current procedures take two or more days to 
achieve this level, but efforts are underway to abbreviate this period with­
out sacrificing assay sensitivity. This sensitivity level of a million organ­
isms per milliliter is not a trivial task.
Table 1 Analyte Concentration 
Target Concentration (moles/L)
Glucose 10'3
Theophylline i o -5
hTSH i o -11
1,000,000 E. coli/ml (rRNA) i o -12
100 Hepatitis A/ml i o ”
Table 1 shows a list of clinically relevant analytes typically determined 
by immunoassay and the target levels provided in a broth containing a mil­
lion organisms per milliliter. Assays for human thyroid stimulating hor­
mone (hTSH) are the most sensitive assays done in the clinical immunoas­
say laboratory today. Antibody assays targeting antigens with copy num­
bers of 10,000 per cell and DNA probe assays that target ribosomal RNA at 
the same copy number per cell must therefore be an order of magnitude 
more sensitive that these hTSH assays. Assays targeting viral agents where 
no ribosomal RNA is available must be even more sensitive.
Foodborne illnesses 
are estimated to af­
fect as many as 81 
million people per 
year in the U.S. and 
to cost the American 
economy 40 billion 
dollars per year 
(Miller, 1990).
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These techniques 
are so sensitive that 
it is likely that they 
will detect dead mi­
croorganisms in food 
that are of little sig­
nificance.
Biotechnology assays face several design hurdles that must be over­
come. Increasing target levels to detectable levels has already been discus­
sed in the context of cultural enrichments. For probe assays, there is also a 
tantalizing opportunity for in vitro amplification. Because nucleic acids 
have evolved to be copied in order to transmit their information to the 
next generation or to the next process in a cell, very 
efficient enzyme systems exist in nature that can very 
rapidly produce millions of exact duplicate copies of 
an original nucleic acid sequence. These enzyme sys­
tems have been harnessed to provide nucleic acid am­
plification schemes to enhance the sensitivity of 
probe assays. The best known of these is a procedure 
known as the polymerase chain reaction (PCR) (Saiki 
et al., 1985). It can amplify a target sequence a million fold in several hours. 
More recent discoveries have lead to a system based on an enzyme called 
Q-beta replicase that can amplify probe signals by a billion fold in as little 
as 15 minutes (Lomelli et al., 1989).
Application of the amplification technologies to food microbiology will, 
however, be limited by several problems that are related to the very sensi­
tivity that makes them so attractive. These techniques are so sensitive that 
it is likely that they will detect dead microorganisms in food that are of lit­
tle significance. The other issue that will need to be dealt with is the po­
tential for cross contamination (Kwok and Higuchi, 1989). These detec­
tion systems are so sensitive that even the slightest cross contamination of 
a negative sample with materials from a positive sample can lead to a false 
positive result. It is most likely that nucleic acid amplification will be used 
to shorten enrichment times rather than to replace cultural enrichments 
altogether. The cross contamination issue will probably be minimized with 
automation.
Sample preparation is the next hurdle in the design of biotechnology as­
says. Bacterial antigens must be released from cell walls or internal struc­
tures so that they can bind to the detecting antibodies. Heating aliquots of 
the terminal enrichment culture in a boiling water bath is a common ap­
proach (D’Aoust and Sewell, 1988). Nucleic acids targets can be freed from 
the intracellular matrix of bacterial cells by treatment with strong base or 
by enzymatic processing, thus eliminating the need for a boiling water 
bath.
All of these processes also kill pathogens, thus providing a level of bio­
safety for the operator. Inherent in all high-sensitivity biotechnology as­
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says are a separation step in which label bound to some solid phase as a re­
sult of the presence of target is separated from unbound label. Solid phase 
supports are usually made of plastic and facilitate the wash steps that en­
hance signal-to-noise ratios. Most immunoassays use a microtiter plate as 
a solid phase. Ninety-six wells that can hold approximately 0.3 milliliters 
are arranged in an 8 by 12 array. The wells are coated with a capture anti­
body by the manufacturer. The assay is run by adding the sample to a well 
and then adding the antibody-enzyme conjugate. If the desired antigen is 
present, it will be bound by the antibody on the well and the antibody-en­
zyme conjugate in solution will in turn bind to the antigen. This results in 
an antibody-antigen-antibody “sandwich” that forms only when antigen is 
present. Unbound antibody-enzyme conjugate is washed away and en­
zyme is detected as described below. A schematic representation of this 
format appears as Figure 1.
Sandwich Immunoassay
Solid Phase 
Antibody
Antigen Antibody—Enzyme 
Conjugate
Product
Figure 1 Antigen is released from cultured organisms by boiling. Solid 
phase antibody and solution phase enzyme labeled antibody react with an­
tigen, if present. After a wash step, the amount of enzyme present is pro­
portional to the amount of antigen present initially. Enzyme is detected by 
reaction with substrate and chromogen to produce color.
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The DNA probe assays that are produced by GENE-TRAK Systems are 
based on another type of “sandwich”. Target nucleic acid is allowed to react 
with two different probes in a test tube. These synthetic probes are exact 
matches for areas of the target that are fairly close together. One probe (re­
porter probe) is labeled with fluorescein and the other 
(capture probe) has a homopolymer tail of polydeoxy- 
adenylic acid (dA). The target and these two probes 
form a probe-target complex. A plastic dipstick coated 
with the matching homopolymer polydeoxythymi- 
dylic acid (dT) is placed in the test tube. Any probe or 
probe-target complex that contains a poly dA tail is 
captured on the dipstick. A subsequent washing step removes any un­
bound material including fluorescein-labeled reporter probe not bound in a 
probe-target complex. The dipstick is now incubated with an antibody-en­
zyme conjugate which binds to any fluorescein residues present. Since the 
fluorescein-labeled reporter probe can only be present at this point as part 
of a probe-target complex, the amount of antibody-enzyme conjugate 
bound is proportional to the amount of target initially present. A second 
wash step removes unbound conjugate. Exposure of the dipstick bound en­
zyme to an appropriate substrate chromogen mixture produces a blue color 
in direct proportion to the amount of enzyme present on the dipstick. Re­
moval of the dipstick and addition of dilute sulfuric acid stops the enzyma­
tic reaction and intensifies the color, completing the assay. The results are 
read in a differential photometer at 450 nm. The entire reaction scheme ap­
pears as Figure 2.
To ensure that the assay has been carried out correctly, two controls are 
run with each assay, a positive control and a negative control. Both con­
trols must meet certain criteria for the assay to be considered valid. Sam­
ples that read 0.1 O.D. units above the negative control are considered pre­
sumptively positive for the organism in question.
DNA probe assays target the most fundamental level of information in 
a cell (Parsons, 1988). The practical significance of this fact is that they 
produce a better quality result in a shorter time. Table 2 illustrates the time 
savings possible with the use of our current generation Salmonella assay. 
Additional improvements in time frame to result are being actively re­
searched. In addition, the quality of the result is also significantly better. 
One of the more dramatic examples of how much better these results can 
be was recently provided by some results of our quality control depart-
The future of food mi­
crobiology has 
bean brightened by 
the emergence of 
biotechnology 
diagnostic assays.
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DNA Probe Assay
1. Sample Lysis
NaOH
Sample —► rRNA
2. Solution hybridization
Reporter Probe Capture Probe 
- dA 
Target rRNA
3. Capture
poly dT coated 
dipstick
4. Wash
5. Addition of HRP—conjugate
HRP
123
6. Wash
7. Add chromogen/substrate
8. Incubate and add stop reagent
9. Read color at 450 nm
Figure 2 After organism lysis to expose the intracellular nucleic acid, the 
target nucleic acid is reacted with two probes to form a probe-target com­
plex. The dA tail on the capture probe allows capture of this complex on a 
dT coated dipstick. Detector probe in the complex is detected with an anti­
body-enzyme conjugate. After a wash step, enzyme present is proportional 
to the amount of target nucleic acid initially present. Enzyme is detected 
by reaction with substrate and chromogen to produce color.
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ment. We participate in a Check Sample program provided by the Ameri­
can Association of Cereal Chemists (AACC) (Sail et al., 1988). Every eight 
weeks, this organization provides the subscribers of this Check Sample 
program with two unknown samples of flour or flour-based bakery mix­
tures. These samples may contain Salmonella, Staphylococcus aureus, Escheri­
chia coli and/or other organisms of interest to food microbiologists. Alter­
natively, they may also be free of such organisms. Each subscriber labora­
tory tests these samples to the best of their ability and returns their results 
to the AACC under their own individual code number. The AACC then 
tabulates the results and reports the results by code number to assure ano­
nymity. Only AACC and the respondent know their own code number. 
One can, however, compare one's own results against the results obtained
Table 2 Salmonella Microbiology
Steps Conventional Probe
Primary enrichment 18-24 hours 18-24 hours
Selective enrichment 6 hours 6 hours
Final enrichment 18 hours 18 hours
Plating 18-24 hours —
Biochemical ID 5-24 hours —
Serology 4 hours —
Assay 2.5 hours
Total Time 72 hours 
95+ hours for 
a positive)
48-52 hours
by all of the other respondents. Since our colorimetric Salmonella assay 
was available in internal pilot lot form, we have been running these Check 
Samples in our Salmonella test. Our results represent perfect agreement 
with the stated AACC results for the entire duration of the present study 
with one exception. Despite exhaustive efforts, we were unable to find any 
viable Salmonella in the samples received in January of 1989. Twenty-two 
percent of the other respondents also reported an apparent false negative. 
We believe that there may have been a sampling problem with that par­
ticular Check Sample series or that there may have been some die off of the 
inoculated organisms.
What is striking about this study is the occasional spikes of high rates of 
false negatives experienced by other participants in this program. False 
negative rates have run as high as 38 percent for one recent sample. Al­
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though we do not know the identity of any of the other participants in this 
study, their participation in such a check sample program speaks eloquent­
ly to their commitment to very high quality food microbiology. We believe 
that these results speak to the limitations of conventional food microbiol­
ogy which is still used by a vast majority of the industry at this point. An 
assay such as ours removes the subjectivity and extensive work with vari­
ous media to avoid missing biochemically atypical strains. These results 
are reported in greater detail at the Institute of Food Technologists (IFT) 
meeting in Anaheim, CA (McKenzie et al., 1990).
The future of food microbiology has been brightened by the emergence 
of biotechnology diagnostic assays. Time to results have been shortened 
and the quality and universality of results has been improved by the cur­
rent generation of tests. Yet there remain additional challenges. Tests for 
additional pathogens and spoilage organisms are in development and will 
make their appearance on the market in the next few years. Enrichment pe­
riods must become shorter to give even faster turnaround times. Minimal 
enrichments of 4-12 hours will probably always be necessary to avoid de­
tection of dead organisms.
In vitro amplification methods will extend the range of present tech­
niques so that viral agents such as Hepatitis A and Norwalk agent would 
be detectable in amounts sufficient to cause human disease. Agents caus­
ing diseases such as scrapie and bovine spongiform encephalopathy have 
the potential for causing serious economic loss (Holt and Philips, 1988). 
Amplification technology will provide the tools necessary for rapid, reli­
able detection of these agents as well.
Automation of these tests will also become important in the next de­
cade. As more biotechnology pathogen tests become available, the volume 
of testing will mandate the implementation of cost effective automation 
to streamline and standardize testing in food microbiology laboratories.
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Calgene is a leading United States plant biotechnology 
company organized in 1980 to develop and commercial­
ize new crop varieties and plant products developed 
through the use of biotechnology. Plant biotechnology 127
offers the opportunity for both the proprietary protec­
tion of genes which are isolated and patented, and the 
development of new plant cultivars which are produced 
using these genes. In some cases, researchers will be able 
to develop multiple products from a single gene, while in 
others the developmental cycle of new plant products 
will be shortened given the tools of biotechnology. Cal­
gene currently focuses on three crops: rapeseed for use in 
the production of both edible and industrial oils; cotton 
for improved fiber quality, herbicide safening and insect 
resistance; and tomatoes for both the fresh and process­
ing markets.
The work described here presents the current status 
of Calgene’s anti-sense polygalacturonase tomato. 
Polygalacturonase (PG) is a pectin-degrading enzyme 
found in ripening tomatoes which has been correlated to 
tomato fruit softening and rotting by numerous investi­
gators in the past. Polygalacturonase was selected as a 
target for the genetic engineering process of tomato fruit 
quality improvement based in part on characteristics 
found in naturally-occurring mutant tomato lines 
which lack substantial levels of PG activity. Historically, 
tomato ripening mutants such as the Never Ripe (Nr) 
and ripening inhibitor (rin) have been used for many 
years in tomato breeding programs based on certain char­
acteristics determined by these mutations. Two of the 
most obvious characteristics are very slow softening and 
extended shelf life. The difficulty with these mutations
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has been that they are pleitropic in nature, as demonstrated by the fact 
that genotypes containing these mutations do not evolve ethylene nor do 
they develop color to any significant degree. These pleitropic effects have 
limited the utility of these mutant lines in commercial production.
The antisense approach to eliminating polygalacturonase in tomatoes 
seeks to avoid the pleitropic effects associated with ripening mutants and 
create a product that is more than just an extended firmness tomato, but 
is a better quality tomato in both fresh market and processing applications. 
On the fresh market side, this means a tomato that will provide the 
grower, shipper and packer with reduced spoilage and improved shelf life.
It will allow the grower to vine ripen the tomato. It will allow the packer 
the option of eliminating refrigeration and/or ethylene treatment of the 
vine-ripened material, enhancing the flavor of the product over the mature 
green or gassed tomato commonly produced today. On the processing side, 
inhibiting pectin degradation results in improved field holding of the ripe 
tomatoes and increased serum viscosity in processed product. Extended 
field storage will allow the grower to more accurately time the harvest and 
eliminate waste due to rot. Improved serum viscosity translates into a 
higher quality processed product.
The antisense approach to regulation of gene expression involves clon­
ing of the gene of interest and transforming that gene into the plant in the 
reverse orientation. Analysis of mRNA, protein and enzyme activity of 
transformed plants has confirmed the utility of this approach. Selected 
transformants have reductions of PG mRNA levels and subsequent enzyme 
activities of over 99 percent relative to non-transformed controls. Calgene 
has produced a number of lines of transgenic tomato to test the utility of 
these new genotypes relative to both the naturally-occurring ripening mu­
tants and non-transgenic controls. To accomplish this evaluation it has 
been necessary to produce this material on a large scale in the field. This 
has been accomplished in cooperation with the Campbell Institute for 
Research and Technology.
Our first field evaluation was planted in Guasave Sinaloa, Mexico, dur­
ing the winter of 1988-89. There were several objectives of this trial: mor­
phological evaluation, a test of field holding, and an evaluation of fruit 
processing characteristics. Morphological evaluation confirmed the lack 
of any of the commonly observed pleitropic effects associated with the 
known ripening mutants. Results of the field holding experiments indi­
cated a significant difference in the ability of the transgenic fruit to hold
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up under adverse field conditions, and processing evaluation indicated a 
highly significant improvement in the serum viscosity and juice consis­
tency of transgenic fruit versus non-transgenic controls.
To confirm these results, as well as make additional selections from nu­
merous transgenic lines, a second field trial was planted during the sum­
mer of 1989 in Yolo County, California. Fruit from selected lines was pro­
cessed for analysis. Results indicated that in all cases, for each non-pectin 
related parameter measured, (total solids, soluble solids, pH, titratable 
acidity, and color), there were no differences between transgenic and non- 
transgenic controls. In the case of the pectin-related parameters examined, 
very significant positive differences were observed in serum viscosity 
(Ostwald test). Additional observations made both in the laboratory and 
in the field indicated the possibility of enhanced resistance of the trans­
genic material to certain fungal pathogens that are normally encountered 
both in the field and post-harvest during commercial production. Results 
of initial laboratory experimentation demonstrated enhanced resistance 
of transgenic fruit to two common post harvest pathogens, namely Rhizo- 
f>us stolotiifer and Geotrichum canadum. While initial results are encouraging, 
additional research needs to be carried out to determine the range of en­
hanced resistance which exists as well as the mechanism involved.
Our most recent field evaluation was conducted in Ruskin, Florida, dur­
ing the winter of 1990. Material grown included third generation transfor­
mation events of three genotypes, CIR1, CIR2, and Rutgers. The focus of 
this experiment was to evaluate transgenic fresh market tomatoes homo­
zygous for the antisense PG gene for their ability to withstand commercial 
packing and handling practices at different stages of ripening relative to 
non-transgenic controls. The trial was planted in February and harvested 
in late May. Fruit was harvested by hand following standard commercial 
practices in Florida, sorted depending upon developmental stage (mature 
green, pink, red) and packed into 25 pound boxes for storage. The finished 
harvest totaled just over five thousand pounds. Harvested fruit was trans­
ported by truck to a commercial packing shed were it was treated as fol­
lows: mature green fruit was gassed with ethylene for five days while be­
ing stored at 65°F and 65 percent relative humidity and then removed from 
the gas rooms and stored as described above for an additional five days 
with the exception of the ethylene gas. Fruit harvested pink and red was 
stored for ten days as described with no ethylene treatment. After the ten 
day storage period, the three genotypes, CIR1, CIR2, and Rutgers, were
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evaluated for firmness relative to non-transgenic controls by measuring de­
formation of the fruit under a 500 gram load for a period of 15 seconds. In 
all, more than 900 fruit were evaluated and the results of the analysis indi­
cate that in all cases, the transformed material was firmer and more intact 
after ten days of storage as described. Currently, further experimentation is 
underway to evaluate the utility of this trait in hybrid combination as well 
as to expand the breeding effort into commercial lines.
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The 1990s have become the decade of food safety and 
environmental awareness. The entire social contract 
between consumers, food producers and provisioners is 
in transition. From a consumer's perspective, safety, 
healthfulness, and the environmental aspects of food 
are interrelated and inseparable. The dramatic success 
of agricultural biotechnology has led to expectations 
and demands for products with desirable composition 
and food value that are safe and wholesome, and a food 
supply that is bountiful, appealing, nutritious, health­
ful, economic, convenient and safe.
In addition, as the American consumer has become 
more weight-and health-conscious, food is expected 
to impart health benefits which extend beyond mere 
nutritive value. Consumers recognize weight gain and 
its' associated effects on health as a national health 
problem. The Institute of Food Technologists (IFT) re­
cently estimated that over 34 million people in the 
United States are overweight—13 percent are described 
as severely obese. The population has evolved into a 
“lean conscious society” where a high priority is placed 
on ways to get and stay trimmer. People are more con­
cerned about exercise, consumers' diet, and food qual­
ity assisting in this change in lifestyle. This conscious­
ness is evident in the desire for leaner animal products 
with less fat and cholesterol than found in traditional 
animal products.
Along with consumers, the animal industry also 
wishes to reduce the wasteful production of excessive 
carcass fat. The current yearly production of six billion 
pounds of waste and trim fat from beef cattle is equiva-
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lent to two Iowa corn crops in feed energy, and must 
be reduced as rapidly as possible. While extensive 
trimming of animal products’ fat occurs from slaugh­
ter through to the consumer and results in a reason­
ably lean animal product, preventing excessive fat 
deposition where it occurs will minimize carcass 
waste, increase production efficiency, and effectively 
reduce the caloric content of the animal product de­
livered to consumers.
To accomplish this requires use of biotechnology in the production seg­
ments; for animals this is during stages of growth and production. A rap­
idly increasing fraction of consumers also expects foods to be further pro­
cessed and table or consumption ready, requiring new technologies in 
post-harvest segments of food production. Further, the desire for food 
safety assurance will require development and integration of sensitive 
biotechnology-based monitoring throughout all stages of producing a food 
from conception to consumption in HACCP quality assurance systems.
Role of Biotechnology in Quality and Safety of Animal Foods
The use of biotechnology will be evident in foods which are modified in 
composition or character, while technologies used to produce or to assure 
safety may not be as obvious in the food ytr si. Nonetheless, all are impor­
tant in economically producing consumer-desired products. Perhaps, in 
part, because such a small fraction of the United States population (i.e., 
less than three percent) is directly involved in production agriculture, time 
and opportunities exist to surface concerns regarding the way in which 
foods are produced.
Consumers, for several reasons, have become increasingly concerned 
about the quality and safety of the food supply, including animal derived 
foods. This reflects concerns surfaced through media and special interest 
attention to unknown risks in the environment and food supply. Consum­
ers are now questioning whether, in fact, biotechnology should even be 
used in food production. The basis for biotechnology's use in producing 
consumer-desired animal products must be explored in order to further un­
derstand these concerns.
Why Use Biotechnology in Animal Production?
The animal industry must regulate animal production in order to deliver 
consumer-desired foods and/or other required specialty (i.e., health) prod­
ucts. Appropriate technologies allow the modification of animal products
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to better fit consumers' nutritional needs and desires. Currently it is diffi­
cult sometimes to separate food from medicine since many foods contain 
components (i.e., specific types of fibers) associated with improvement in 
some body function. As opportunities arise to genetically engineer animal 
systems to produce specific needed protein compounds, such as insulin 
and other life-support proteins in milk, the distinction between medicine 
and food will become even more clouded. Biotechnology will become an 
even more important component in the modification or regulation of key 
aspects of animal production from conception of the animal through deliv­
ery to the consumer, to allow the efficient provisioning of needed animal- 
based food and health products.
Current technologies used in animal production modify growth, result­
ing in leaner products with less fat. For example, beef production incorpo­
rates anabolic implants which produce a leaner product. Emerging technol­
ogies promise similar options for pork and poultry, with applications for 
fish as well. It would be unfortunate if safe, efficacious technologies for 
producing safer and healthier consumer-desired animal products were re­
jected by consumers on the basis of misinformation through special inter­
est (i.e., vegetarian, animal rights) agendas. In assessing options for the 
use of biotechnologies, those which enhance real and/or perceived product 
quality or safety and the quality of life of the consumer are most readily ac­
cepted. Unfortunately, the value of these technologies has not been com­
municated to consumers with the same message penetration as the emo­
tional appeal for “natural” food production systems.
What Needs To Be Modified In Animal Food Products?
Food products suitable for biotechnological modification include meat, 
milk, and eggs. Many animal products currently produced may need to 
be modified to provide foods more closely aligned with contemporary nu­
trient needs and food choices of specific consumers. For many reasons, 
amounts of fat, specifically those fatty acids known to elevate cholesterol 
production (saturated with more than 16 carbons) or those known to en­
hance tumor growth (i.e., 18:2, Iinoleic), may need to be reduced in com­
mon diets in many people. Hence, appropriate changes in both fat content 
of foods and composition of fat present (fatty acids) may be desirable. 
Cholesterol levels in foods per se are not as important, because only a small 
fraction of this cholesterol is absorbed—therefore diet contributes only a 
very small fraction of the overall daily cholesterol production in humans. 
Nevertheless, consumer perceptions indicate that a reduction in choles­
terol levels in animal foods would also be desirable.
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Other modifications could also be useful. For example, the amount and 
type of protein present in foods is also important, and changes in animal 
function to produce consumer-desired types of protein (e.g., white vs. red 
meat, fiber size, etc.) would be useful. Biotechnology which reduces levels 
of natural carcinogens, or enhances levels of anti-carcinogens also would 
be important in producing animal foods which are perceived as safe. Op­
tions to accomplish this currently exist for some components (e.g., aflatox- 
ins) and have been studied or are in development for others (e.g., pesti­
cides).
Mechanisms To Modify Animal Products
Animal food products represent an integration of events ranging from ini­
tiation to harvest, and from post-harvest processing to produce, preserve 
and deliver foods to consumers. In turn, biotechnological options to mod­
ify animal products exist in all segments of production. Some key options 
include: modification of substrates used, modification of growth and sys­
temic production processes, and post-harvest product processing. These 
are accomplished in several ways and can be categorized as follows: 
feedstuff selection and processing 
digestive tract processing physiology 
physiological repartitioning 
tissue specific modification
Feedstuff Selection and Processing Although this is an area that has re­
ceived substantial attention, especially in recent years, feedstuff selection 
and processing is not a new phemomena. For quite some time, mechanisms 
which modify the fatty acid composition of animal products have been es­
tablished, particularly in animals, with minimal microbial modification of 
feeds prior to absorption. For example, the fatty acid composition of pork 
and poultry products largely reflects dietary fatty acid composition. As a 
consequence, composition of fat within some limits can be modified easily 
in meat products from these species through the selection of feed ingredi­
ents.
Once a desirable combination of fatty acids for human needs is clearly 
established, feeding-management systems can be developed to produce 
products which better reflect these needs. Challenges in the preservation 
and development of consumer-acceptable products with modified fatty 
acid composition are substantial and will provide numerous opportunities 
for biotechnology.
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Further opportunities to modify the fatty acid composition of products 
such as meat and milk from cattle and sheep are limited currently and will 
require development of novel biotechnology to make 
substantial progress. Selection and processing of feed- 
stuffs to limit microbial access to, and modification 
of, fatty acids represents an area of current interest 
and considerable challenge. Some progress with cal­
cium and other salts of fatty acids (i.e., fatty acid 
soaps) has been demonstrated and products are cur­
rently being marketed for dairy cattle, primarily to in­
crease energy intake and milk fat production with 
lesser emphasis on modification of milk fat composi­
tion. Further development of related biotechnology 
will be required to produce significant modification of 
fatty acid composition of beef or lamb products.
Another area of biotechnologically important feedstuff processing is the 
development of procedures to sequester, degrade and/or limit absorption of 
natural and synthetic toxins such that safer animal products without these 
toxins can be produced consistently. For example, products developed for 
other feed uses have found application in binding aflatoxins to limit ab­
sorption in animals, thus reducing levels of toxins in products such as milk. 
Further development of this technology is encouraged, emphasizing op­
tions which limit further transfer of natural, environmental, crop produc­
tion and microbial feedstuff toxins to animal products. Such measures will 
be required to establish consumer confidence in the production of safe 
meat and milk products.
Digestive Tract Processing Physiology Much research has been con­
ducted on digestive physiology in order to understand the absorption 
mechanisms for various nutrients and substrates for metabolism. Biotech­
nological applications in two major areas may be important. One, options 
which alter the distribution or function of specific microbes in the fermen­
tative compartments of the digestive tract of ruminants may in turn alter 
the substrates delivered for use to the animal tissues. Possible modifica­
tions include: volatile fatty acids and long chain fatty acid modification 
and synthesis resulting in altered composition of fat in animal food prod­
ucts produced. Two, modification of the digestive tract conditions and pro­
cessing through pH, enzyme activity, flow rates, passage, retention time, 
and absorptive mechanisms, among others, will allow altered substrate
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delivery to the animal tissues. This will modify the 
rate and composition of animal tissue growth, pro­
ducing modified food products.
Physiological Repartitioning to Produce Leaner 
Animal Products Repartitioning of growth and the 
consequent modification of animal products has re­
ceived major attention in recent years. Repartitioning clearly provides the 
most direct and efficacious mechanism for changing the protein and fat 
content of animal tissues. The objective is to repartition the growth pat­
terns in animals to produce leaner animal products and less fat from all ani­
mals. While repartitioning is the eventual goal of many genetic engineering 
initiatives, systems employing these concepts such as transgenic animals 
are not likely to surface any time soon. A number of options are feasible in 
developing systems employing growth regulating biotechnology in several 
forms to produce leaner animal products, and these include the following:
a. Genetics
b. Endogenous regulation
intact animals
castrated-spayed
autoimmunization
c. Exogenous regulation
repartitioning agents
estrogens
zeranol
androgens (e.g., TBA) 
growth hormone 
beta-agonists
growth hormone releasing factor
Mechanisms of regulation include: priorities for protein vs. fat, redirec­
tion of nutrients, tissue mobilization, and limits for daily deposition
All options listed above have been investigated to varying degrees across 
animal species in developing targeted growth management systems to 
most efficiently produce desired leaner animal products. While genetic di­
rectives provide general targets for body and carcass composition, other 
factors really determine the extent to which these theoretical limits will 
actually be reached, or how patterns and priorities for growth will be fol­
lowed or translated into and realized as growth. In all animal types, the en­
ergy available translates genetic directives through tissue regulation into 
patterns of growth.
The objective is to re­
partition the growth 
patterns in animals to 
produce a leaner ani­
mal product and less 
fat from all animals.
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Nutrition is directly linked to rate and composition of growth in several 
ways. Available energy is used to meet maintenance needs, protein growth, 
and fat deposition, primarily in that order. Thus, composition of meat 
products reflects levels of available substrates provided relative to mainte­
nance and limits for protein growth with additional energy usually depos­
ited as fat. The magnitude of nutritionally regulated changes in body com­
position at a given weight reflect animal priorities, rates of growth and 
length of time that animals are growing at respective rates. Slower (defer­
red) growth for extended periods of time invariably results in leaner car­
casses at any selected weight. External regulation through growth-regulat­
ing biotechnology redirecting growth allows the integration of growth po­
tential with nutrient supply resulting in the desired animal products.
Repartitioning mechanisms involved in redirection of growth include: 
modification of priorities for nutrient use for protein vs. fat deposition; al­
teration of tissue turnover; modification of daily tissue deposition limits; 
and modification of nutrient supply. Eventually, growth hormone, releas­
ing factors for growth hormone, beta-agonists and/or immunization strat­
egies to remove negative feedback on growth (e.g., somatostatin) may pro­
vide additional mechanisms with which to regulate growth. These may 
work in concert with, or replace, current growth regulation technology. 
These alternatives are currently in development.
Current estrogenic growth regulators such as growth hormone, and 
beta-agonists used in development for several animal species, are effective 
repartitioning agents which modify growth by shifting nutrients from fat 
to protein accretion (Fig. 1). Also they usually enhance rate of growth as 
well, serving to further increase lean tissue production. Rate and efficiency 
of lean tissue growth are critical components in enhancing lean animal 
production through conventional animal feeding and management sys­
tems. In addition to more efficient production, they provide the opportu­
nity to regulate growth in order to tailor animal production to meet con­
sumer desires for leaner animal products. While current growth regulators 
have been used for several decades, the basis for their function has only re­
cently begun to be understood. This understanding is important for the de­
velopment of growth regulation systems which allow programmed growth 
of animals.
Recent research provides new insights into the mechanisms by which 
growth regulating biotechnologies operate in animals. Protein growth is a 
daily function, and theoretically, cellular mechanisms establish the maxi-
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Figure 1 Rate vs. composition of gain and repartitioning of nutrients from 
fat growth to protein growth vs. rate of growth.
mal rates for daily protein synthesis. In actuality, cellular limits for protein 
growth are not often reached due to physiological factors, including hor­
monal and nutritional mechanisms which set priorities limiting protein 
deposition.
Carcass animal products reflect accumulative growth from birth to 
slaughter. As a consequence, use of growth regulation biotechnologies 
from birth to slaughter provides lifetime growth regulation and provides 
the maximal redirection of nutrients from fat to protein and lean tissue 
production. The longer growth regulators are provided, the greater the in­
crease in total lean animal product with a simultaneous reduction in fat.
While several options exist for producing leaner animal products, the 
product must be acceptable, even desirable in the marketplace. Thus, the 
degree to which these production strategies impact the production of lean 
animal products must also be assessed in terms of product acceptability. 
For example, forage-fed beef, because of its darker and softer lean will not 
have the retail case shelf-life equal to that of grain fed beef. This presents a 
serious problem from the consumer acceptance standpoint. Meat from 
these carcasses is also borderline in taste acceptability.
Tissue Specific Modification Growth regulators and repartitioning 
agents function through reducing fat deposition. Since a relationship of 
fatness to marbling exists, a reduction in marbling and resulting quality
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grade can be expected when fatness is reduced. However, for example, with 
current estrogenic growth regulators, consumer acceptability, shear force, 
palatability and tenderness are altered to a lesser extent than expected 
from the reduction in fat. This reflects the greater reduction in subcutane­
ous and kidney-pelvic fat than in intramuscular or marbling fat with es­
trogenic growth regulators when nutrients are redirected from fat to lean. 
This allows carcass quality to be maintained with a lower total degree of 
fatness.
Safety Background
Growth regulators currently approved for use with beef cattle are either 
endogenous compounds already present in human and animals (e.g., estro­
gen, testosterone, or progesterone), or are compounds developed through 
biotechnology to mimic these endogenous substances (e.g., zeranol or 
trenbolone acetate). None of these compounds are ever fed to animals in 
the United States. Instead, they are placed in the ear, which does not nor­
mally enter the food chain. When used in cattle, production residues in 
meat are extremely low and lower than naturally occurring levels in meat 
from cows and bulls. Levels of hormones produced in people every day are 
many thousands to millions times greater than present in meat either 
naturally or as a result of use of a growth regulator in cattle. Also, other 
foods, especially vegetables, salad oil, etc. provide thousands of times more 
estrogen than meat from cattle, whether receiving growth regulators or 
not, and less than 10 percent of what is consumed is absorbed by hu­
mans—so the contribution from beef is truly negligible.
Growth regulators in development, including growth hormone, beta- 
agonists, growth hormone releasing factor, and immunization will be 
equally safe but also subject to public perception.
European Economic Community Safety Issues
The European Economic Community(EEC) imposed a ban on beef imports 
from the United States and other countries using anabolic growth regula­
tors commonly referred to as “hormones”. The ban was originally launched 
under the guise of “safety” issues. The directive for the ban has been adop­
ted by the EEC although all safety issues were dismissed long ago by both 
the EEC's own commission, “The Lamming Commission” and by the 
United States own regulatory agencies, the Food Safety and Inspection Ser­
vice (FSIS) branch of USDA, and FDA).
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In contrast to the United States, where biotechnol­
ogy is tightly and efficiently regulated such that no 
violative residues were found in the past four years of 
the USDA-FSIS National Residue Program, as much 
as one fourth of the beef produced in the EEC con­
tains unacceptable residues of compounds never 
cleared for use in cattle. Some of these compounds are 
known carcinogens such as DES. A safety issue exists 
with EEC beef because of the use of unapproved 
“cocktails” of many potent drugs directly injected 
into the muscle of growing cattle on EEC farms which came about as a re­
sult of bans on the use of approved products instated during the past two 
years.
While the need to 
produce leaner, 
health-promoting 
animal products has 
become painfully 
clear, the segmenta­
tion of the industry, 
and its’ divergent 
goals, objectives and 
profit centers, has re­
sulted in mixed sig­
nals at best.
Current Market Signals
While the need to produce leaner, health-promoting animal products has 
become painfully clear, the segmentation of the industry, and its' divergent 
goals, objectives and profit centers, has resulted in mixed signals at best. In 
typical scenarios, incentives to produce fatter animal products often pre­
vail. Incentives for producing leaner animal products must be established 
in all segments of the industry to assure coordination of growth toward 
optimal market endpoints.
One of the major problems is the short “shelf-life" of animals nearing 
slaughter endpoints. The concept of shelf life was developed to define the 
time and/or weight interval over which an animal maintains its current 
quality or yield grade. For some animal types, shelf-life in the feedlot may 
not be appreciably longer than post-harvest shelf-life in the retail trade. 
Extending this interval would provide more flexibility in marketing, and 
animals could increase in fatness at a slower rate, so that overfeeding 
would be less deleterious to lean animal production. Repartitioning agents 
provide options for increasing the shelf life of animals.
Diet-Health Aspects of Modified Animal Products
In concert with consumer desires to be, think, and eat “leaner”, there is 
also an interest in reducing fat consumption, particularly saturated fat, 
and cholesterol levels—both dietary and circulating. The most common 
concerns are that animal products are high in calories, saturated fat, and 
cholesterol.
An average three-ounce cooked lean beef, for example, provides only 73 
mg of cholesterol, which is less than 25 percent of the American Heart 
Association’s recommendation of 300 mg per day. This average three ounce
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portion of cooked lean beef provides only 192 kcalories of energy, less than 
10 percent of a 2000 kcalorie diet. Less than half of this energy (85 kilocalo­
ries) comes from fat and the saturated fat component contributes only half 
of that. These levels of calories from fat are far below the American Heart 
Association’s recommendations of no more than 30 and 10 percent of total 
calories from fat and saturated fat, respectively. As is evident, lean animal 
products fit well within dietary guidelines; the challenge from the produc­
tion perspective is to produce inherently lean animal products which do 
not require extensive trimming along the retail chain. Opportunities for re­
duction in fat and fatty acid modification will further advance the poten­
tial to deliver consumer-tailored, safe and healthful animal products.
Implications of Social/Political Policy
Recently, the EEC proposed a ban on imports of animal products from 
countries using growth regulators. Recent data were summarized to assess 
the impact on the industry in the United States. In a summary of growth 
regulation studies at Texas A&M University, the change in net return on a 
lean retail product basis including feed, interest, implant cost, yardage and 
with an average retail product value of $2.50/Ib, averaged $96.68 per ani­
mal. This represents a net value to the United States beef industry of ap­
proximately 2.5 billion dollars with these data as above. These data are 
consistent with results of a 1987 USDA study indicating a $2.4 to $4.1 bil­
lion reduction in net return on a retail products basis if currently approved 
growth regulators were not used in the United States depending on feeding 
and marketing management alternatives. Worldwide implications would 
obviously be much greater, and this is borne out in the USDA study.
Clearly, when safe, approved, efficacious biotechnology is banned to 
serve popular, protectionist, or political purposes, only unapproved tech­
nology will be available for use. Use of approved safe growth regulators al­
lows application of biotechnology to produce leaner beef products consis­
tent with dietary and health needs of consumers. The ban on this technol­
ogy in the EEC has resulted in the delivery of fatter beef products to Euro­
pean consumers, a situation inconsistent with the needs of United States 
and other consumers.
Similar restrictions are forthcoming or are currently in place regarding 
the use of growth hormone-based technology currently in development to 
modify meat animal products (i.e., EEC) or quantity of milk produced per 
animal (as seen in Minnesota and Wisconsin).
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In producing environmentally sensitive animal products, the adoption 
of technology (such as grain feeding, ionophores) to reduce methane, or 
growth regulators to enhance lean tissue growth, reduces the methane per 
unit of beef produced. Elimination of these technologies (i.e., growth regu­
lation ban by EEC) would result in decreases in rates of lean tissue growth 
and more methane per unit of beef produced. Hence, disallowing technol­
ogy for more efficient production of meat (growth regulators by EEC) or as 
suggested for milk production (i.e., BST) would directly increase the ani­
mal contribution to global warming by requiring the production of more 
methane per unit of product, be it meat, milk, fiber or draft power. While 
the contribution of the United States beef cattle industry to annual global 
methane production (0.5 percent of total estimated production, 0.1 per­
cent of all global warming) is not outstanding, it will be important to fa­
cilitate transfer of all available technology to enhance rate and efficiency of 
growth to reduce methane emissions from beef cattle production systems 
in the United States and worldwide, to further limit the contribution of 
cattle to global warming and changing of the earth's climates.
Conclusions
Meeting the demands imposed by consumers and industry for health con­
sciousness and animal efficiency in the production of high quality, safe, 
lean, and healthful animal products requires immediate attention to the is­
sue of increasing lean tissue and reducing fat deposition in animals. The 
ability to produce highly palatable and acceptable lean animal products is 
of critical importance for the animal industry. The calorie consciousness of 
consumers requires a sincere effort on the part of the animal products in­
dustry to produce leaner animal products to meet diet and health concerns 
of an increas.. Jly perceptive consumer. Lean animal products fit well 
within dietary guidelines; the challenge is to produce animal products that 
are lean in the carcass and do not need extensive trimming along the retail 
chain to make them lean.
Unique challenges face the animal industry in the design and develop­
ment of new technologies that will allow production of lean animal prod­
ucts rather than require extensive trimming to make them lean. This will 
require development of greater lean tissue deposition throughout the life 
cycle and extensive redirection of feed energy from fat to protein growth 
through all phases of growth.
However, society is increasingly concerned about the use of chemicals 
and residues in our food supply. The animal industry must develop, com­
municate and extend the use of current and new biotechnologies and sys­
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tem to efficiently produce leaner animal products. Technologies providing 
economic return without known benefit in enhancing quality of life and/ 
or with perceived negative human health implications (e.g., residues) may 
be short-lived.
Our primary challenge is to develop systems employing current and 
new biotechnologies which will allow us to produce specific uniform prod­
ucts from diverse animal production systems in a range of designer foods.
Most importantly, we must clearly 1) define needed 
consumer attributes of specific products and then 2) 
derive targeted-integrated biotechnology based pro­
duction systems to efficiently produce these products 
in order to 3) develop more desirable products than 
currently exist in the animal products industry. Our 
total system from conception to consumption must 
be consumer driven and must focus on the final target 
product as biotechnology-production-management-marketing options 
are selected. Concurrently, all technology implemented in the production 
system must eventually be marketed to the final consumer as well; cur­
rently this is seldom accomplished. There will be increasingly limited op­
portunities to use technologies inconsistent with quality of life of consum­
ers, and in the future, both the product as well as the system used to pro­
duce it will need to be consistent with consumer needs and attitudes.
The successful development and implementation of animal products 
will depend on consumer desires and demands. While animal-product bio­
technologies have the potential to provide seemingly desirable products 
more efficiently than current systems, their introduction and development 
relies ultimately on consumer acceptance. In addition to consumer con­
cerns, consumers and developers alike need to consider carefully the social 
and economic implications of biotechnological developments.
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The food chain can be viewed as a continuum from the 
planted seed to the processing, distribution and market­
ing of products, to the consumer’s table. The food pro­
cessing industry serves as the vital link between the 
farmer and the supermarket. Except for fruits and veg­
etables that are often consumed raw, most agricultural 
products undergo some kind of processing after leaving 
the farm gate. Biotechnology can obviously be used to 
improve the safety and nutritional quality of the food 
supply at every link in the chain. Previous examples 
have focused on how it can be used to improve the pro­
duction end of the food chain. Any genetic improve­
ment in plants and animals that serve as raw materials 
for processed foods will impact the processing of that 
product; therefore, processing parameters are an essen­
tial element of any strain improvement strategy. How­
ever, the following discussion will focus on how bio­
technology can be used to improve the processing of 
food — the utilization end of the food chain — from the 
time the raw product leaves the farm gate until it is con­
sumed.
A stroll through a modern supermarket vividly illus­
trates how processed foods have changed in the last 10 
years. With increased consumer awareness and concern 
about food quality, safety, nutrition, and convenience, 
the food processing industry has responded by formu­
lating and marketing products that meet consumer de­
mands and expectations. It is common to see expanded 
refrigerated and frozen food sections, a wide variety of 
fresh fruits and vegetables, extensive delicatessen sec­
tions featuring partially processed foods, and a vast ar­
ray of microwavable products. New product develop-
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ment often requires the utilization of new processing, preservation, pack­
aging and distribution systems, and these new systems may create the po­
tential for new microbiological, safety, quality or nutritional concerns. For 
example, although modified atmosphere or controlled atmosphere packag­
ing (MAP/CAP) and vacuum packaging can be used to improve quality and 
extend shelf-life of minimally processed refrigerated products, it also cre­
ates an environment that could permit the growth of deadly pathogens. 
Restricted use of nitrate in bacon or sulfite in potato processing creates si­
milar microbiological safety concerns. Microwave ovens have revolution­
ized home food preparation, yet uneven heating could create microenvi­
ronments that allow survival of pathogenic organisms. To meet consumer 
demands and at the same time ensure food quality and safety will require 
application of innovative and effective technologies, including biotechnol­
ogy-
What is Biotechnology?
Biotechnology has been defined as a collection of technologies that use liv­
ing systems (plants, animals, or microorganisms), or compounds derived 
from living organisms, for the production of industrial goods and services 
(Office of Technology Assessment, 1981). Biotechnology is not new to the 
food processing industry as humans have been exploiting living systems 
for the production, processing and presevation of food for centuries. Muta­
tion and selection techniques have been used to improve strains of bacteria 
and yeast used to produce fermented foods, such as cheese, sausage, bread 
and wine. Many ingredients used in processed foods including vitamins, 
stabilizers, enzymes, flavor enhancers and preservatives are currently pro­
duced by bacteria. What distinguishes the more traditional “old” biotech­
nology from the “new” biotechnology is the emergence within the last 20 
years of genetic engineering that allows the exchange of genetic informa­
tion between related and unrelated organisms. Other molecular biology 
techniques, including hybridoma technology, DNA probe technology, en­
zyme and protein engineering, bioengineering and fermentation technol­
ogy, and plant and mammalian cell culture, are also included under the um­
brella of biotechnology.
Applications of Biotechnology to Food Processing
Genetic improvement of food fermentation microorganisms Bacteria, 
yeasts and molds have been used for the production of fermented foods for 
thousands of years. Classical strain improvement methods involving muta­
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tion and selection are imprecise and uncontrollable, it is impossible to 
screen for all mutations that might occur, and the screening process is la­
borious and time consuming. In addition, one is limited to the genetic in­
formation already present in the organism. Genetic engineering provides a 
mechanism for overcoming many of these limitations as it allows for the 
selection and transfer of single, well-defined traits from virtually any liv­
ing organism in a precise, controllable and predictable manner. Table 1 il­
lustrates how genetic engineering can be used to improve microorganisms 
used in food fermentations. Examples include the impact of genetic im­
provements on the processing, nutritional value, microbiological safety 
and shelf-life of fermented foods.
Table 1 Genetic improvement of food-grade microorganisms 
Type of Nature of
Fermentation Improvement Implications
DAIRY
Cheese Bacteriophage (virus) Eliminate economic losses
resistance due to destruction of culture 
by viruses
Accelerated ripening Decreased storage costs
Yogurt Higher levels of More digestible product for
betagalactosidase lactose-intolerant individuals
MEAT
Sausage Bacteriocin production Inhibition of pathogens and 
spoilage organisms
CEREAL
Beer Alpha-amylase Used for production of “lite”
production or low calorie beer
Bread Higher levels of maltose More consistent and im-
permease and maltase proved leavening
(Taken from Harlander, 1989)
It is important to note that the first genetically engineered food-grade 
microorganism was approved for use by the British Ministry of Agricul­
ture, Fisheries and Food on March 1,1990. The manufacturer, Gistbro- 
cades, was granted permission to manufacture and supply the particular 
strain of yeast, Saccharomyces cerevisiae 352 Ng, used in the baking industry. 
The strain was genetically engineered to produce elevated levels of two en­
zymes involved in starch utilization, maltose permease and maltase. Con­
sistent fermentations result in doughs containing widely different sugar 
concentrations thus ensuring product quality.
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Healthy microbes Over 70 percent of the world’s population lose the 
ability to ferment lactose due to the gradual loss of lactase, an enzyme 
present in the brush border of the intestine that hydrolyzes lactose into 
glucose and galactose. Several investigators have demonstrated that lac­
tase-deficient individuals digest lactose from yogurt much more efficiently 
than lactose from other dairy foods (Savaiavo and Levitt, 1987). Genetic 
engineering could be used to enhance the level of microbial betagalactosi- 
dase produced by Streptococcus thermophilus and Lactobacillus bulgaricus, the 
two organisms used in the manufacture of yogurt, making the product 
more easily digested by lactoseintolerant individuals. Because elderly indi­
viduals frequently experience difficulty in digesting certain food products, 
it may be possible to use yogurt culture as delivery systems for other diges­
tive enzymes for certain target populations.
Probiotics Numerous strains of bacteria are capable of implanting 
and competing in the gastrointestinal tract of humans and animals. These 
organisms are often classified as “probiotic” as their function is to aid the 
host in some beneficial manner. Construction of strains capable of com­
petitively inhibiting potentially pathogenic gut organisms could have sev­
eral applications in agriculture and food. For example, nonpathogenic 
strains of Salmonella or other gut organisms could be engineered to produce 
broad spectrum bacteriocins. These strains could be supplied in poultry 
feed and water for biological control of pathogenic strains of Salmonella or 
other gut pathogens. The same concept could be applied to other animal 
species and to humans, as well. Lactobacillus acidophilus, a food-grade mi­
croorganism used in the production of acidophilus milk, is capable of sur­
viving passage through the stomach, and under certain circumstances is 
able to colonize the GI tract. It may be possible to engineer bacteriocin- 
producing strains with enhanced colonization capability could be used to 
modulate the ecology of the gut. Consumption of products containing 
these engineered strains could be recommended for individuals who have 
completed antibiotic therapy, for travelers who might be exposed to food- 
borne pathogens, or for immunocompromised individuals who are suscep­
tible to endemic diarrhea or yeast infections.
Microbiallyderived ingredients Microorganisms produce a host of 
metabolites currently used as ingredients in processed food products 
(Neidleman, 1990). These include acidulants (acetic, lactic, benzoic, propi­
onic), flavors (diacetyl, pyrazines, lactones, esters), flavor enhancers 
(MSG), pigments (monascin, astazanthan), stabilizers and thickeners
BIOTECHNOLOGY, FOOD SAFETY AND NUTRITIONAL QUALITY FOR THE CONSUMER
(xanthan gum, dextrans), nutritive additives (vitamins, amino acids), 
sweeteners (aspartame), enzymes (proteases, lipases, cellulases, pectin- 
ases) and preservatives (nisin). These ingredients add functionality, en­
hance nutritional quality, extend shelf-life, improve convenience and en­
sure safety.
Many of the ingredients listed above are produced by organisms that 
have a long history of safe use in foods. However, there are many microbes 
in nature that produce interesting compounds that could be used in pro­
cessed foods. For example, many bacteria produce extracellular biopoly­
mers that could be used as stabilizing agents, viscosifiers, surfactants, fla­
vor encapsulating agents, noncaloric gelling agents, and as a source of 
soluble fiber in the diet. There is tremendous interest in transferring the 
gene(s) that code for production of these biopolymers into food-grade mi­
croorganisms.
Enzymes Enzymes are used extensively by the food industry as pro­
cessing aids to control texture, appearance, flavor development, and nutri­
tive value of processed foods. For example, various proteases are used to 
tenderize meat, pectinases are used to decloud fruit juices, amylases are 
used to degrade starches, caffeinases are used to decaffeinate coffee, and 
oxidases are used to remove off flavors (Neidleman, 1986).
An historic event for food biotechnology was the re­
cent affirmation (March 23, 1990) by the Food and 
Drug Administration (FDA) of “generally regarded as 
safe” (GRAS) status for the first recombinant enzyme 
to be used directly in food. Recombinant chymosin or 
rennet is an enzyme that is used to accelerate curd 
formation during cheese manufacture. Recombinant 
rennet is produced by a genetically engineered strain 
of Escherichia coli and is purified from the fermenta­
tion broth. It is interesting to note that the plasmid 
vector codes for an antibiotic resistance marker and 
that the producing strain, although not pathogenic in nature, is a gut or­
ganism that did not enjoy a long history of safe use in food prior to this ap­
plication, yet achieved FDA approval. Approval of this enzyme is a signifi­
cant milestone for the food industry as it establishes a critical regulatory 
precedent and serves as a model for other biotechnologically-derived en­
zymes and ingredients. It is also interesting to note that the recombinant 
product contains more active enzyme per unit protein and is microbiologi- 
cally safer than the traditional counterpart which is extracted from the 
forestomach of calves.
Approval ot this en­
zyme is a significant 
milestone for the food 
industry as it estab­
lishes a critical regu­
latory precedent and 
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cally-derived en­
zymes and ingredi­
ents.
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Enzyme engineering Most enzymes function optimally at physiologic 
temperature and pH; this is not the conditions encountered in food pro­
cessing operations that frequently involve high temperature and low pH. 
Genetic engineering techniques (site-specific mutagenesis) have been used 
to specifically alter the primary amino acid sequence of enzymes to im­
prove their functionality in food systems. Some examples of how enzyme 
engineering could be used to improve enzymes used in food processing are 
provided in Table 2.
Table 2
Suggestions for improved enzymatic activity through enzyme engineering
Enzyme Application Useful Improvement
alpha-amylase Starch liquefaction Acid-tolerant and 
thermostable
amyloglucosidase High fructose corn Immobilized with higher
syrup production productivity
esterases, lipases, Flavor development Improved substrate
proteases, etc. specificity
glucose isomerase High fructose corn Increased thermo-
syrup production stability
limoninase Debittering of fruit More complete limonin
juices degradation
protease Beer chill proofing Improved substrate 
specificity
pullulanase High fructose corn Increased thermo-
syrup production stability
(Taken from Neidleman, 1986)
More Efficient Utilization of Raw Materials
Environmental concerns and economic issues necessitate better utilization 
of raw materials and reduction of waste generated by the food processing 
industry. In the past, food processing waste streams were discharged into 
the environment or buried in landfills. However, the bioburden is great 
and soil microorganisms are not capable of degrading compounds at a fast 
enough rate. Whey from cheese manufacture, cellulosic waste from veg­
etable processing, shells from nut processing, and starch from potato pro­
cessing are but a few examples of the kinds of waste streams generated by 
the food industry. More innovative methods for converting these materials 
to valueadded products must be developed. In other countries, food pro­
cessing waste streams are used as feedstock for subsequent fermentation
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processes used to produce food and nonfood products 
including pharmaceuticals and specialty chemicals. 
As our supply of petroleum-based chemicals are de­
pleted, biotechnology-based methods will be needed 
to more efficiently utilize waste streams, surplus 
commodities and other renewable agriculture re­
sources.
Food Safety
Although it is generally agreed that the U.S. enjoys 
the safest food supply in the world, emerging pathogens, not previously as­
sociated with food, have been responsible for recent outbreaks of food- 
borne illness. Within the last five years, the dairy industry has had to cope 
with the emergence of the pathogenic organism, Listeria monocytogenes, 
which is capable of causing spontaneous abortion in pregnant women, and 
meningitis in infants, the elderly, and immunocompromised individuals.
A strain of Salmonella enteritidis has been isolated from intact eggs and en­
tire flocks of poultry appear to be endemically infected with the organism. 
There is also increasing consumer concern about microbial toxins, afla- 
toxin, chemical residues (herbicides, pesticides, fertilizers and fungicides), 
antibiotics, and animal drug residues in raw and processed foods. Rapid 
and sensitive methods based on the development of DNA probes and poly 
and monoclonal antibodies could revolutionize quality control and quality 
assurance in the food industry. Theoretically, these tests should be capable 
of detecting a single organism or toxin molecule, thus dramatically increas­
ing the sensitivity over current methods. In addition, test results are avail­
able in hours or days rather than days or weeks.
Biosensors
The highly specific action of enzymes and microbial cells can be exploited 
as analytical tools to measure the concentration of specific components in 
complex mixtures. Enzymes, antibodies or whole cells can be immobilized 
onto solid surfaces, and the specific reactions they mediate can be detected 
electrochemically, photometrically, thermometrically or mechanically 
(Wagner and Schmid, 1990). In food systems, biosensors can be used to 
measure low molecular weight, single compounds such as glucose, organic 
acids, amino acids, alcohols or food additives; complex compounds such as 
microorganisms and biological or chemical contaminants; and complex 
quality parameters such as freshness, shelf-life prediction, flavor, maturity
As our supply of pe­
troleum-based chemi­
cals are depleted, 
biotechnology-based 
methods will be 
needed to more effi­
ciently utilize waste 
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other renewable agri­
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or thermal stress. Some examples of biosensors currently under develop­
ment are listed in Table 3.
Table 3 Commercially available biosensors for food analysis
Analyte Biocomponent Application
Glucose Whole bacterial cells 
Glucose oxidase enzyme
Molasses production 
Brewing, various fermentations, 
fruit juice and soft drink manu­
facture, banana maturation
Lactose P-galactosidase enzyme Raw milk
Sucrose Invertase enzyme Instant cocoa manufacture
Lactate Lactate dehydrogenase 
enzyme
Dairy products, yogurt, whey
Ethanol Alcohol dehydrogenase 
enzyme
Alcoholic beverages, wine, 
beer, cider, fermentations
Peptides Amino peptidase enzyme Casein hydrolysis
Amino acids Amino acid dehydrogenase 
enzyme
Many foods
Glutamate L-glutamate oxidase 
enzyme
Soy sauce manufacture
Aspartame L-aspartase enzyme or 
alcohol oxidase enzyme
Level of sweetener in many 
foods including soft drinks
Ascorbic acid Ascorbate oxidase enzyme Fruit juices
Sulfite Sulfite oxidase enzyme Dry fruit, wine, vinegar, juices, 
potato flakes
Penicillin Antibody-enzyme
conjugate
Milk
PHB ester
Taken from Wagner
phydroxybenxoate 
hydroxylase enzyme
and Schmid, 1990).
Fruit juices and drinks
Conclusions
Biotechnology could have a dramatic impact on the entire agriculture and 
food sector. It has the potential to reduce the need for agricultural chemi­
cals; improve the productivity, efficiency, and profitability of food produc­
tion and processing; open new markets for improved or unique processed 
food products; and, improve the nutritional quality, safety, cost, and conve­
nience of consumer food products. Any improvement of the food supply at 
any point in the food chain will ultimately impact the utilization end of the 
system and the ultimate beneficiary of the improvement — the consumer.
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This paper provides a brief outline of the regulation of 
biotechnology across the board in the United States to­
day. An important feature of this discussion is that its 
focus is not on laws and regulations for the issues of 
biotechnology, but rather on science.
It is no surprise to those who work in this legislative 
area that regulation is not driven by legislators, law­
yers and regulators, but that it is driven by the science 
that underlies the regulation. The history of govern­
ment regulation of the food supply is the history of sci­
ence, not the history of the laws and regulations that 
have been involved.
This is illustrated by the following example from a 
statute enacted by the English Parliament in 1263. Par­
liament decreed, in order to protect the safety of the 
food supply, that nothing could be added to the then 
staple foods in England that was “not wholesome for 
man’s body”. The statutory standard today is remark­
ably similar, stating that nothing can be added to foods 
if it is a “poisonous or deleterious substance that may 
render the food injurious to health”. And I challenge 
anyone to point out the difference between “not 
wholesome for man’s body” which was the statutory 
standard 700 years ago, and “poisonous or deleterious 
substance which may render the food injurious to 
health”, which is our statutory standard today and has 
been since the English statute of 1860. There is no dif­
ference.
If the 1263 law was the only law of the land today, 
the Food and Drug Administration (FDA) and United 
States Department of Agriculture (USDA) would be
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doing nothing differently. Thus the issue is clearly an 
issue of science, not of laws and regulation. 
Government regulation of food and drugs, (which 
have always been related), has been of concern in our 
country for its entire 200 year history. Our earliest 
governmental federal statutes regulating any form of 
business were directed at the drug supply. From the 
Vaccine Act of 1813 on through the latter part of that century there was a 
plethora of laws and regulations enacted to prevent importation and ex­
portation of adulterated food of any kind. These laws and regulations did 
not deal with regulation of domestic commerce of food and drugs because 
of a concern that these were matters for state and local governments only. 
In the last quarter of the 1800s in the United States we had a constitu­
tional debate in Congress, in particular, over the role of the Federal Govern­
ment which at that time was thought to be restricted to foreign commerce. 
Domestic commerce was considered a matter solely for state, local and 
county governments.
It was only the first decade of this century that Congress’ and the Su­
preme Court’s view changed. At that time, the laws that are seen today 
were put in place. Between 1900 and 1910, there was the Vaccine Act of 
1902, the Food and Drugs Act of 1906, the Federal Meat Inspection Acts of 
1906 and 1907, and the Insecticides Act of 1910. These laws effected what 
we still regard, with years and decades of enactment and revision, as our 
basic food protection laws. In the 1970s a plethora of amendments and re­
visions and new environmental statues were added. In addition to these 
regulatory laws, an overlay of broad statutory authority exists, vested in 
the United States Government, which regulates indirectly.
For example, the National Institutes of Health (NIH), the Department 
of Defense and other government agencies have broadly contracted grant 
authority, and that authority can be used to impose any form of restriction 
believed reasonable. That was the origin of the recombinant DNA guide­
lines created in the 1970s at NIH.
Many basic research scientists in the debate that occurred in the mid- 
1970s were shocked to discover that they could be regulated. The theory 
was promoted in conferences such as this from 1976 to 1978, by scientist 
upon scientist who took the lectern and said, “We demand the right to free­
dom of speech!”, to which I always responded “Everybody in this country 
has the right to freedom of speech, but you do not have the right to free-
PETER BARTON HUTT
Scientists are as dom of action, if freedom of action, including research,
subject to regulation means potentially putting others at danger.” Our 
in our country as any . . . .
other form of com- courts have always been quick to point out the differ-
mercial enterprise. ence between speech and action. Any research scien­
tist who wished to espouse recombinant DNA re­
search was free to do so without restrictions. But once in action, the basic 
bench scientist stands in no different a position than the railroad or the 
pharmaceutical industry, or the food industry or anybody else. Scientists 
are as subject to regulation in our country as any other form of commercial 
enterprise. I cannot tell you how disappointed the research scientists were 
to hear that news.
Regulatory statutes can often be divided into two basic kinds of stat­
utes—those that deal with products, like foods and drugs, and those that 
deal with processes, usually industrial processes, like clean air and clean 
water.
For the purposes of looking at how recombinant DNA and biotechnol­
ogy can be regulated, it is presented as a progression from the laboratory to 
the consumer. This progression begins with basic chemicals. Is there any 
regulation of basic chemicals in our country? Absolutely; starting with the 
Toxic Substances Control Act, enacted in 1976 precisely to fill the gaps of 
all the other regulatory controls enacted over the years and to make sure 
that there was no lack of regulation. Before a new chemical of any kind 
may be put to any use in this country, it must survive a pre-market notifi­
cation submitted to the Environmental Protection Agency (EPA), and it 
must not be vetoed for marketing. The Environmental Protection Agency 
has the identical authority over all new chemicals that the FDA had over 
all new drugs between 1938 and 1962. Not pre-market approval, but pre­
market notification and veto—a slightly different form of regulation, but 
one which is effective nonetheless. And very stringently used by EPA these 
days. Therefore, basic chemicals are fully subject to regulation by the 
United States Government.
Next, an examination of plants and animals. Just plants as they sit there 
in the field, and animals as they walk around. Suppose we start tinkering 
with them, as we all know we are. Are they regulated? There are actually 
more regulations and more regulatory laws authorizing USDA in particular 
to regulate plants and animals as such than there are anything else in this 
entire system.
1 will name some of these. The Organic Act allows USDA to prevent 
plant pests; the Plant Pest Act, the Plant Quarantine Act, the Noxious
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Weed Act, the Federal Seed Act, Animal Quarantine 
laws, the meat and poultry, egg and food laws, the En­
dangered Species Act, and then the Department of the 
Interior has the authority to restrict the import and 
introduction of exotic plants or animals into the 
natural ecosystem. There are enough laws here. In 
fact, we have more than enough laws. It makes sense to take all of these 
crazy statutes and try to put them all together and make sense out of 
them. Something that Congress has never considered, and in its current 
state of affairs, probably will not get around to.
It is silly to think that entire new plant systems or animals could be in­
jected into our environment without government control. Having at one 
point served on an Office of Technology Assessment (OTA) Committee 
looking precisely at the issue of whether there were regulatory gaps in this 
area, we could find none.
The introduction of plants and animals into consumer products—do we 
have authority there for the government to control the issue? We have the 
FDA, of course, and its control over food safety, that I will come back to in 
a moment; EPA continues to control pesticides; the Consumer Product 
Safety Commission was authorized in 1972 to control all consumer prod­
ucts not otherwise regulated by USDA or FDA; and we have USDA author­
ity with continuous inspection over meat, poultry, and eggs. The odds of 
anything slipping through that system are very small indeed.
Let us go on to the workplace, where these products are produced. The 
Occupational Safety and Health Administration (OSHA) was created in 
1970 precisely to deal with all workplace effects. In 1985, OSHA an­
nounced that its controls applied to all use of biotechnology in any work­
place whatever including the research laboratories.
Let us look then at the environmental effects. Effects in the air, the wa­
ter, the so-called, one of the great misnomers of all time—“deliberate re­
lease” problem. The Environmental Protection Agency has plenary author­
ity under Clean Air Act, Clean Water Act, Resource Conservation and Re­
covery Act (RCRA), Superfund, the Marine Protection Act and a variety of 
statutes and regulations that we need not get into. The environment is as 
clouded with regulatory control as is the food and drug supply.
Transportation—is there any way that these rambunctious recombi­
nant DNA molecules can be transported around the country under unsafe 
conditions? Well, the post office itself has already issued regulations saying
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you cannot mail them. The Center for Disease Con­
trol (CDC) has control over all etiologic agents of any 
kind; nobody can deal with them without CDC ap­
proval. The Department of Transportation deals with 
them under the Hazardous Materials Transport Act. 
So we have more than enough authority there.
Now you might say that pretty much covers everything. But additional 
regulatory controls in the United States make sure there are no cracks in 
this entire regulatory edifice. To make certain that everything else is con­
trolled, Section 301 of the Public Health Service Act in effect authorizes 
the Public Health Service to do anything they need to do to protect the 
public health. Section 361, which I actually authored in the debates in 
1976, is the single regulatory control mechanism for all of the new biotech­
nology. It states that the public health service, including FDA, may take 
any action of any kind whatever, intra-state or inter-state, in order to pre­
vent (not control) the spread of communicable disease of any form. It is a 
holdover from 100 years ago, in the days when we were terribly concerned 
about the spread of infectious disease. That statute, one sentence long, 
could be used to control all aspects of biotechnology.
Thus we have a regulatory scheme in place in the United States today 
that is more than sufficient to control biotechnology. The real problem is 
enormous overlap of among these statutes. There is virtually nothing that 
cannot be controlled. I will get to two issues that have been raised about 
that. My judgement is there is no gap here, only the real problem of admin­
istrative overlap and therefore the need for administrative comity. I always 
pronounce that very carefully; we have enough administrative comedy.
The problem is one of coordination, making certain that we do not kill an 
industry, kill a research, kill the greatest opportunity for humankind to im­
prove public health that the world has ever seen.
There have been many people who have suggested that on top of all of 
this, we need new statutes and regulations to deal with biotechnology per 
se. I find that ludicrous. The attempt by the United States Senate in par­
ticular in 1978, to enact legislation designed to deal precisely with a broad 
new overarching control of biotechnology in my judgement would have 
nipped the scientific promise of biotechnology before it could have begun. 
That was successfully avoided by scientists uniting in their opposition; by 
discussions in particular with Senator Edward Kennedy, scientific progress 
and the need for flexibility; and by taking upon themselves in one of the
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most extraordinary and wonderful events 1 have ever seen in the field of 
science, self-regulation through basically a voluntary regulatory system 
set up by the NIH in the form of the recombinant DNA guidelines; the de­
velopment of the Recombinant Advisory Committee (RAC). If science had 
not acted responsibly, and had not done that, we would have seen the Sen­
ate enact legislation and we would not have the progress that we have seen 
to date.
The two issues mentioned as needing additional controls are: worker 
surveillance, (as though OSHA did not exist and did not have its author­
ity), and “deliberate release”, (to return to what I regarded as one of the 
great misnomers of all time). I keep pointing out the whole purpose of 
biotechnology is to release something into the environment, otherwise if 
you contained it, it would not very useful. Nonetheless, that has become 
one of the issues in terms of adequate regulation.
Our OTA committee reviewed the issues in detail and concluded that 
once again, we have more than enough laws. If we needed to energize some 
of our regulatory agencies to utilize those statutes, to take the opportunity 
to increase regulation in particular areas where it was needed, that was 
fine. But we did not need new laws and regulations.
Now let me turn very briefly to FDA and the regulation of food in par­
ticular. No new food ingredient—whether we call it a whole food or a food 
substance (we are not going to call it a food additive because that prejudges 
the issue), may be used in the food supply in the United States whether in 
meat or poultry or any other food unless it satisfies one of three criter­
ia: 1) it must have been approved by USDA or FDA between 1938 and
1958, (i.e., a prior sanctioned substance); or 2) it must be “generally recog­
nized as safe”, a GRAS substance; or 3) it must be the subject of a food ad­
ditive regulation. If it is not one of those three, it is illegal.
It is very simple. We have a wonderfully easy system, when you get 
right down to it. All you have to do is understand those three concepts. 
Now obviously there were no recombinant products prior to the Food Ad­
ditives Amendment of 1958, and so one might easily conclude that ends at 
all. New biotechnology has to be regulated through a food additive regula­
tion. Not true.
When one takes a plant and alters it, one can do that by natural breed­
ing or selection or one can do it by recombinant DNA. When FDA issued its 
regulations well before biotechnology in the early 1970s, the agency antici­
pated the kinds of issues from breeding and selection and said that it is a
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matter of judgement—a matter of science, not of laws and regulations—as 
to when a food ingredient is so changed that it is no longer subject to a 
prior sanction or a GRAS determination and requires a food additive regu­
lation. Or when it changes just slightly, but not enough to worry about, it 
can remain subject to that prior sanction, or subject to an existing GRAS 
determination, or indeed subject to an existing food additive regulation, 
and does not need a new regulation.
Now FDA issued those regulations before Paul Berg did his work and the 
Recombinant Advisory Committee was formed. The regulations have not 
changed and they do not need to be changed. Some have argued that FDA 
should be more explicit; they should lay down heavy, rigid rules, telling ev­
erybody when things have changed so much that you need a new regula­
tion and when they are sufficiently similar that you do not need a new 
regulation. I think that would be foolhardy. I think we would have rules 
and regulations that would tie us in knots rather than being helpful. Flex­
ibility is a far greater attribute in government regulation than rigidity. It is, 
I hope, as meaningful to all of you as it has been to me, that the first FDA 
approval of a recombinant product came not in the form of a new, rigid, 
regulation, but in the form of a GRAS determination, thus sending a signal 
that FDA is prepared to remain flexible in its regulation in the future.
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Biotechnology and Food Safety
Creat economic and social forces flow like a tide over half-conscious people. The 
wise are those who foresee the coming event and seek to shape their institutions and 
mold the thinking of the people in accordance with the most constructive change.
The unwise are those who add nothing constructive to the process, either because of 
ignorance on the one hand or ignorant opposition on the other.
English economist and philosopher John Stuart Mill
Lester M. Crawford
Administrator
and
Denise L. Clarke
USDA
Food Safety and 
Inspection Service 
14th & Independence 
Washington, DC 
20250-3700
Biotechnology will yield an expanding array of new 
foods, food ingredients, food additives and new pro­
cesses to produce existing products. These include 
bruise-free fruit, crisper celery and sweeter carrots, caf­
feine-free coffee beans, and low-calorie sweeteners. 
The Food and Drug Administration (FDA) recently ap­
proved rennet, the first biotechnologically produced 
enzyme approved for use in food. Much animal bio­
technology research focuses on producing transgenic 
livestock and poultry that will utilize feed more effi­
ciently, grow to desired slaughter weights at an earlier 
age, and be resistant to a variety of diseases. Farmers 
stand to benefit from reduced production costs, im­
proved efficiencies, and higher quality products. Con­
sumers will benefit because farmers will be able to sup­
ply leaner meat and poultry produced with a decreased 
dependence on vaccines, drugs and insecticides. In ad­
dition, consumers may see reduced prices at the grocery 
store, since farmers will produce animals of the same 
weight as is currently produced, but in a shorter period 
of time with lower production costs.
While these products and events are exciting possi­
bilities, difficult decisions lie ahead in biotechnology. 
For example, bovine somatotropin (BST) which only 
needs to pass long-term animal health tests before re-
To best prevent food 
safety problems, gov­
ernment, industry 
and consumers must 
acknowledge their 
respective responsi­
bilities for ensuring 
safe food.
ceiving FDA approval, holds great promise for dairy 
farmers. Bovine somatotropin has been declared safe 
by FDA; yet it continues to be the target of food 
safety accusations.
Food safety is an easy target for biotechnology critics, 
as consumers are already confused and worried about 
food safety. A recent survey by the Food Marketing 
Institute reported that only 15 percent of those sur­
veyed were “completely confident” that the food sold in grocery stores is 
safe. Sixty-four percent of consumers said they were “mostly confident” 
about supermarket food.
A recent Michigan Department of Agriculture survey indicated consu­
mer confidence in food had declined and that food safety depended upon 
government inspection and regulation. Those surveyed said increased food 
product testing was the single best method to improve food safety. From 
the perspective of the FDA this may appear to be a positive finding, how­
ever, it gives rise to a concern that some consumers feel that more sampling 
and testing is the single key to safer food.
Sampling and testing are important for detecting potential violations 
and problems, but detection is not the optimal way to ensure food safety. 
At the Food Safety and Inspection Service ( FSIS), the emphasis is on pre­
venting rather than detecting food borne contamination. Prevention is the 
best way to deal with drug abuse, and it is the best way to ensure food 
safety. To best prevent food safety problems, government, industry and 
consumers must acknowledge their respective responsibilities for ensuring 
safe food. The inspection services are becoming more science driven, and 
intend for their evaluation of biotechnology products to be based on sound 
science.
The Food Safety and Inspection Service is responsible for ensuring the 
safety and wholesomeness of meat and poultry. Last year, 121 million head 
of livestock, almost 5.9 billion birds, and 150 billion pounds of processed 
product were inspected. The Food Safety and Inspection Service is the 
agency that provides the final assurance that the meat and poultry prod­
ucts of biotechnology are safe. Some food safety responsibilities are shared 
with other agencies. In order to ensure that plans for new products are 
well coordinated, a Food Animal Biotechnology Information Exchange 
Group has been organized. Representatives from USDA, which includes 
FSIS and the Animal and Plant Health Inspection Service (APHIS); FDA
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which includes the Center for Veterinary Medicine and the Center for Food 
Safety and Applied Nutrition; and the Environmental Protection Agency 
(EPA) meet regularly to consider jurisdictional issues and anticipate prob­
lems and concerns.
Bringing improved foods to market requires the scientific assurance of 
safety. Biotechnology products are expected to be safe, but that safety 
must be demonstrated and documented to ensure 
public health and to win public confidence. At FSIS, 
animal products of biotechnology will be reviewed 
and approved under existing regulations. A formal po­
sition is currently being developed regarding how 
products of biotechnology that affect the meat and 
poultry industry will be reviewed and evaluated. The 
current position is based on technology as it is now, 
but the position will evolve over time to keep pace as 
new technology becomes available and as scientific findings point to the 
need for changes. We want our regulatory process for biotechnology to be a 
public one. Surprises do not do anyone any good. We cannot afford to oper­
ate behind closed doors with consumers questioning our actions or deci­
sions. We intend to share our recommendations with USDA's Agricultural 
Biotechnology Research Advisory Committee to ensure all scientific con­
siderations have been taken into account. Scientific considerations are our 
number one priority.
Food safety decisions must be based on the best science available. Emo­
tional and socioeconomic issues, while important, cannot play a role in de­
termining the food safety of biotechnology products.
There are two main areas to review in the current thinking on evaluat­
ing the safety of biotechnology products for the meat and poultry indus­
try: substances added to meat and poultry products, and transgenic ani­
mals that carry a desired gene.
Substances added to meat and poultry products With a biotechno- 
logically-derived enzyme, flavoring or other food additive, FDA is the 
agency responsible for approving the products for safety. Once the prod­
ucts have been approved by FDA, a safety and efficacy evaluation will be 
conducted for the specific use of the product in meat and poultry products 
at defined concentrations and specific formulations. This secondary re­
view certifies the substance as safe and effective in meat and poultry in its 
planned use and that it presents no nutritional or other concerns.
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Transgenic Animals The safety assessment of transgenic animals 
should be conceptually very similar to the evaluation of traditional ani­
mals. Biotechnology merely provides methods for making well-understood 
and precise genetic changes. In most cases, the changes themselves will be 
modest, directed at health, disease prevention and nutritional quality. In 
fact, the precise nature of the genetic change is known with transgenic ani­
mals, directing the safety inquiry to the appropriate issues. Traditional 
breeding provides no such clues. Also, if the animal containing the desired 
genetic material is healthy, it is very likely the animal will be safe to eat. 
Just as is the case with traditional animals, the health of the animal is an 
important indicator of its safety.
The safety evaluation of transgenic animals focuses on two topics: the 
genetic insert and the nature of the gene product. The genetic insert is
the piece of DNA added to the genome of transgenic animals. Unless it is 
infectious, it is of no consequence. The DNA of ani­
mals and plants that are consumed is all part of the 
food.
Although the gene product must be examined care­
fully, the safety questions are not new. Genes produce 
proteins, the evaluation of which is not new. Genes 
produce proteins and the evaluation of proteins is a routine food safety 
consideration. The FDA will be consulted on animal drug and other phar­
macological products, and EPA on gene products that have pesticidal activ­
ity. If the protein product is alleged to be identical to other proteins already 
in the diet, we will require data to support its identity. In all cases, we will 
use existing tolerances and safety considerations for gene products that 
have the same effect as traditionally produced drugs, pesticides or addi­
tives.
Should biotechnology provide new products for which there are no tol­
erances or safety guidelines, we will require the appropriate toxicity and 
pharmacokinetic data to ensure the safety of the product.
To summarize our regulatory plans, FS1S expects that once the safety of 
the gene product is established, transgenic animals are likely to require 
similar safety considerations as traditional animals.
The use of biotechnology is not always an appropriate trigger for over­
sight. However, the method of production should not be ignored. As in the 
safety review of traditionally produced food additives, the safety assess­
ment takes into account contaminants likely to result from the particular
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tory process for bio­
technology to be a 
public one. Surprises 
do not do anyone any 
good.
BIOTECHNOLOGY, FOOD SAFETY AND NUTRITIONAL QUALITY FOR THE CONSUMER
process. The same will be done with products of biotechnology. Plans for 
regulating biotechnology products will afford consumers the same high 
level of safety and confidence they have enjoyed for years. Science will 
drive FSIS decisions. Hopefully science will drive regulatory decisions 
worldwide.
Biotechnology is international in scope and it is imperative that its 
safety be judged with scientific standards. We intend to work with Codex 
and other international organizations such as the International Plant Pro­
tection Conference and the International Office of Epizootics to review in­
ternational food standards as they relate to biotechnology. These groups 
can help coordinate scientific standards that ensure the food safety of bio­
technology products. Harmonized food safety standards will help settle in­
ternational disputes, reduce trade conflicts and improve consumer confi­
dence.
Codex will hold a biotechnology consultation in November, 1990, at 
which experts will discuss the food safety implications of biotechnology 
and will determine whether there are any food safety questions that can­
not be handled by the current Codex organizational structure. The United 
States is also working with the European Community (EC) to resolve food 
safety disputes. Secretary of Agriculture Clayton Yeutter and Under Secre­
tary Richard Crowder met in early June with their counterparts from the 
Office of European Community Development. The Secretary has also set 
up regular consultations with the European Community’s Director Gene­
ralship for Agriculture to discuss food safety. These forums should prove 
useful in discussing potential disputes early rather than waiting for con­
flicts to arise.
Biotechnology will see its share of conflict. It is a new technology that is 
entering the marketplace at a time when consumers are anxious about the 
use of technology in food production. Consumers want “natural” products 
that are free of synthetic additives. They also want nutritious, convenient, 
high quality, well-packaged foods—all of which require technology. Bio­
technology will help give consumers what they want.
Biotechnology will help fight bacteria that contaminate food. Biotech­
nology can reduce the fat in meat products and add nutritional value to 
other products. A long road lies ahead in convincing the American public 
that technology and its use in food production is not bad, and FSIS is com­
mitted to helping consumers understand the role of technology—including 
biotechnology— in food production and safety. Biotechnology critics are
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poised to impugn food safety as a rallying point against the new technol­
ogy. The government, along with the food and biotechnology industry, 
must use sound science to prove food safety and to stand behind our public 
health decisions. If emotions were allowed to overrule sound science, un­
justified food safety scares are risked along with a total loss in consumer 
confidence. We would also be breaking our trust with the public, which ex­
pects us to do the right thing, even when it is difficult and controversial.
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There was a time when food safety was a relatively con­
cise discipline. In those halcyon days, foods were con­
sidered safe unless eating them made one ill. People 
based the selection of their daily fare on fondness, not 
fear. But times have changed. Today, many people eat to 
prevent disease, especially chronic diseases such as ath­
erosclerosis and cancer. Food safety has come to encom­
pass much more than the prevention of foodborne ill­
ness.
1 recently heard a lecture by one who tends toward 
zealotry on the subject of nutrition. He charged that 
our food supply is inherently unsafe because of its com­
position. The enthusiast of whom I speak happens not 
to like fat very much—nor salt, nor meat, nor a host of 
other things including the cooking practices Americans 
routinely use, and he blamed all of this for causing can­
cer, heart disease, or both.
Now I happen to support the notion of eating a well 
balanced diet in moderation. But there is no reason to 
be an extremist on the topic. Moreover, it seems self-ev­
ident that a nation blessed with the world's largest and 
most diverse supermarkets cannot, at the same time, 
suffer from a compositionally unsafe food supply. That 
is, unless every single food is unsafe—and if such is the 
case, one might wonder why the Social Security system 
is in so much trouble. But regrettably the unsafe food 
charge is heard again and again, and it is having an ef­
fect. An effect, I would argue, that is not particularly 
healthy.
Continual harping from some quarters about the 
supposed “unsafeness” of the traditional food supply -
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be it too much saturated fat or too many pesticides - 
has eroded public confidence in its own institutions 
like the Food and Drug Administration (FDA) and the 
United States Department of Agriculture (USDA), as 
well as trust in the food industry, and even the pro­
nouncements of academic scientists. (That last hits 
too close to home.) The simple fact is that every person in this room who 
wishes to market a novel food is affected by a malignant climate of mis­
trust that pervades the land. If the public worries about the safety of the 
traditional food supply, it will worry ten times more about the safety of 
new foods.
So we really have two tasks: convincing ourselves that a novel food is 
safe, and then convincing the public that it is safe. I will address the former 
task.
It is essential that the burgeoning food biotechnology industry develop 
a firm grasp of the scientific data base underlying food safety. Additionally, 
the scientific data base must not be confused with, or dismissed because of, 
concerns raised in the context of arguments that really center on non-sci- 
entific matters. I am thinking here of economic or political issues where 
food safety may be inappropriately raised in an attempt to bolster a partic­
ular point of view. A good example is the furor in Wisconsin over the use of 
bovine somatotropin.
Table 1 shows a ranking of food safety concerns. It was developed by 
FDA in the mid-70s. According to FDA, the most important food safety 
hazard is microbial contamination. This conclusion is based on tangible ev­
idence, not theoretical possibilities. Foodborne pathogenic microorganisms 
and their toxins cause substantial amount of illness and economic loss (Ar­
cher and Kvenberg, 1985; Todd, 1985).
Table 1 FDA Ranking of Food Safety Priorities
1. Microbial Contamination
2. Nutritional Imbalance
3. Environmental Contaminants
4. Naturally-occurring Toxicants
5. Pesticide Residues
6. Food Additives
(Schmidt, 197$)
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Next in line from microbial contamination is nutritional imbalance. By 
this the FDA means two things. First are the crazy, dangerous diet plans 
that many Americans are lured into trying each year. Serious illness and 
even death is a tragic, but well documented, by-product of such ill-advised 
personal experimentation. But in addition to this there is also the general 
problem of poor eating habits, in particular gluttony, which when com­
bined with the lack of physical activity can compound a genetic tendency 
toward certain chronic diseases. An outcome of poor eating habits and too 
little exercise is obesity with its clear link to heart disease, diabetes, and 
some forms of cancer. Unfortunately obesity affects too many Americans.
In contrast to microbiological contamination and nutritional imbal­
ance—risks for which clear and unequivocal scientific evidence certainly 
exists—there are only theoretical calculations for the possible adverse ef­
fects of environmental contaminants, naturally-occurring contaminants, 
and pesticide residues. One of the most comprehensive scholarly reports 
in the peer-reviewed scientific literature to address this issue—an epidemi­
ological report published in 1981 by Sir Richard Doll and Richard Peto—es­
timated that the cancer risk associated with these sources is extremely 
small. And as for food additives, there is no evidence that they are harmful 
under the intended conditions of use. To the contrary, some additives (e.g., 
antioxidants) actually protect against cancer in animal experiments and 
may also reduce cancer risks in humans (Ames, 1983; CAST, 1987).
Given all of this, one might imagine a slightly different depiction of this 
table. Table 2 is the expert’s view of food safety. It comes closer, but still 
does not do the situation true justice. Indeed, if microbiological concerns 
were set at, say, a million, then food additives would be “worth” at most 
one, if that much.
Table 2 Proportional Representation Of Food Safety Issues
microbial contamination 
nutritional imbalance
environmental contaminants 
naturally-occurring toxicants
pesticide residues 
food additives
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Table 2 is based on science, and anyone who takes the time to become 
familiar with the scientific data is bound to concur. Unfortunately, the 
public inverts this ranking believing that the last three are major causes of 
human health problems. It is going to take a lot of education to straighten 
this mess out, made all the more challenging because of the cries from 
those who intentionally distort food safety issues for reasons that are not 
at all related to food safety or science.
But let us go back to hurdle number one—convincing ourselves that a 
new food is safe. How can the information in this table be applied to that?
First, let us talk about microbiological issues. In general, foods derived 
through biotechnology will not carry greater risks of contamination with 
pathogenic microorganisms or microbial toxins than do conventional 
foods. In this regard it is worth reviewing the factors that control microbi­
al growth in food: pH, type and concentration of acid, water activity, the 
concentration of sodium chloride and other electrolytes, the availability of 
nutrients and growth factors, and the levels of microbial growth inhibi­
tors. Any change in the composition of a food that affects one or more of 
these factors will influence the chances of that food becoming a vehicle for 
foodborne illness (Pariza, 1990).
For example, most varieties of tomato exhibit a pH value no higher than 
4.5 which is sufficiently low to preclude the growth of pathogens such as 
Clostridium botulinum, the causative agent for botulism. However, the pH of 
some tomato varieties is above 5, clearly too high to prevent the growth of 
C. botulinum and many other pathogens (Powers, 1976). Hence, foods pre­
pared with high pH tomatoes may have to be handled differently than 
foods prepared with conventional tomatoes. It is very important to keep 
this sort of thing in mind when developing low acid varieties of fruits and 
vegetables.
A second consideration is the intentional removal of a microbial growth 
inhibitor. For example, one might imagine some bright geneticist coming 
up with the idea of intentionally removing genes involved in caffeine syn­
thesis from coffee plants. The development of such a “naturally” decaf­
feinated coffee bean might be desirable for a variety of reasons including 
making the marketing department happy. But it could also have a down 
side. Caffeine is reported to be an effective suppressor of aflatoxin biosyn­
thesis by certain toxigenic molds (Nartowicz et al, 1979). Hence, coffee 
beans without caffeine could be at greater risk for contamination with af­
latoxin, which is a potent carcinogen in laboratory animals.
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Another potential problem could arise from the intentional introduc­
tion of a new nutrient into a food plant. Suppose, for example, that the nu­
trient should happen to be a required growth factor for a particular patho­
gen. Suppose further that the pathogen does not now grow in the tradi­
tional food because that nutrient is lacking. The conclusion is that some 
other means will now have to be found to control the pathogen in the new 
food containing the nutrient.
Fortunately there are bright sides too. Biotechnology has great potential 
to aid in controlling the contamination of food by some microbial toxins. A 
case in point is a project in my department aimed at preventing aflatoxin 
production in the field, thereby controlling this mold-generated carcino­
gen at the source. Later this year we hope to begin testing the idea in the 
controlled environment of our Biotron.
The next major issue on FDA’s list is nutritional imbal­
ance, which includes poor eating habits. An important 
consequence of poor eating habits is obesity which is 
linked to increased risk of several chronic diseases in­
cluding diabetes, heart disease, and cancer. One of the 
most important contributing factors in obesity is the 
excessive consumption of dietary fat (Pariza and Si- 
mopoulos, 1987; CAST, 1987). Biotechnology can cer­
tainly help here, through the development of new 
lower fat animal and plant based foods.
There is also a big future for biotechnology in the 
development of special foods for persons with special medical problems, 
(e.g., peanuts minus the major peanut allergens), foods for those who must 
avoid certain other dietary factors, and so on. One must also be careful 
about understanding the nutritional role of traditional foods in the diet.
For instance, it would be unwise to inadvertently reduce the vitamin C 
content of an orange while in the process of introducing other changes.
With regard to environmental contaminants, it is difficult to imagine 
biotechnology contributing to the problem. But one can easily envision en­
gineering microorganisms, for example, that are able to efficiently degrade 
industrial waste products.
Naturally-occurring contaminants represent a potential focus of con­
cern. It is well known that some food plants produce potentially toxic sub­
stances, some of which are involved in protection against insects (Ames, 
1983; NAS 1973). Obviously in developing new plant foods, the level of
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naturally-occurring toxic constituents that may be hazardous to humans 
should not be increased either through direct introduction of relevant 
genes or through an unintended pleiotropic effect, that is, a secondary phe­
notypic alteration resulting from a single genetic change (Tiedje et al., 
1989). In this regard one should investigate new food plants developed by 
biotechnology for increased levels of naturally-occurring toxicants known 
to be associated with the species.
Biotechnology offers opportunities for reducing pesticide dependence 
through the introduction of naturally-occurring pesticides that exhibit 
limited host range and are also biodegradable. An important example is the 
introduction of the gene for Bacillus thuringiensis toxins into food plants 
such as tomatoes and corn.
Finally, on the list is food additives, long the bane of the so-called con­
sumer movement. It is worth recalling that food additives are used because 
they have important beneficial effects— effects which are not clearly artic­
ulated for the public as they might be. Among these effects, for example, is 
the control of microbial pathogen growth in food. Prospects for the pro­
duction via biotechnology of safe and effective antimicrobials for addition 
to food is an area of particular interest in my department. There are, of 
course, many additional opportunities for the use of biotechnology in the 
manufacture of antioxidants and other beneficial products.
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In any consideration of the potential impacts of bio­
technology on the food supply, health, safety, and envi­
ronmental impacts are emphasized first. Economic im­
pacts are next, such as societal benefits and costs, the 
organization of production, processing, and distribu­
tion; and firm profitability and market shares.
For both sets of impacts, at issue is how biotechnol­
ogy affects the chain of production and distribution 
running from input manufacturers to producers, proces­
sors, distributors, retailers, and consumers. Food safety 
and nutrition are fascinating because they link health 
and safety concerns with economic concerns. This is be­
cause the economic success of food marketing firms is 
becoming more closely linked to the safety and nutri­
tional attributes of the products they produce and sell. 
This is a key point since the closeness of this link is rela­
tively new.
The focus here is on the marketing level aspects of 
biotechnology, particularly on consumer acceptance 
which will ultimately determine biotechnology’s suc­
cess or failure in the marketplace. This paper operates 
with a premise that sets aside considerations of what 
safety standards government agencies will apply to ac­
ceptance of biotechnology-related products. These con­
siderations, while important and a major topic of dis­
cussion at this conference, are not directly relevant 
to this discussion.
Therefore, it will be assumed that the biotechnol­
ogy-related ingredient, drug, process, or product under 
discussion has been accepted under roughly the same 
government safety standards currently in effect for con­
ventional ingredients, drugs, processes, and products.
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The question then is: How will biotechnology-re­
lated products be marketed? Several earlier presenta­
tions, particularly Carol Tucker Foreman and Kenneth 
Taylor, noted that biotechnology is coming on the 
market in a very specific context, which is the result of consumers’ experi­
ences in the 1980s. This context will be considered first, and then market­
ing issues particular to biotechnology-related products will be discussed.
The Current Food Marketing Environment
In the last decade, increased scientific evidence and consumer awareness of 
links between diet and health have created an expanded market for food 
products that fit specific safety and nutrition profiles. The shift in demand 
coincided with significant changes in the regulatory environment during 
the 1980s. Firms have developed at least two major strategic responses in 
the face of these changes in demand and the regulatory environment 
(Caswell and Johnson, 1990). The first response has been the development 
of strategies that create product or establishment differentiation based on 
food safety and nutrition. The second response has been to develop strate­
gies that attempt to manage any potential liability or exposure to govern­
ment regulation associated with food safety and nutrition issues.
The differentiation-based strategies are domain offensive in nature. 
Firms using them seek to increase or, at a minimum, maintain their market 
shares by emphasizing the food safety and nutrition attributes of their 
products or services. Such differentiation may be based on product charac­
teristics or, in the case of retailers, on the services offered by the firm (e.g., 
screening of fresh produce for pesticide residues). These strategies empha­
size positive information and, where possible, suppress negative informa­
tion. In the current marketing environment, food safety and nutrition 
have become a new basis for non-price rivalry between firms in the food 
system. For example, market shares in the ready-to-eat cereal industry 
have shifted based on the leading firms’ relative success in marketing high 
fiber cereals.
This new emphasis on differentiation and marketing based on food 
safety and nutrition developed in the 1980s because of several factors.
First, as noted above, scientific and consumer knowledge improved and 
consumers subsequently altered their demand for some food products in 
response. Second, the federal government’s policy on health claims made 
by firms on their food labels changed. After 1984, and certainly after 1987, 
such health claims became legal under lenient standards and enforcement
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by the Food and Drug Administration (FDA). This change gave firms a 
much broader scope for effectively communicating differentiation based 
on food safety and nutrition. Third, and at the same time, the Federal 
Trade Commission was lax in pursuing deceptive advertising cases against 
major food products. These latter two factors combined to create a virtual 
free-for-all atmosphere for firms wishing to pursue differentiation strate­
gies.
Fourth, and finally, there was an increased perception among consumers 
in the 1980s that the federal regulatory system was not adequate to insure 
food safety. Many commentators, and several speakers at this conference, 
have implied that this erosion in confidence was the result of hyping of the 
food safety issue by the media and special interest groups. In fact, however, 
the erosion in confidence was due in large part to inadequate government 
regulation during the 1980s, which was documented in a long series of re­
ports (U.S. General Accounting Office 1986a, 1986b, 1989; National Acad­
emy of Sciences, 1987).
Examples of marketing based on food safety and nutrition attributes are 
abundant. Growers and manufacturers have engaged in product innova­
tion to produce frozen foods that meet nutritional recommendations (e.g. 
ConAgra’s Healthy Choice line), baked goods that contain no fat or choles­
terol (e.g., Entenmann’s No-Fat, No-Cholesterol line), and beef products 
produced without use of hormones, antibiotics, feed additives, or preserva­
tives (e.g., Coleman’s Natural Beef). Distributors and retailers have simi­
larly engaged in differentiation by offering services to consumers such as 
in-store nutrition information programs and testing of fresh produce for 
pesticide residues.
The second major strategic response of food firms to changes in demand 
and regulation has been to develop strategies which aim to manage any po­
tential liability associated with food safety and nutri­
tion or attempt to protect the firm from the impacts 
of government regulatory activities. This strategic re­
sponse tends to be defensive in nature and focuses on 
the management of negative attributes and informa­
tion. While often designed to protect specific aspects 
of the firm’s operations, these strategies may also at­
tempt to influence public opinion on the general issue 
of food safety and nutrition, often though repeated 
assurances that the food supply is safe.
Biotechnology re­
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Thus the marketing of biotechnology-related products will take place in 
the context of a market that is sensitized to food safety and nutrition is- • 
sues. It is a market made up of firms and consumers who now have experi­
ence with marketing and differentiation based on food safety and nutrition 
attributes. Biotechnology related products will have to compete not just 
against traditional or conventionally grown products but also against an ar­
ray of products that are sold based specifically on their food safety and nu­
trition characteristics.
Marketing Biotechnology-Related Food Products
A crucial decision facing firms is how to market biotechnology-related food 
products. There appear to be two basic choices. First, firms can treat 
biotechnology related production processes and products as if they were 
just another process or product. In this case, marketing would emphasize 
the positive attributes of the product but not focus on its unique or new 
origins. Second, firms may differentiate the product based on its biotechno­
logical origins. This may work well if the firm has some exclusivity (or at 
least temporary exclusivity) in marketing the product. For example, mar­
keters may be able to stress positive food safety and nutrition attributes re­
sulting from the biotechnological origins of the product, e.g., grown with 
fewer pesticides or containing a higher nutrient content.
But marketers must be aware that even if they prefers the first approach 
events are, at least in the foreseeable future, unlikely to allow a firm to sim­
ply finesse the biotechnology issue. The experience to date with bovine so­
matotropin (BST) bears this out, as will be discussed further below. The dif­
ference in today’s market is that passing a government approval process, 
even when the process is stringent, is no longer enough for the consumer. 
Wishing that it was, is simply howling at the moon at this point in time. As 
several speakers noted yesterday, consumers will evaluate these products 
and the processes with which they were developed based on a range of risk 
and value considerations.
Unfortunately, there appears to be a great deal of resentment in some 
parts of government and the food industry that this is the case. Without 
question, there is ample room for a better understanding of food safety, nu­
trition, and biotechnology among consumers. But this is not a one-way 
street with experts presenting information and “straightening out consum­
ers' perceptions”. To look at the process this way is to take a condescending 
view toward consumers' own safety and value agenda. This agenda may 
not be that of the scientists but it is no less valid.
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As we look to the marketing of biotechnology-related 
food products, there are two major issues. First, again 
assuming that the food product has been approved for 
sale by the government: Who is going to sell 
biotechnology to the public? The candidates are drug 
or ingredient manufacturers, growers or farmers, food
Who is going to sell 
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gredient manufactur­
ers, growers or farm­
ers, food manufactur­
ers, retailers, trade as- r .
sociatlons, govern- manufacturers, retailers, trade associations, govern­
ment, or public inter- ment, or public interest groups, 
est groups. The experience to date with BST illustrates the diffi­
culties associated with this question. It is not at all 
clear who will market BST to the public (Richards, 1989a). It appears to 
me, as an outsider, that the introducers and users of BST hoped this was an 
issue they could finesse. In other words, they hoped they could treat BST 
use as just another production process not requiring any special consumer 
marketing program. They have found that in the current marketing envi­
ronment this cannot be done. Several firms are reported to have refused to 
handle milk from cows treated with BST, either entirely or until FDA ap­
proval. These firms include one dairy cooperative (Associated Milk Produc­
ers Inc.), at least three processors (Kraft, Borden, and Ben and Jerry’s 
Homemade Ice Cream), and four retail chains (Safeway, Stop & Shop, 
Kroger, and Van's). In a situation where processors and retailers are increas­
ingly basing major parts of their marketing strategies on food safety and 
nutrition, firms will be very hesitant to risk their hard-earned differentia­
tion by selling products that raise safety concerns while yielding only small 
benefits to themselves. The firms mentioned above apparently found this 
private benefit/cost tradeoff to be negative for BST milk, at least in its ini­
tial period of use.
So, who will sell BST to the public? Supermarkets complain that the 
makers of BST are dumping the responsibility for allaying consumer fears 
regarding BST on them. An official of the Kroger Co., for example, is 
quoted as saying, “If they think it's safe, let them step up the plate and de­
fend it" (Richards, 1989b) and, “If we’re going to make any mistakes on 
this, we’re going to make them on the side of safety” (Ingersoll, 1989). The 
firms’ differentiation strategies make them reluctant to accept any risks to 
their reputations that might be associated with marketing biotechnology- 
related products that have not already been broadly accepted by the public.
The second major marketing issue facing biotechnology-related prod­
ucts is: What information disclosure will be required in the presentation of
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In marketing, the the products? And, in addition: Who (federal or state
biotechnology issue government) will require this information? Labeling 
can not be simply fi- . . . .  ,
n8ssad is an attractive option in the current market atmo­
sphere of increased consumer awareness because it is 
responsive to consumers’ desire for control. It is also 
attractive to regulators who wish to place more reliance on markets rather 
than government agencies for making choices regarding food safety and 
nutrition.
We are, I think, groping for a policy on when provision of information 
through labels is a desirable regulatory strategy. Many firms have not pre­
sented a consistent front on this issue. If firms believe that more informa­
tion is better for the consumer in the area of health claims, can they in 
good faith object to the labeling of biotechnology-related products? My 
prediction is that for controversial biotechnology-related products, label­
ing will be widespread. Either government units will require labeling to 
identify such products or some firms will voluntarily label that they do 
not use any biotechnology-related processes or ingredients in their prod­
ucts. In either case, consumers are likely to be able to identify products 
that are biotechnology-related from those that are not. Again, in market­
ing, the biotechnology issue cannot be simply finessed.
The key question, ultimately, is how biotechnology-related products 
will compete in a marketplace made up of traditional and conventionally 
processed products and those that are being marketed specifically on the 
basis of food safety and nutrition attribute. This is a clouded question at 
this point in time.
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An integral part of modern society is the socio-econo­
mic change associated with scientific advance. Biotech­
nology promises potentially significant changes in agri­
cultural production and food processing. Emerging ap­
plications of biotechnology to crop and livestock pro­
duction are capturing the attention of researchers, the 
business community, farmers, policy-makers, and vari­
ous special interest groups. Yet, surveys indicate that 
many people are unaware of agricultural biotechnology, 
while others are concerned about its potential negative 
impacts on food safety, small farmers, and rural com­
munities (Office of Technology Assessment, 1985, and 
Hassebrook and Hegyes, 1989).
Four fundamental questions appear to surround the 
agricultural biotechnology debate: Is it safe? Is it ethi­
cal? Who wins? Who loses? This paper focuses on the 
latter two questions: Who wins? Who loses? More spe­
cifically, some of the potential socio-economic impacts 
of agricultural biotechnology on farmers and consum­
ers are addressed.
The paper is divided into three parts. First, a few 
crop, livestock, and food processing examples of bio­
technology applications are very briefly reviewed to 
place in context the subsequent discussion of the socio­
economic issues. Next, some of the socioeconomic im­
plications for farmers and consumers are addressed. 
Then, a few of the technology assessment research and 
extension issues are outlined. The paper closes with a 
few concluding comments.
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Some Examples of Biotechnology Applications
Our discussion of the potential economic implications of agricultural 
biotechnology must be cast in the context of an often emotionally and po­
litically charged and technically and economically difficult paradox: too 
much food for a few in the developed countries and 
too little food for many in the developing countries 
where 85 percent of the world’s population lives. 
Feeding a growing world population has been a con­
cern of agriculturalists and others for centuries. Dur­
ing the past several decades, scientists, farmers, the 
agribusiness sector, and government agencies have 
worked together to achieve enormous agricultural 
productivity increases, especially in the more devel­
oped economies. Often this has resulted in surpluses 
and extensive and often costly, government efforts to 
restrict production and support farm prices and income. Yet, the world 
population has passed the 5 billion mark and is expected to double by the 
mid-21st century. The challenge before us is to increase agricultural pro­
duction to meet the growing world-wide demand for food without harm­
ing the environment and without exhausting nonrenewable resources. Fur­
thermore, this must be accomplished in a world where countless agricul­
tural and trade policy distortions exist. These are currently under discus­
sion in the General Agreement on Tariffs and Trade (GATT) negotiations in 
Geneva, Switzerland.
Biotechnology holds promise for contributing to additional agricultural 
productivity increases. But it is important to remember that biotechnology 
tools complement and extend, rather than replace, traditional methods 
used to enhance agricultural productivity and to develop new production 
systems. While some see biotechnology as a revolutionary development, 
others, including myself, see the development and application of biotech­
nology tools as an evolutionary process in a stream of agricultural technol­
ogy developments that began with the mechanical inventions of McCor­
mick and Deere and the genetic discoveries of Mendel. But, of course, mod­
ern agricultural production and food processing systems have their earliest 
roots in humankind’s domestication and genetic selection of plants and 
animals and food fermentation processes that span many centuries.
In plants, genetic engineering can be used to enhance classical breeding. 
Engineering plant resistance to herbicides, insects, diseases, and environ­
The challenge before 
us is to increase 
agricultural produc­
tion to meet the 
growing world-wide 
demand for food 
without harming the 
environment and 
without exhausting 
nonrenewable re­
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mental stress shows great promise. Excessive or improper herbicide and in­
secticide use can cause environmental damage. Altering the genetic make­
up of plants to render them resistant to insects will lessen the need for 
chemical insecticides. Except for some concern about possible buildup of 
insect resistance to genetically-altered plants, there is relatively little con­
troversy about the development of insect-resistant plants and bioinsect­
icides.
Controversy is growing concerning the development of herbicide-resis­
tant plants, however. The critics suggest that this will result in more herbi­
cide use and more soil and water pollution (Hassebrookand Hegyes, 1989, 
p 26). They also worry about excessive dependence on monoculture of row 
crops such as corn or cotton, rather than the use of rotations that include 
nitrogen-fixing legumes and biological weed and insect control tech­
niques. The critics fear that the development of herbicide-resistant crops 
will not encourage a more sustainable agricultural system. In contrast, ad­
vocates claim that with herbicide-resistant plants, more environmentally 
benign herbicides can be used. They believe that fewer and less toxic com­
pounds will be applied. Frequently, this debate centers around who will 
control the technology, i.e., what control the agricultural chemical and 
seed companies will have (Doyle, 1985).
In animals, biotechnology has already made economically feasible the 
use of bovine somatotropin (BST) to increase milk production and feed ef­
ficiency in dairy cattle. Milk productivity increases in 
commercial herds of 10 to 15 percent are anticipated 
with a 5 to 10 percent increase in feed efficiency. Use 
of porcine somatotropin (PST) and ractopomine, two 
swine repartitioning agents, can result in leaner pork 
and more efficient feed conversion. Research trials 
have reported increases in rate of gain of 10 to 45 per­
cent, feed efficiency increases of 15 to 35 percent, 
backfat reductions of 15 to 70 percent, and increases 
in loin-eye of 10 to 50 percent. Other promising ap­
plications of biotechnology to animal agriculture in­
clude disease diagnostic probes, embryo transfer, and genetically-engi­
neered vaccines (Riepe and Martin, 1989).
Some believe that biotechnology will have its greatest impact on in­
creasing food processing efficiency. There are several ways this could be 
achieved: altering raw materials, such as the water content of tomatoes;
Thus tar, there seems 
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processing. This is 
somewhat surprising 
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food safety.
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altering enzymes and microorganisms used in bioprocessing, such as 
chymosin for cheese production; or discovering new uses for food process­
ing wastes, such as whey from cheese production. Thus far, there seems to 
be less controversy surrounding the applications of biotechnology to food 
processing. This is somewhat surprising given the growing national inter­
est in nutritious diets and food safety. Yet, much of the diet debate has 
been on cholesterol and red meat consumption, fiber intake and oat bran 
consumption, weight control and exercise programs, and fat and calorie in­
take. Much of the food safety debate has been on pesticide residues. This 
may change, however, as biotechnology is increasingly used to alter the in­
gredients in processed foods and food processing techniques. A current ex­
ample of this are the concerns raised by some about the safety of milk from 
BST-treated cows.
Producers and Consumers
Many biotechnology innovations will be cost-reducing which will benefit 
farmers and food processors initially. However, consumers can ultimately 
benefit through lower prices and improved food quality and variety. This 
has been the pattern of most agricultural technology adoption over the 
past one-half century or more (Cochrane, 1979). However, the magnitude 
and distribution of these potential cost-saving benefits to producers and 
consumers will depend on the nature of the technology, its review and ap­
proval by government regulatory agencies, its acceptance by producers and 
consumers, the market structure for the commodity or food, and regula­
tions in the food industry. Consumers will benefit more in relatively com­
petitive markets with price inelastic demand functions.
Much of the concern over agricultural biotechnology is directed to­
wards its potential to accelerate the long time trend towards fewer and lar­
ger production units (Office of Technology Assessment, 1985). This trend 
may increase the influence of large corporations on the decision-making 
and fate of farmers and residents of rural communities. Technology-driven 
changes in farm structure are not new. Over the past 3 decades the number 
of farms in the United States has fallen by 45 percent from 4 million in 
1960 to 2.2 million in 1990, while average farm size has increased by over 
50 percent. Concurrently, the farm population declined from 19 million to 
5 million, i.e., from about 9 percent to 2 percent of the United States popu­
lation. Also, farm employment declined from 7 million to 2.8 million 
people (Council of Economic Advisers, 1990 and United States Depart­
ment of Agriculture, 1974 and 1989). The controversy surrounding BST in
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the dairy sector offers an object lesson in the biotechnology and structural 
change debate (Sun, 1989). Mechanical milking machines, artificial insemi­
nation, nutrition research, and other innovations have pushed average 
milk production per cow from 5,842 pounds in 1955 to 14,244 pounds in 
1989, about a 2.5 percent annual increase. Since cow numbers fell by about 
one-half from 21 million to 10.3 million during this period, the total milk 
supply increased only about 0.5 percent annually. However, during the 
most recent 15-year period increases in milk production per cow and total 
milk supplies both have grown about 2 percent annually. A recent United 
States Department of Agriculture (USDA) study estimates that with a 
dairy price support of $10.10 per hundred weight (cwt) and the introduc­
tion of BST, the annual increase in milk productivity per cow would be 
about 3 percent and the annual increase in the total milk supply would be 
about 1.5 percent (Fallert et al., 1984). These anticipated increases in milk 
production and productivity due to BST are not significantly different 
from the impacts of past dairy technologies. The interpretation of the 
above data for the dairy sector depends, in part, on one’s policy goals and 
value system. The critics of the introduction of BST emphasize that, in 
most years, milk has been in surplus, and that in the early-1980s the fed­
eral government spent about $ 2 billion annually to support the price of 
milk through Commodity Credit Corporation removals of cheese, butter, 
and nonfat dried milk (United States Department of Agriculture, 1990). 
Despite these government programs with relatively high milk price sup­
ports, the number of farms with milk cows has declined from 1.8 million in 
1959 to 202,068 in 1987 (United States Department of Commerce, Bureau 
of the Census). Those who have left the dairy industry generally have been 
the smaller, less efficient producers, poorer managers, those with less ac­
cess to capital, or those less able to make technological adjustments. A coa­
lition of consumers, save the family farm advocates, and critics of biotech­
nology have successfully influenced legislation in Wisconsin and Minne­
sota that placed a temporary moratorium on the use of BST
On the other hand, advocates of BST emphasize that most technologi­
cal advance begins with early adopters who benefit from the new technol- 
ogy by increasing production efficiency, reducing per unit production 
costs, and increasing per unit profits. Eventually, competitive pressures en­
courage a wider adoption of the new technology and the efficiency and 
cost-saving attributes of the technology are passed on to food processors 
and consumers in the form of lower prices and more abundant supplies.
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The advocates of BST claim that this technology is just the latest in a long 
stream of new technologies in the dairy sector that has influenced the 
structure of the dairy industry and resulted in a more efficient, competi­
tive dairy sector, with most of the economic benefits eventually being 
passed on to consumers. Advocates of BST also note that it is not a capital- 
intensive technology such as the installation of milking facilities, but a 
relatively inexpensive variable cost of production. However, BST use will 
require excellent production, record keeping, and financial management 
skills.
Both critics and advocates of BST recognize the influence that govern­
ment dairy price support policy has had on the rate of structural change in 
the dairy sector and on taxpayer costs. Where they disagree is on the desir­
ability of further structural change in the dairy industry and on whether 
consumers will actually realize any benefits from the technology. Food and 
environmental safety and government program costs also are sometimes 
mentioned.
There are some interesting similarities and differences between the pub­
lic debates over biotechnology products in the swine and dairy sectors. Al­
though PST and ractopomine also are awaiting Food and Drug Administra­
tion (FDA) approval in the near future, there has not been the public out­
cry as in the case of BST. This may be because of less media attention, be­
cause pork is not associated with mothers and babies as is milk, or because 
consumers want leaner pork with less fat. The application of these new 
technologies in the swine sector will offer larger supplies of cheaper, leaner 
pork and make pork more competitive with beef and chicken at the retail- 
level.
The swine industry in the United States has experienced considerable 
structural change as evidenced by a 50 percent reduction in the number of 
hog producers over the last 10 years. Potential structural changes in the 
hog sector due to biotechnology parallel those of the dairy sector, i.e., early 
versus late adopters, additional management requirements, and increased 
competitive pressures (Riepe and Martin, 1989). It is also important to ex­
amine the effects of a new technology on the input markets such as the de­
mand for various feeds when BST is introduced into the dairy sector or PST 
and ractopomine into the swine sector (Kuchler and McCelland, 1989).
There has been less assessment of the economic implications of the ap­
plication of biotechnology to crop production and food processing. In 
many cases the farmer, and consumer, will not even be aware that a
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biotechnology tool has been used. An example might be restriction frag­
ment length polymorphism (RFLP) techniques to assist conventional plant 
breeding programs in improving the disease resistance of a plant. These ef­
forts to rapidly screen genetic material should reduce the research and de­
velopment costs and time required to produce new varieties, and in this 
turn should help reduce seed costs to farmers. In other cases, such as in­
sect- and herbicide-resistant plants, the agricultural chemical and seed 
companies will promote the sale of these genetically-engineered varieties 
as substitutes for current seed varieties and chemical pesticides.
The Research and Extension Agenda
Until very recently most technology assessment research by agricultural 
economists and rural sociologists was ex post analysis. Such studies exam­
ined observed adoption rates, surveyed farmers about their production 
practices and financial conditions, or calculated the benefits and costs as­
sociated with a technology that farmers had already adopted. (For more de­
tail on technology assessment see Martin, 1990).
The challenge before us as a research community is to conduct ex ante 
research. Policy-makers and various public interest groups want to know 
more about a new technology before it is approved by a government 
agency. Information on efficacy, proper scientific testing protocols, and 
possible environmental impacts will continue to be an important part of 
the FDA or the Environmental Protection Agency 
(EPA) approval process. Furthermore, socioeconomic 
information, even though not part of the official sci­
entific approval process, will be demanded by legisla­
tive and public interest groups.
Such socioeconomic assessment requires much closer 
interdisciplinary cooperation among social scientists 
and biotechnology researchers. We must learn to 
speak each others’ language, to write joint research proposals, and to pub­
lish in appropriate cross-disciplinary research journals and extension out­
lets.
Extension specialists must learn to treat biotechnology as a public 
policy issue much like we have treated agricultural policy. In the past, ex­
tension agents basically helped farmers adopt a new technology without 
much public discussion of its broader social and economic impacts. Today a 
much broader clientele wants to influence the development and adoption 
of agricultural biotechnology. There clearly are issues and choices that soci­
Extension special­
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ety must make through both the input and product markets as well as 
through the “political” markets.
A public policy extension approach that has been successfully used in 
many states involves public meetings where extension specialists help de­
fine the problem and explain policy choices. Furthermore, policy specialists 
provide objective technical and economic information on the implications 
of each of the potential policy choices. The goal of these public policy 
meetings is not to tell people what technology is best for them but to help 
them make more informed judgments as producers, consumers, and “vot­
ers” at the ballot box or through the lobbying process.
As scientists, we sometimes forget that few in society have the training 
or time to understand emerging scientific developments. Yet the public is a 
“consumer” of our “product”. Ultimately, it is the public that adopts or re­
jects the products generated through our research. Moreover, their under­
standing and approval of what we do influences the allocation of tax dol­
lars to support our research activities.
In a democratic society such as ours, we have an obligation to inform 
and involve the public in the process of scientific development and tech­
nology transfer. The public is no longer willing to accept self-regulation by 
scientists. But if we can provide objective, understandable information on 
the potential technical and socio-economic consequences of emerging agri­
cultural biotechnologies, most people will be able to make rational, in­
formed decisions.
For many of us this is a new role, and one which may take us away from 
our research laboratories. Yet it is critical, if the benefits of biotechnology 
are going to be enjoyed and the economic, social, environmental, and po­
litical costs minimized.
Concluding Comments
It is vital that the public becomes aware of and knowledgeable about the 
scientific advances of our day and the implications and issues surrounding 
these innovations. Biotechnology offers great potential to increase farm 
production and food processing efficiency, lower food costs, enhance food 
quality and safety, and increase international competitiveness. There are, 
however, potential environmental risks and adjustment costs that must be 
assessed.Careful evaluation of the likely benefits and costs of biotechnol­
ogy can ensure the timely and reasonable application of these emerging 
technology developments in our society. This will require increased re­
search cooperation among bench and social scientists from a wide range of
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disciplines. Moreover, we in the Land-Grant system must design and 
implement appropriate public policy extension programs to help the public 
better understand the technical and socio-economic ramifications of alter­
native choices before us as a society. If we fail in this task, controversy will 
grow and potential benefits to society will be lost. Yet, it is important to 
listen and respond objectively to those who are critical of biotechnology. 
Through this dialog we can perhaps avoid some of the errors or accidents 
that have occurred with new technologies in the past. Furthermore, by be­
ing sensitive to the concerns of those who do not understand or who fear 
the emerging biotechnologies, we may be able to design appropriate public 
policies to help people anticipate and adjust to changing market and struc­
tural conditions as the new technologies are introduced.
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Introduction
The family farm is disappearing. The family farm is 
quite enduring. New technology is the cause of social 
change. New technology is the consequence of social 
change. Biotechnology is revolutionary. Biotechnology 
is really more of the same. The world needs more food 
production. The world already produces enough food 
to meet its needs. Biotechnology will radically alter 
living nature. Biotechnology will merely reveal the po­
tential inherent in nature.
These and other antinomies are commonplace in 
discussions of the impact of biotechnology on farming 
and food production. They tend to polarize the partici­
pants in the debate, though not all participants can be 
found on the same side of each antinomy. In fact, each 
of us can be found on both sides of the debate at differ­
ent points in time. This position is representative of 
recent developments in the social studies of science. 
See, for example, Latour (1988) and Busch, Lacy, Burk- 
hardt, and Lacy (1990). Rather than attempting to 
place myself on one or the other sides in these antimo­
nies, or, alternatively, trying to arrive at some sort of 
compromise between the two, I wish to begin instead 
by asking the question: What is it about technical 
change that gives it this dual appearance? Why does 
technology appear on the one hand to be the result of 
deliberate human endeavor and on the other hand the 
revealing of nature's grand design? Why does it appear 
on one hand to be the result of heated debate and on 
the other the irresistible working out of a grand 
Hegelian plan?
Let us begin by considering the work of plant breeders. Plant breeders, 
according to textbook definitions, would appear to be engaged in the pro­
cess of modifying the genetic makeup of plants within the constraints of 
Mendelian genetics. But that is only part of the work of breeders. In addi­
tion, they perform another kind of equally important work—work that 
is essential if their discipline is to succeed. What breeders also do is to 
change the behavior of farmers, processors, wholesalers, retailers, and 
consumers. In short, plant breeders are responsible for changing human 
behavior.
Now at first this may appear absurd. After all, we have been brought 
up to think that it is sociologists, psychologists, or perhaps advertising 
agents who change people’s behavior. However, consider what it means to 
be a good plant breeder. First, a good plant breeder amasses a wide range of 
promising materials from all over the world. A good breeder knows the 
material with which he or she works very well. This kind of knowledge is 
essential since only someone who knows the material well can pick out 
the anomalies, the mutations, the extraordinary from the mass of materi­
als that have been collected. Then, the breeder selects only those materi­
als that contain the character(s) of interest which are crossed with other 
plants to produce a new cultivar. Once the cultivar is produced, we are 
told that it is simply the best that nature could offer. All the work, all the 
effort made over several years, is incorporated into the new seed, but it is 
no longer visible. The new seed looks to all much like the older seeds that 
have been around for some time. Yet, it contains within it new characters 
that were never put together in that sequence before.
This does not mean that the work of the breeder is complete. Far from 
it. If so, we would be very proud of the breeder who collected hundreds of 
jars filled with samples of new cultivars that never went beyond his or her 
office. No, the good breeder must also get people to use the new varieties. 
The diffusion models of technical change (e.g., Rogers, 1983) suggest that 
breeders develop their new varieties without much regard (at least initial­
ly) to the needs and interests of farmers, processors, consumers or anyone 
else outside the scientific community. Yet, if this were the case, it would 
be the rare, accidental innovation indeed that actually met the wants or 
needs of some individual or group. To the contrary, the good breeder will 
be in touch regularly with farmer groups, processor organizations, trans­
porters, and others to find out just what they will find advantageous to 
them. Therefore, as soon as he or she has a new cultivar to release, there 
will already be a market for it. Hightower (1973), in his much acclaimed
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and much attacked book of nearly twenty years ago, Hard Tomatoes, Hard 
Times, took the diffusion model seriously. Since all the good ideas were to 
emerge from the heads of clever scientists and be packaged as technolo­
gies that would be available to all, he was scandalized by what he saw as 
the overly close linkages between certain farmers and agribusiness corpo­
rations and public sector scientists.
But let us return to our plant breeders. The good plant breeder must 
necessarily be in touch with a wide range of (potential) constituent 
groups in order to know just which two or three of the myriad characters 
for which one could possibly breed should be the object of breeding work. 
This will involve negotiation, persuasion, and even coercion on the part 
of the breeder and the constituent groups (Busch, 1980). However, in the 
final analysis, our good breeder will choose those characters that are of in­
terest to his or her audience: those involved in the production, processing, 
and consumption of a particular agricultural commodity. In some cases, 
breeders take into account some clients but not others, leading to disas­
trous consequences. See, for example, Flora (1986). Other clients are often 
ignored by virtue of their powerlessness (Friedland, et al., 1981). In so do­
ing, the good breeder will assure that what has been created by breeding 
will be rapidly and widely adopted as the new industry standard. In short, 
the good breeder will and must be just as interested in changing the be­
havior of people as in changing the genetics of plants.
However, the agricultural sector is different from other sectors of the 
economy in at least two very important ways and these differences make 
technical change in agriculture very different than technical change in 
other economic sectors. First, in agriculture research and development are 
separated from the production of agricultural products. General Electric 
and AT&T produce nearly all of their technical innovations within their 
respective companies. Only a handful of farm businesses (e.g., poultry) do 
their own research and development work. Instead, public sector institu­
tions such as Land-Grant universities and the United States Department 
of Agriculture (USDA), and increasingly private companies of various 
sorts, provide nearly all of the desired research and development. When a 
scientist at General Electric begins to work on a technical change which 
appears to have no relevance to the firm's products or processes, his or her 
work is quickly brought under corporate scrutiny (Reich, 1985). Its po­
tential is discussed and analyzed. Market testing might even be per­
formed. In the agricultural sector, input suppliers and public sector scien­
tists perform the research and development for farmers. Private sector
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firms can and do engage in product testing on farms. And public sector sci­
entists often test new varieties in on-farm trials. However, farmers and 
other potential users are usually brought into the process much further 
down the line and they virtually never have the same interests as the pro­
ducers of the innovation.
A second difference between the agricultural sector and the rest of the 
economy is the inelastic character of the demand for most agricultural 
products. If the cost of production of automobiles or television sets is 
forced downwards through technical change, there is a compensatory in­
crease in the number of television sets sold. Certain firms may lose out as 
a result of this technical change, but the total value added within the 
commodity subsector will actually rise. Within very wide limits this is 
true for nearly all industrial products. In contrast, with a reduction in the 
cost of production of agricultural products, there is virtually no change in 
the quantity demanded. As a result there is a (temporary) glut on the mar­
ket until some farmers are forced out of business, the remaining farmers 
increase their market share, and the remaining value added in agriculture 
is distributed elsewhere—usually off the farm. Thus, public sector agri­
cultural scientists are faced with a very complex ethical decision: Do they 
not work for any organization directly involved in the production of an 
agricultural commodity? Their goal is to further the public good, so their 
loyalty must be divided among all the constituents of a given commodity 
subsector. Yet, it is almost inevitable that the result of technical change 
will be the redistribution of wealth and income within that subsector. 
Boysie Day (1978) has argued that agronomists should be revolutionaries, 
pushing aside all who would block the technical changes they propose; 
doubtless, other agricultural scientists would disagree. Ruttan (1982) has 
argued at length that scientists should not be asked to shoulder too much 
responsibility for their actions. Nevertheless, even he notes that “When 
credit is claimed for the productivity growth generated by advances in ag­
ricultural technology, responsibility cannot be evaded for the impact on 
environmental amenities or on the health of workers and consumers” 
(1982, pp. 13-21). With this rather lengthy but necessary background, let 
me now turn to agricultural biotechnology. As I noted in my introduc­
tion, there are two competing views that may be taken of the new bio­
technologies. On the one hand, it may be argued that biotechnology is 
much like other technical change. Its consequences will be little different 
from what has already been experienced. On the other hand, it may be ar­
gued that biotechnology represents a qualitative shift in the process of
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technical change in agriculture. I shall not argue for one or the other posi­
tion here. Instead, I wish to argue that both positions are in some sense 
right.
Biotechnology Is Like Other Technical Change
Biotechnology will probably have less impact on the total number of 
farms than previous mechanical and chemical technologies adopted by
farmers during the last 50 years (Buttel, 1989). This is 
the case simply because the overwhelming majority 
of farms that once existed in the United States are 
now no longer in existence. The largest 13 percent of 
farms now produce over 75 percent of the value of to­
tal production. The rate of increase is bound to slow 
as we approach 100 percent. With only two percent of 
the population on farms, the cost of replacing more people with capital 
will be far greater than it was in the past. In addition, the vast majority of 
small farms are now buffered from the effects of technical change by the 
fact that farm income is no longer the primary source of income for their 
owners. Thus, irrespective of the changes wrought through biotechnology, 
small farms are likely to continue to exist. In short, biotechnology will not 
exacerbate the decline in the number of farms, though it will certainly con­
tinue present trends.
Biotechnology will certainly continue to produce labor saving farm 
level technologies. This has little to do with the total amount of labor 
available. It has to do with the fact that labor control on the farm has al­
ways been and will continue to be a source of difficulty for farmers 
(Friedland, et al., 1981). Farmworkers, on the other hand, have rarely en­
joyed access to research laboratories and, in any case, are not the purchas­
ers of the new technologies. However, this is only a continuation of a 
long, well-established (though not necessarily morally justified, end sub­
stituting technology for labor in farming (and in most other industries as 
well)). Social scientists and others in Land-Grant Universities have been 
concerned for some time about the inattention paid to the problems of 
farm labor. See, for example, Cargill and Rossmiller (1969), Friedland 
(1984), and Coye (1984). On the other hand, biotechnology will probably 
also create some new high technology jobs in the farm input and food 
processing sectors. The factory setting in these industries makes labor 
control much easier. Again, the same could, and has been said, about 
older mechanical and chemical technologies.
In short,
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Biotechnology will 
increase the value- 
added off-farm at the 
expense of value- 
added on-farm.
Biotechnology will also continue to reduce produc­
tion costs. This, as with any new technology is an es­
sential component—though certainly not the only 
one—in its adoption. Thus, we can expect biotech­
nology to cut further both on-farm and off-farm ag­
ricultural production costs. However, the impact on consumers is likely to 
be greatest for off-farm cost reductions as the on-farm component is 
now a negligible percentage of the total cost of food and fiber.
Biotechnology will increase the value-added off-farm at the expense 
of value-added on-farm. Here again, this is an old pattern of technical 
change, due in large part to the inelastic demand for farm products as 
noted above. However, since most value is now added off-farm, new bio­
technologies will likely have less effect than the older mechanical and 
chemical technologies. In short, as Goodman, et al., (1987) have argued, the 
new biotechnologies will further both appropriation and substitution. On 
the one hand, they will further appropriation by continuing to remove cer­
tain processes from the farm and inserting them into indus- trial produc­
tion (e.g., the removal of butter processing from the farm to the factory). 
On the other hand, they will further substitution by creating whole new 
processes (e.g., the substitution of margarine for butter). In these senses, 
the new biotechnologies do not represent a significant change; they are 
merely more of the same.
Biotechnology Is Unlike Other Forms of Technical Change.
Yet, at the same time, we may argue that biotechnology is quite unlike 
other forms of technical change that have affected the agricultural sector. 
First, biotechnology will bypass the Extension Services. Previous forms of 
biological research have been marketed through the Extension Service. 
New seeds may often have been produced by private seed companies, but 
the Cooperative Extension Service has played the role of telling farmers 
what seeds would do best in given climates and soils. The creation of 
seed-chemical packages puts together decisions previously made serially. 
Extension has been skillful in recommending specific incremental changes 
in products and practices, but it has never been able to distinguish be­
tween various combinations of inputs and practices. This has always been 
left to the farmer. Hanway (1978, p. 5) has noted that “Up to the present 
time we have not really developed comprehensive, integrated, multidisci­
plinary research programs that deal with improvement of crop produc­
tion systems as systems.... In the United States most individual compo-
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Biotechnology will nents are studied independently of others. Recom-
also accelerate the mendations and educational efforts are carried out 
trend toward con­
tract integration by specialists each traveling his own way and telling
his own story. The farmer is confronted with making 
a system out of all the diverse information that comes his way. I'm sure 
experiment stations have not often assembled all the components of the 
systems they recommend to see how they function together.” In fact, in 
many states Extension no longer has the expertise (when compared to 
farmers) even to carry out its old mission; evaluation of packages is a task 
for which Extension is totally unprepared. Moreover, since the new pack­
ages will not emerge from Land-Grant research, public sector scientists 
will have little knowledge with which to support Extension programs. In 
short, the evaluation of the various packages will require skills that sur­
pass those in the Extension Service. Given the current funding shortfalls 
in Extension, it is unlikely that this problem will be remedied. More 
likely, Extension will (not so) gradually be reduced to playing a secondary 
role in farm change.
Biotechnology will also accelerate the trend toward contract integra­
tion. Already, commodities such as poultry and most processing veg­
etables are produced on contract. Such contracts specify the seeds, chemi­
cals, planting and harvesting times, and other aspects of farm production.
Some have argued that farmers who produce on con­
tract are best viewed as employees of the contracting 
company as their role in decision making has been so 
reduced as to eliminate their autonomy (e.g., Heffer- 
nan, 1984). Through the development of functional 
attribute crops, biotechnology will speed the push 
toward contract production into other commodities 
(Moshy, 1986). It will also increase the importance of precision in plant­
ing, growing, and harvesting crops in order to fit certain markets. This 
will further reduce the autonomy of farmers and will most certainly re­
duce their contacts with and needs for Cooperative Extension.
A third change that is on the horizon as a result of the new biotech­
nologies is an increase in the number of market niches in farming. Func­
tional attribute crops, already noted above, will make it possible to pro­
duce special grains for starch production, crops designed for the produc­
tion of plastics (e g., Pool, 1989), and other yet to be invented specialty 
crops. This differentiation within farming will actually reverse the long
A third change that is 
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trend toward dedifferentiation within agriculture. However, it will not 
merely involve the return to some earlier time. Consider a crop like wheat. 
One hundred years ago wheats varied enormously in quality, yield, color, 
texture, etc. Over the last century, largely as a result of breeding combined 
with product standards, there are not only fewer wheat cultivars, but also 
far less variation in the quality of wheat products. This homogenization of 
wheat has been advantageous to some in that it made it possible to trade 
internationally in wheat without seeing the product before delivery. It also 
virtually eliminated poor quality bread from the market. On the other 
hand, it is unlikely that consumers ever wanted white pan bread with the 
startling uniformity it had for more than half a century in the United 
States (Giedion, 1975). This said, the new biotechnologies offer the possi­
bility of specialized wheats designed for use in the manufacture of specific 
food products as well as for industrial uses (e.g., Aus­
tin, 1986). These new market niches will involve the 
proliferation of standards rather than a return to the 
situation of 100 years ago when standards did not ex­
ist.
The new biotechnologies will also restructure the re­
lations between farmers and researchers. Until very 
recently, farmers were seen as the primary clientele 
for public sector research. However, the entry of mo­
lecular biology into agricultural research has been accompanied by the in­
sertion of the agribusiness sector between farmers and researchers. The 
Rockefeller Foundation report (1982) and the National Research Initiative 
have supported a move to what is commonly called basic research. Agri­
culture, and particularly the plant sciences, have suffered from a lack of 
attention to fundamental questions. However, the National Association 
of State Universities and Land-Grant Colleges has noted a considerable 
decline in the numbers of plant and animal breeders employed at Land- 
Grant Universities (NASULGC, 1989). It is apparent that most of these 
positions have been filled with molecular biologists. Breeders have tradi­
tionally seen their prime clientele in the farm population. Farmers often 
visit breeders to make specific requests of them. In contrast, much of the 
work of molecular biologists only benefits farmers (to the extent that it 
benefits them at all) by contributing to the product development work in 
the private sector. As a result it is quite possible—indeed, likely—that cer­
tain problems not of interest to the agribusiness sector will not be the 
subject of public research either.
.. .the entry of mo­
lecular biology into 
agricultural research 
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The new biotechnologies also have within them the potential to 
change the very nature of food itself. In the past, the ability of scientists 
to alter food has been limited by three factors: First, nearly all genetic 
change in crop plants has been limited to that which could be achieved 
through sexual reproduction. Thus, the categories of food plants and ani­
mals were grounded in certain natural obstacles that could not be over­
come. Now it is possible to move genetic material virtually at will among 
plants, and between plants, animals, and microorganisms. Second, while 
it has been possible to mix ingredients from various sources to produce 
food products for millennia, it was very difficult (and in many cases im­
possible) to break down food products into their essential components. 
Now it is possible to consider the production of fabricated foods (e.g., 
Stanley, 1986) in which basic foods are broken down into their compo­
nent parts (e.g., starch, fat, sugar) and recombined to make wholly new 
types of foods. Finally, while human beings were required to raise entire 
plants and animals in order to obtain the parts that were edible or useful, 
we are now on the verge of being able to produce just those plant or ani­
mal parts we desire in vitro (Rogoff and Rawlins, 1987). Already, Imperial 
Chemical Industries (ICI) has managed to synthesize vanilla in vitro (Bock 
and Marsh, 1988). That product will be cheaper than vanilla from vanilla 
beans but more expensive than the artificial vanilla currently available.
Its use now hinges on whether or when the Food and Drug Administra­
tion (FDA) will grant ICI the right the call the new product “natural va­
nilla.” I shall refrain here from speculating as to the short- or long-term 
consequences of such a restructuring and industrializing of the food sup­
ply (but see Busch, 1990). Suffice it to say that such new forms of food 
will make it far more difficult for the consumer to obtain a balanced diet 
than at present. It will also make food production more and more like the 
production of other manufactured goods.
Last, the new biotechnologies will increase the possibility of what 
Charles Perrow (1984) has called normal accidents through tight cou­
pling. Until very recently, foods have been adulterated only by virtue of 
deliberate human decisions. In some cases, adulteration was the result of 
adding things to food (e.g., watering down milk), while in other cases it 
was the result of neglecting to take necessary precautions in processing. 
Our pure food and drug laws were passed with those notions in mind. 
However, the new biotechnologies raise yet another possibility: that the 
increasing complexification of food production, the creation of more and 
more complex systems in which food passes near potentially harmful sub­
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stances, raises the possibility of accidental contamination that is not due 
to any human decision but to the complexity of the systems themselves.
Conclusions: Research For What and For Whom?
In short, the very fact that the new biotechnologies have to date had very 
little effect on farming or food production makes it possible to argue both 
sides of the case. Consider the case of the gasoline-powered farm tractor. 
When initially introduced it was the subject of raging debate among 
farmers and scientists alike. Would it replace the horse and ox? Would it 
transform world agriculture? Now, with the advantage of 20/20 hindsight 
we can argue that the triumph of the gasoline powered tractor was cer­
tain. It had the necessary flexibility, it did not require feeding all through 
the winter like a horse, and it was lighter than steam tractors and there­
fore not as likely to get bogged down in the mud. In other words, the 
gasoline tractor was an inevitable step on the path to progress.
However, to do that is to forget the powerful interests that lined up 
behind the tractor and those that eventually abandoned the horse and the 
steam tractor. These interests that built repair shops and gasoline distri­
butorships, that permitted and even encouraged bank loans to farmers 
who wanted to buy tractors, and restructured rural society so as make it 
more amenable to tractor production helped to create the “inevitability” 
that the tractor had. And, at the same time, the tractor itself was changed 
considerably (Sahal, 1981). The iron wheels were replaced first with hard 
rubber and then with balloon tires permitting greater buoyancy in the 
field and less soil compaction. The power takeoff was added, permitting 
the tractor to engage in a wide variety of work far beyond what a horse 
could do by dragging a plow.
The situation for the new biotechnologies today is much the same as it 
was for the tractor at its inception. Strong claims on all sides are the order 
of the day. Yet, the outcome is quite unclear. It is conceivable that certain 
biotechnologies will go unused because certain groups see them as too 
dangerous, as a violation of deeply held values, or less desirable than other 
existing alternatives. It is equally conceivable that the new biotechnolo­
gies will push aside existing technology and social relations and transform 
society once again. Only in half a century will the “inevitability” of the 
process become apparent.
In the meantime we who are in the public sector, who are paid by the 
public purse, need to ask the tough questions that proponents of these 
and other technologies will not and need not ask: What will be the ben-
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efits of the new technologies? Which of them do we need and want?
What limits do we want to put on their development and use? Who will 
benefit from these new technologies? Will the benefits and costs be equal­
ly distributed, or will some benefit while others bear the costs? How 
much power do we want to have over the natural world? Do we have the 
wisdom to know what to do with that power once we have it?
Technology is a human creation. It is not a matter of whether its devel­
opment shall be controlled, but who shall control it? Shall it be developed 
to serve narrow vested interests or broad public goods? Shall it serve to re­
inforce widely held values or to shatter them? As I noted above, scientists 
always do double work: They at once modify nature and human behavior 
and institutions. If that is the case, then scientists have a special obliga­
tion to take these questions very seriously, and not to let funding sources, 
enthusiasm with the power of the new technology (Idhe, 1979), or per­
sonal gain or glory permit the avoidance of these difficult questions.
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Poets tell us that the locus of value judgments is the 
heart. Cognitive scientists have told us that it is the 
brain. I am here to tell you that it is the stomach. Upton 
Sinclair learned this when he wrote The Jungle, intended 
to expose the appalling conditions under which recent 
immigrants to the United States were forced to live. In­
stead, his discussion of slaughter and packing houses in 
the Midwest spawned the public outcry that initiated 
our current laws on food safety and quality. The Ameri­
can public’s ability to translate a broad range of social 
and ethical issues into food consumption issues is truly 
amazing. Criticisms of bovine somatotropin’s impact 
upon economies of scale in dairy production have been 
translated into concerns about the safety of milk, and 
animal rightists’ protests against production methods 
for veal calves have been translated into concerns about 
the human health effects of eating the meat (Browne, 
1987, Burton and McBride, 1989).
The most important ethical value associated with 
food safety and nutritional quality is human health. 
Ethical controversies associated with food safety and 
quality have evolved around the question of when to al­
low substances into the food chain, and at what levels. 
The controversy over recombinant bovine somatotro­
pin (BST) appears to raise the same question. The val­
ues and decision rules that are applied to the regulation 
of additives and residues are extremely diverse, and they 
are not mutually consistent (Halloran, 1986). Part of 
the diversity and inconsistency arises from competing 
accounts of health itself (Sagoff, 1985) but this compo­
nent of the food safety debate will not be discussed
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here. There is a pattern of argument in food safety debates that is wide­
spread across policy issues in which scientific evidence is expected to be de­
cisive. The first element of the pattern is criticism of the data, conclusions, 
or methods that have been used in assembling the scientific evidence. The 
second element is an inference to the effect that uncertainty in data, con­
clusions or methods entails risk to members of the public. The final ele­
ment is an attack upon the motives or values of scientists themselves, who 
are portrayed as trying to conceal risks and uncertainties from public view 
(Thompson, 1986).
The public discussion of foods, food additives, and chemical residues 
produced using techniques of recombinant DNA transfer has yet to move 
through each phase of this pattern. Nevertheless, the appearance of news­
paper articles raising questions about the human health implications of 
BST would appear to justify the fear that technical solutions to the mea­
surement of human health risk from the products of biotechnology will 
not resolve the public controversy. If controversial biotechnologies follow 
the pattern of energy and chemical technologies, ethical values will be in­
terwoven with statements and attitudes about the nature of risk, and with 
beliefs about evidence and behavior influence risk. Controversy and mis- 
communication arise to a considerable degree from the public's inability or 
unwillingness to understand and accept the technical definitions of risk 
used by the scientific community. This paper will first examine some of 
the breadth and vagueness in common applications of the word “risk'', then 
will discuss three types of ethical issue that emerge readily from the com­
mon grammar of risk, but not from accepted technical concepts.
Qualitative and Conceptual Elements of Risk
Scientific research techniques are well suited to the 
measurement of certain key relationships between 
exposure to a given substance and the subsequent oc­
currence of harm. These relationships are important 
in food safety because high correlations between ex­
posure and harm give cause for concern about the hu­
man health effects of exposure to the substance. 
Though important, the measurable relationships between exposure and 
harm are misleading policy indicators when they are taken to define risk to 
the exclusion of qualitative characteristics. One often hears the opinion 
that scientists study the reality of risk (Starr, et ai, 1976; Ruckleshaus, 
1983). People who are concerned with other factors relevant to risk are
“Risk" is a common 
English word. It can 
not be appropriated as 
a technical term 
without inviting mis- 
communication.
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dealing with mere perception; only the scientists deal with reality. This 
view of risk is logically insupportable (Thompson, 1990) but what is im­
portant here is that it conceals a normative judgment to emphasize the 
measurable correlations between exposure and harm behind the language 
of perception and reality. Risk and reality are both politically potent no­
tions. The judgement to emphasize measurable relationships is often justi­
fied; taking these relationships to model the reality of risk is not.
“Risk” is a common English word. It cannot be appropriated as a techni­
cal term without inviting miscommunication. Careful listening to the way 
that the word “risk" functions in ordinary speech reveals a varied pattern 
of use. One variation of particular importance concerns a tendency to use 
the word risk both as a classifier for acts and as a descriptor of future 
events. Risk is both a verb and a noun. As a verb, it denotes something that 
people do. The most common formulations imply intentionality, that is, 
that when people risk, they do so on purpose (through intentional acts of 
risk can have unintended consequences). When people run risks they have 
not consciously taken, the tendency is to shift the word “risk” to its nomi­
native form. Even as a noun, however, risk is ambiguous between its act- 
classifying and its event-describing meanings. As a classifier of actions, the 
noun “risk” names those actions that might have been described using the 
verb form, as in “She risked her life unknowingly by smoking cigarettes.” 
Note that although this act-classifying use of the word does not always 
imply that a person has knowingly chosen to risk, it does imply that the 
act in question is an intentional one. We would not, for example, describe 
an epileptic seizure as “risking one’s life," despite the clear indication that 
there is a significant probability of harm associated with seizures. The rea­
son is that enduring a seizure is not an intentional act. This grammatical 
pattern allows us to say that, in one sense, enduring a seizure is not a risk, 
because the seizure is not an intentional act. Calling the seizure a risk in 
this sense would be a category mistake. The grammar of risk allows “Why 
do you risk your life by having a cigarette?" but not “Why do you risk your 
life by having a seizure?”.
It is clear, however, that the word “risk” is also used to describe a trait of 
future events, e.g. that if they occurred they might be harmful. We talk 
about the risk of an earthquake or a flood, and sometimes even ordinary 
people say that floods and earthquakes are risks, (though in my experience 
this form of speech is far more common among risk analysts and scien­
tists). If the word risk is used to describe this trait of events, or if it is used 
to refer to events having this trait to a strong degree, different grammatical
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rules come into play. Since situations such as enduring a seizure are signifi­
cantly correlated with some probability of harm, they would be clear cases 
of risk. Indeed, there appear to be no situations that do not involve some 
degree of risk, at least when it is the event-describing sense of risk that we 
have in mind. As such, when grammatical rules for act-classifying are ap­
plied, an epileptic seizure is not a risk, but when rules for event-describing 
are applied, it is.
The philosophical grammar that distinguishes these two senses of risk 
is admittedly subtle (Thompson, 1987a). An epileptic seizure is a risk to 
one’s life, but to have a seizure is not to risk one’s life. Simply inverting the 
word order entails the semantic change. The differences between act-clas­
sifying and event-describing uses of risk are not sharp enough to warrant 
the claim that there are two, fully distinct meanings. Nevertheless, the dif­
ferent uses of the word “risk’’ suggest opportunities for technical or formal 
specifications of the term risk that stress event-describing grammar to the 
exclusion of act-classifying grammar (or vice versa).
The expected value analysis of risk, for example, defines risk as a func­
tion of the probability and value (utility) of future events (Friedman and 
Savage, 1948). Expected values are themselves computed as a function of 
value or utility associated with the event and the probability of the event’s 
occurrence. There are several ways of representing risk as an expected val­
ue. One simple and intuitive function is for all. This concept of risk can be 
linked to decision-making through the expected utility theory of choice. 
Although there are several decision rules that can be applied to convert ex­
pected utility calculations into action (Rescher, 1983), the simplest one as­
sumes that the objective of decision making is to select the option with op­
timal expected utility. The option with the highest net expected utility, 
once costs and benefits are weighed, is the one that should be chosen.
The expected value analysis of risk places a great deal of emphasis upon 
quantifiable probabilities, plus it is easily linked to a theory of choice.
These two factors make it very attractive as a conceptual approach for sci­
ence-based public policy (Kneese et al., 1983; Freeman and Portney, 1989). 
The expected value analysis of risk also provides a rigorous and sophisticat­
ed development of the event-describing applications of risk that we note 
in ordinary language. The rigor in the expected value analysis, however, is 
achieved at the expense of act-classifying shades of meaning that can be 
detected in the ordinary concept of risk. I suggested above that correlations 
between exposure and harm are extremely important in setting policy for 
food safety and quality, but that they do not exhaust the ethically signifi-
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cant aspects of risk policy. 1 shall, in the next three sections of this paper, 
offer some examples of ethically significant issues that are conceptually 
linked to the act-classifying grammar of risk.
Human Action, Risk, and Responsibility
As noted above, the expected value analysis of risk applies equally well to 
intentional actions and natural events. One can quantify the fatality risk 
of driving drunk, of undergoing a seizure, or of being caught in an earth­
quake. Simple comparison of the expected values makes these events ap­
pear morally commensurate, but they are not. We hold people responsible 
for their action when they drive drunk, but we do not hold people respon- 
208 sible for the consequences of enduring a seizure or an earthquake. The ex­
pected value analysis of risk provides no clue as to whether an agent would 
be held responsible for their actions, or correlatively, as to whether it 
would be responsible to act in a prescribed way.
We do not classify the seizure or the earthquake as acts, but drunk driv­
ing is an act. The act-classifying rules of grammar for risk are part of a tax­
onomy for sorting different kinds of action. Some actions are considered 
risks, others are not. The criteria for sorting seem to involve paradigm cas­
es or ideal type classifications, so that judgments as to whether an act is a 
risk can be drawn by analogy. In our society, driving while drunk is para­
digmatic case of risk; driving while sober is not. It also seems that tradi­
tional familiarity with the act in question is a criterion. Using the new fan- 
gled convection oven is a risk; boiling peas on the stove is not. Here, calling 
an action a risk is one way of noting that a person will be held responsible 
for the consequences. It is a way of urging caution, rather than a claim that 
significant probabilities of harm exist or have been measured.
An idealized depiction of traditional tort law provides the clearest ac­
count of how classifying actions under the category of risk plays a role in 
making decisions and in assessing responsibility. Innovations in the case 
law of torts during the past two decades have introduced the expected val­
ue analysis into liability decisions (Schroeder, 1986), so the following por­
trayal of torts should not be taken as a description of current practice. Tra­
ditional torts are based on common law. The purpose is to assess whether 
the claimant bringing suit was wrongfully harmed by the defendant, and 
whether the defendant should be required to pay damages. The claimant 
may meet his burden of proof by showing that the actions of the accused 
were risks, then that they actually resulted in harm to the claimant. Simple 
demonstration of harm is not enough to warrant damage in traditional
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torts, for the defendant's act is judged to be a risk only when it is some­
thing that a reasonable person would not do. If the act would have been re­
garded as unexceptional and proper by a reasonable person, the claimant 
cannot meet the initial burden of proof. The principle implies a general rec­
ognition that harm can occur as a result of happenstance, freak events or 
so-called acts of God, even when the actions of a defendant are completely 
ordinary acts of the sort that reasonable people perform everyday. Even 
when the claimant meets the dual burden of proof, the defendant has an 
opportunity to demonstrate exculpatory factors, and the list of potential 
exculpatory factors is extensive. They include, for example, whether the 
defendant acted knowingly and whether the claimant had complicity in 
undertaking the risky course of action.
The key concept in proving both the initial claim of risk and in provid­
ing excuses is that of the reasonable person. In the traditional process of es­
tablishing responsibility, there is a large class of actions that are not risks, 
simply because they are so broadly accepted, even though there are measur­
able (and perhaps even relatively high) numerical probabilities that they 
might result in harm. As is generally the practice in common law, criteria 
for deciding what is a risk and what is not are established by drawing anal­
ogies to precedents. These criteria are set forth in judicial opinions and be­
come more deeply embedded into law the longer they endure, and the more 
broadly they are applied (see Thomson, 1986 for a general discussion of risk 
in tort law). Laws regulating food safety are statutory and administrative, 
so the traditional practice of torts may be a poor model. The point is not to 
advocate reliance upon traditional case law, but to show how this idealiza­
tion of torts draws upon the act classifying grammar of risk in making a de­
termination of responsibility.
From a policy standpoint, the principal advantages of stressing the act 
classifying sense of risk arise from its power to link harm with actions for 
which persons could be held legally or morally responsible. The expected 
value analysis, by contrast, stresses the sense in which every instance of 
harm falls into statistical patterns. Since individual persons or corporate 
groups are clearly not responsible for the statistical pattern, this can make 
it seem as if they should not be held responsible for the harm that does ma­
terialize as a result of their actions.
Equivocation Problems and False Authority
Equivocation upon distinct meanings of the same term is one of the most 
egregious and indisputably fallacious forms of logical error. Although
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equivocation fallacies are conspicuous when exposed, their obviousness 
does not preclude their occurrence. Equivocation has ethical implications 
when it is the source of error in judgment, or in communication. Equivoca­
tion can also play a role in the creation of false authority, as when a judg­
ment justifiable on one interpretation of the term is imposed upon a situa­
tion in which the alternative interpretation would be more appropriate. 
More serious ethical issues arise when equivocation is used as a deliberate 
vehicle of deception.
Although simple errors of judgment and intentional deceptions occur in 
the discussion of food safety literature, false authority may be the most 
important ethical issue associated with equivocation on the act-classifying 
and the event-describing meanings of risk. Most people apply the concept 
of risk in ordinary decision making without being fully aware of the se­
mantic content or logical structure of either act-classifying or event-de- 
scribing usage. The context of speech is usually sufficient to specify the 
meaning intended in any given speaker's utterance. If the application of 
risk concepts implied in each usage were to be specified rigidly, as in the ex­
pected value analysis of risk, the result would be two incompatible con­
cepts of risk. The problem of false authority arises when the expected value 
analysis of risk is applied in such a way as to make otherwise reasonable 
judgments appear illogical, uninformed, and even irrational.
One instance of the false authority fallacy occurs 
when actions for which individual or corporate 
agents can be held responsible are compared to 
natural events in order to derive standards for ac­
ceptable risk (Starr, 1969). Many naturally occur­
ring substances are estimated to possess greater 
carcinogenicity than heavily banned additives and 
heavily regulated chemical residues (Ames 1983). 
What should we make of this fact? The expected 
value analysis of risk can be interpreted to imply 
that there are certain trade-offs between risk and 
benefit that are acceptable, without regard to the 
origin of the risks. The preceding discussion of responsibility shows that 
origins are sometimes important. Although it is clear that the dangers of 
natural carcinogens have been tolerated or endured by human populations, 
the expected value analysis of risk begs the question of why we should tol­
erate or endure similar levels of expected harm from human action 
(Thompson, 1987b).
Acceptability, in other 
words, implies an 
intentional attitude 
toward the act, not mere 
tolerance on passively 
enduring a state of 
affairs.. .It may indeed 
be a foolish waste of 
public resources to 
ensure against harms 
that are already far less 
likely to occur than 
harmful natural events.
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When responsibility is important, the permissibility of risk is deter­
mined by comparing the act to the standard range of things that human 
beings do, by considering the importance of the ends sought, and by exam­
ining the alternative ways of achieving the end. In this context, the judg­
ment that a risk is acceptable implies that there are overriding moral or 
prudential reasons for acting in an exceptional manner. Acceptability, in 
other words, implies an intentional attitude toward the act, not mere tol­
erance on passively enduring a state of affairs. There is a genuine philoso­
phical issue here. It may indeed be a foolish waste of public resources to en­
sure against harms that are already far less likely to occur than harmful 
natural events. The important philosophical issue is not illuminated, how­
ever, when the expected value analysis is falsely applied to cases where hu­
man agency and responsibility for risk are clearly important.
There may also be elements of equivocation in the so-called “zero risk” 
debate. When the concept of risk implies a classification of actions, the 
main point is to use case analogies and the vague notion of a reasonable 
person to classify an act as risky or non-risky. As noted above, some situa­
tions get classified as “no risk” for reasons that have nothing to do with 
probability, but everything to do with the grammatical rules for act classi­
fication. The rules for a “no risk” classification depend upon analogies to 
unexceptional, ordinary things that any reasonable person might do, as 
well as to whether the event in question is an intentional act. It is possible, 
for example, to adopt an act-classifying standard of zero tolerance for risk. 
The standard prohibits any intentional action that risks health and safety 
of others. This standard does not imply, however, that there is zero proba­
bility of harm for the category of risk may exclude both traditional practic­
es and natural events. Under an expected value interpretation, risk can be 
zero only when the probability of an event is zero; but it is impossible to 
reach absolute zero probability using standard statistical techniques. At 
face value, the Delaney Clause appears to be a zero tolerance statute, and 
the “generally regarded as safe” (GRAS) list would appear to reflect the rea­
sonable person’s judgment of what is and is not a risk. The regulatory in­
terpretation of the Delaney Clause has come to be understood as requiring 
zero probability of harm, however. If one applies an expected value criteri­
on to the act-classifying standard of zero tolerance, the standard becomes 
absurd (NRC, 1987). Any situation can be statistically correlated to harm­
ful events! How the Delaney Clause should be interpreted is a serious 
philosophical issue, but the serious issue is concealed by the law’s apparent 
absurdity, given an expected value analysis of risk.
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The problem of false authority relates to the role of science in the policy 
making process. There are always good scientific reasons for adopting the 
expected value analysis of risk, and there are sometimes good policy rea­
sons too. When the expected value analysis comes to exclude the multiple 
shades of meaning that are associated with risk in common speech, howev­
er, some of the most natural ways of raising serious issues about responsi­
bility for action appear absurd. People who are applying the grammar of 
risk in very standard and traditional ways appear to be making logically in­
supportable statements, and the ethical issues that would be raised by 
these standard and traditional ways of talking about risk appear chimerical 
and irrational. The danger is that the appearance of irrationality will be 
dealt with by handing policy over to experts; only in this case, the criterion 
for being an expert lies primarily in possessing an impoverished under­
standing of risk.
Optimizing Versus Informed Consent
So far, the main implications of noting the act-classifying sense of risk 
have been rhetorical. One should be careful not use the word risk in ways 
which preclude or diminish the validity of responsibility issues, and one 
should be careful not to imply false authority by equivocating on act classi­
fying and event describing senses of the word. The last set of implications 
are more substantial, and less easily resolvable. The expected value analysis 
of risk fits neatly with a general philosophical commitment to the view 
that policy should be evaluated according to whether it makes an optimal 
use of public resources in providing benefits to citizens. This broadly utili­
tarian view of public policy has long been challenged by opponents who 
stress consent of the governed. The opponents of utilitarianism hold that 
government action is legitimate when it is the result of procedures de­
signed to secure or reflect the consent of all who are affected. In many 
cases these two principles will coincide, but there are no logical entailment 
relations between them, and there are important issues on which they fail 
to coincide.
The contrast between optimizing and informed consent is particularly 
relevant for evaluating questions of risk (MacLean, 1986). Within the area 
of human health risks, we find a stark contrast between risk policies that 
seek efficient or optimal levels of public exposure to risk, and those that 
stress informed consent. Both strategies for assessing and accepting risk 
are enormously complex in their details. Optimizing, as I use the term 
here, includes any strategy that applies a threshold or benefit-risk decision
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rule to a measured risk, though the application of alternative decision rules 
can result in very different risk decisions. Regulatory policies administered 
by the Environmental Protection Agency (EPA) are a clear example of the 
optimizing strategy. Consent policies can delegate decisions that might 
have been made by public agencies to the private sector, and this strategy 
can make it appear that there is no risk policy in place, at all. For example, 
our policy of allowing choices on accepting the risks of specific disease 
therapies to be made on the basis of individual doctor-patient relation­
ships is an application of informed consent. The principle of informed con­
sent places the greatest burden of proof upon parties who are active. In 
standard health care relationships, the active parties are the physician and 
the patient. If government were to become active in this policy arena, it, 
too, would have to meet a test of informed consent.
The main point here is to see how the philosophical conflict between 
optimizing and informed consent occurs in controversies over food and 
health policy. The continuing controversy over whether and what public 
health recommendations should be made regarding dietary cholesterol has 
an element of this conflict. Public health scientists want strong dietary 
recommendations, for they think that dietary changes will save lives. 
Others have opposed general dietary recommendations on the ground 
that, since some (perhaps many) individuals do not need to follow the rec­
ommendations, they are deprived of their right to informed choice when 
given misleading information by public health authorities (Levine, 1986; 
Kunkel and Thompson, 1988).
The politics of the FDA’s attempt to ban substances such as DES or sac­
charin have also became entangled in the optimizing/informed consent 
dispute, with neither the optimizers (Rodricks, 1986; Schultz, 1986) nor 
the advocates of consent (Turner, 1986; Whelan and Havender, 1986), hap­
py with the result. Citing the DES case extensively, Deborah Johnson 
(1986) has marshalled some of the principal arguments against consent, at 
least for food safety and quality. She notes that principles of informed con­
sent presume that food consumers are competent judges of food safety 
and quality, that they have and can interpret all of the relevant informa­
tion, and that they are not coerced into making one food choice rather 
than another. Johnson contends that all of these conditions are, to some 
degree, unfulfilled. As such, she argues, we are forced to develop decision 
rules for acceptable risk, though she cautions against a too simplistic ap­
plication of benefit-risk analysis.
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Taking the side of consent, Henry Shue (1986) rejects optimizing policy 
criteria and risk/benefit analysis in particular. Shue thinks that risk policy 
should be understood as part of governments general responsibility to pro­
tect individuals from harm by others. Optimizing strategies tend to con­
ceal the link between risk and harm. He writes that optimizing policies are 
“.. ,non-starter[s] because ... the numbers of people count, while in mat­
ters of rights, the numbers do not ordinarily count. On the contrary, one of 
the central purposes of rights is to protect the vulnerable, even if they are a 
small minority.” (p. 195) It is only when people have clearly chosen to ac­
cept risks that they can be understood to be acceptable.
Informed consent is only loosely related to the act classifying sense of 
risk, for it is clearly possible to raise questions about consent when risk is 
understood purely as the probability of harm. There is a tendency, howev­
er, for optimizers to gravitate toward the expected value analysis as a way 
to compare risk with other forms of cost and benefit. Similarly, there may 
be a greater tendency for questions of informed 
consent to arise when risk is more transparently 
taken to be a form of action. One way to discharge 
one’s responsibility in taking risks is to ensure that 
all parties who are affected have agreed to hold the 
agent blameless.
Risk is not a real entity 
or relation that yields its 
secrets to objective 
scientific analysis.
Conclusions
My main objective in this paper has been to facilitate food safety debates 
by pointing out some key sources of miscommunication. Risk is not a real 
entity or relation that yields its secrets to objective scientific analysis. 
There are philosophical choices to make about whether to regard risk as 
primarily a taxonomic concept, for which probability considerations are 
secondary, or to regard risk as a purely statistical concept. Committing 
oneself wholly to either option has moral and policy implications that are 
of tremendous significance.
I would not suggest that insupportable food safety judgments, the public 
concerns about BST, for example, are any sense justified by the ethical val­
ues implied in emphasizing action. They are still silly concerns. Under­
standing risk as a type of action, rather than as a probability of harm, does 
indicate a thread of rationality, however. The raising of non-food related 
concerns about BST may have made the introduction of this technology 
seem less standard and unexceptional than it might have been. Having 
been categorized as a risk to the economic well being of dairy farmers, it is
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It Is scientists who 
will have to demon­
strate Insight and 
sensitivity to the non 
quantitative factors 
that inform policy 
decisions on risk.
subjected to much more rigorous conceptual tests 
than it might otherwise have been. One of these tests 
is avoidability, whether there is a reasonable alterna­
tive. In the case of milk production, there surely is.
There are still some logical fallacies in the chain of 
reasoning that I have just described, but they are cer­
tainly less egregious than simply leaping from the 
claim that BST may harm the interests of some small farmers to the claim 
that milk produced with the technology is hazardous to drink. We will, I 
think, get farther with people who commit such fallacies if we can under­
stand how a reasonable person could arrive at such conclusions than we 
will by accusing them of emotionalism, fear and irrationality. It is not, 
however, philosophers who will be called upon to communicate with the 
public about such risk questions. It is scientists who will have to expose 
the fallacies with gentleness and tact. It is scientists who will have to dem­
onstrate insight and sensitivity to the non-quantitative factors that in­
form policy decisions on risk. Rigid adherence to an expected utility analy­
sis of risk will make the scientist's task far more difficult, at least, and may 
preclude their completing it altogether.
Finally, scientific evidence will not always be the appropriate basis for 
risk decisions. Sometimes it may be possible and better simply to let people 
choose the risks they want to take, without even collecting the scientific 
evidence correlating exposure and harm. Sometimes it may even be better 
to allow responsibility for risk exposure to be determined in the courts. We 
currently make huge financial investments in risk assessment, and the sci­
entific assessment of the probability for harmful consequences from bio­
technology could cost many times more. Once we have invested heavily in 
the expected value analysis (both in money and time) it will be hard to ig­
nore the scientific evidence, even if it is inconclusive and irrelevant. There 
are, in other words, philosophical choices that must be made on the first 
day of inquiry. Investment in the acquisition of facts has policy implica­
tions. In this sense, public policy does not recognize the fact/value distinc­
tion. The research and development choices that are made today must be 
made against a broad, cosmopolitan understanding of the values relevant 
to food safety and quality. It is, perhaps, the public’s confidence in scientif­
ic decision makers to faithfully represent the full tapestry of values that 
will ultimately matter the most. Any tendency to disavow or ignore ques­
tions of responsibility for risk will undercut that confidence, and justifi­
ably so.
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